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ABSTRACT 
Over the past couple of decades, technological advancements in sequencing and imaging 
have unequivocally proven that the world of viruses is far bigger and more consequential 
than previously imagined. There are 1031 viruses estimated to inhabit our planet, 
outnumbering even bacteria. Despite their astronomical numbers and staggering sequence 
diversity, environmental viruses are poorly characterized. In this thesis we will demonstrate 
our three-pronged exploration of viruses through the lenses of energetics (Chapters 2 and 3), 
genomics (Chapter 4) and ecology (Chapter 5). We will first focus on one of the defining 
features of viruses, namely their reliance on their host for energy, and demonstrate the 
energetic cost of building a virus and mounting an infection.  In our second study, we 
present one of the largest surveys of complete viral genomes, providing a comprehensive 
and quantitative snapshot of viral genomic trends for thousands of viruses. In our third 
study, we shift our focus towards ecological questions surrounding the large number of 
commensal phages inhabiting the human body. We discovered that phage community 
composition could serve as a fingerprint, or a “phageprint” – highly personal and stable over 
time. To our knowledge, this study is one of the largest studies of human phages and the 
first to demonstrate the feasibility of human identification based on phage sequences.  
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C h a p t e r  I   
Introduction 
 
 
Over the past couple of decades, technological advancements in sequencing and 
imaging have unequivocally proven that the world of viruses is far bigger and more 
consequential than previously imagined (1-7). There are 1031 viruses estimated to inhabit our 
planet, outnumbering even bacteria (8, 9). Viruses have been shown to impact 
biogeochemical cycles (10-13) and evolution of host organisms (4, 14-16).  
Despite their astronomical numbers and staggering sequence diversity (17, 18), we 
have large gaps in our understanding of environmental viruses. This is in part due to the field 
being at its infancy. It is also due to the conceptual and technical challenges that are unique 
to the study of viruses. For example, in contrast to ribosomal RNA sequences that are 
conserved across cellular genomes and serve as the basis for taxonomic and evolutionary 
studies, there are no universally conserved sequences within viral genomes. As a result, we 
have not yet been able to develop a genomic classification for viruses. Moreover, our 
understanding of the deep-time evolutionary history of viruses remains limited. 
However, these alienating differences between viruses and cells can also serve to 
significantly broaden our understanding of biology and overturn what we may have accepted 
as dogma. Viruses, by virtue of encoding their genomes in double- and single-stranded 
versions of both RNA and DNA, provide us a window into an alternative biology. What I 
am alluding to is already a big part of biology’s recent history. For example, the central 
dogma was turned on its head by Baltimore (19) Temin and Mizutani (20) through their 
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discovery of viral reverse transcription. The future of biology will also likely be impacted by 
the study of viruses that are caught breaking biology’s perceived rules.  
Viruses have also offered us the platform and the tools for some of biology’s most 
infamous experiments. Hershey and Chase used a phage infection experiment to contest the 
popular assumption that proteins, rather than DNA, were responsible for inheritance (21). 
Luria and Delbruck also used a phage experiment to challenge Lamarckian evolution (22). 
Furthermore, Viruses have significantly contributed to our molecular biology toolbox (23). 
In lieu of recent technological advances, the study of viruses will inevitably result in even 
greater number of tools and insights.  
In this thesis we will demonstrate our three-pronged exploration of viruses through 
the lenses of energetics (Chapters 2 and 3), genomics (Chapter 4), and ecology (Chapter 5). 
We will first focus on one of the defining features of viruses, namely their reliance on their 
host for energy, and demonstrate the energetic cost of building a virus and mounting an 
infection. Although many experimental studies make it clear that viruses are parasitic entities 
that hijack the molecular resources of the host, a detailed estimate for the energetic cost of 
viral synthesis was largely lacking. To quantify the energetic cost of viruses to their hosts, we 
first had to develop a framework for describing cellular energetic costs and their evolutionary 
consequences (Chapter 2).  
With the energetic cost of molecular building blocks in hand, we then enumerated the 
costs associated with two very distinct but representative DNA and RNA viruses, namely, T4 
and influenza (Chapter 3). We found that for these viruses, translation of viral proteins is the 
most energetically expensive process. Interestingly, we found the cost of building a T4 phage 
and a single influenza virus were nearly the same. Due to influenza’s higher burst size, 
however, the overall cost of a T4 phage infection is only a small fraction of the cost of an 
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influenza infection. The costs of these infections relative to their host’s estimated energy 
budget during the infection reveal that a T4 infection consumes about a third of its host’s 
energy budget, whereas an influenza infection consumes only about 1%.  
Building on our estimates for T4, we show how the energetic costs of double-stranded 
DNA phages scale with the capsid size, revealing that the dominant cost of building a virus 
can switch from translation to genome replication above a critical size. Lastly, using our 
predictions for the energetic cost of viruses, we provide estimates for the strengths of selection 
and genetic drift acting on newly incorporated genetic elements in viral genomes, under 
conditions of energy limitation.  This novel, physical approach to the study of viruses provides 
a promising path towards a deeper understanding of factors governing viral burst sizes, life-
cycle strategies, and evolutionary trajectories.   
In our second study we turned to another hallmark feature of viruses, namely their 
genomic diversity. We developed one of the largest surveys of complete viral genomes, 
providing a comprehensive and quantitative snapshot of viral genomic trends for thousands 
of viruses (Chapter 4). We explored the diversity and biases of the NCBI viral database and 
provided distributions of viral genome length, gene length, gene density, noncoding DNA 
(or RNA) percentage, and abundances of functional gene categories across thousands of 
viral genomes. We also created a coarse-grained method for visualizing viral genome 
organization. Because existing viral classification systems were developed prior to the 
sequencing era, we present our analysis in light of different classification systems in order to 
assess the utility of each classification in capturing genomic trends.  
In our third study, we shifted our focus towards ecological questions surrounding 
viruses. Just as they are abundant in the oceans (24), viruses are abundant in the human 
body. For example, up to 108 viruses can be found in just a milliliter of human saliva (5). For 
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this reason, we chose to specifically target human oral phages to explore their communities 
as a function of space and time.  Considering the lack of universal phage markers, we aimed 
to discover environment-specific markers so that we could study previously unexplored 
phage families. As we will demonstrate, this marker-based approach reveals phage 
community composition with a resolution that cannot be achieved through typical 
metagenomic studies. We will further demonstrate that at this resolution, phage community 
composition can serve as a fingerprint, or a “phageprint” – highly unique to each individual 
and stable over at least 30 days.  
By creating sample collection kits and instructional videos, we crowd-sourced sample 
collection, thereby gathering ~700 samples from individuals living in different parts of the 
world, including samples from genetically related individuals and couples. To our knowledge, 
our study is one of the largest studies of human oral phages and the first to demonstrate the 
feasibility of human identification based on phage sequences. It highlights yet again the 
astounding viral sequence diversity that underlies the highly complex and personal phage 
communities.  
Whether it is through energetics, genomics, ecology, or any other lens, viruses offer 
us a unique view of biology, and one that perhaps deserves greater attention. We often look 
up at the night sky to be amazed and inspired by the possibility of life elsewhere. We have 
the desire to explore these uncharted territories in part because we want to know whether 
we, as life forms with a DNA-written history, are unique or simply one of the many 
possibilities. Yet, here on our own planet and even in our own bodies, there are just as 
equally amazing and unexplored worlds with strange and unfamiliar inhabitants. In this 
thesis, we hope to shed some light on these fascinating biological entities that have overrun 
our planet.   
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C h a p t e r  I I  !
A Quantitative Framework for Estimating Cellular 
Energetic Costs and their Evolutionary Consequences 
 
 
2.1 Introduction 
The possible interplay between the energetic cost of a cellular structure and its 
evolutionary fate is a subject that will become increasingly important as evolutionary cell 
biology matures as a science. All of biology starts at the level of the cell, which houses a myriad 
biochemical processes, information storage mechanisms, and physical substructures. To fully 
understand the mechanisms of evolution, it is ideal to start at the cellular level, where we can 
tease apart the ways in which complex molecular structures emerge from the assembly or 
transformation of building blocks such as amino acids, nucleotides, and lipid molecules. 
Thanks to the advances in biochemistry, much of the information to accomplish this task is 
either in hand or within reach. As a result, we argue it is time to outline a logical framework for 
quantifying the relationships between the energetic costs of cellular structures and their 
susceptibility to establishment and modification by the processes of evolution. Here, the 
phrase “cellular structure” will be used as an umbrella term broadly referring to any cellular 
entity built from building blocks, be that entity a few base pairs of DNA, an entire 
chromosome or an organelle.  
At the heart of this subject are two important concepts: 1) all cellular structures have 
strict energetic costs of construction and maintenance; and 2) the energetic costs and benefits 
of these cellular structures can translate into fitness differences that influence long-term 
evolutionary trajectories. Here, we attempt to provide a quantitative framework for addressing 
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these issues. We first aim to provide a clear depiction of the definitions and subtleties in 
performing energetic censuses of the cell. We then attempt to examine the evolutionary 
consequences of cellular structures based on their energetic cost. Finally, we highlight some of 
the remaining conceptual uncertainties in this area. 
 
2.2 The energetic cost of a cellular structure 
We start with the total cost of a simple cellular structure, e.g., a protein molecule or 
complex, an information-bearing molecule at the DNA or RNA level, or a membrane. The 
basic principle here is that all cellular structures, regardless of their fitness costs or benefits, 
entail some baseline energetic costs of construction and maintenance. In accounting for 
cellular energetic costs, we could report the costs using several different units, but the 
underlying premise is that the hydrolysis of ATP and ATP-equivalent molecules serves as the 
universal currency of bioenergetics across the different domains of life (1, 2). We could, for 
example, report energetic costs in units of Joules. Under physiological conditions, ATP 
hydrolysis and conversion into adenosine diphosphate (ADP) and orthophosphate (Pi) results 
in about -50 kJ/mol free energy change (1). However, the actual change in free energy depends 
on the exact concentrations of reactants and products. It is usually much more convenient to 
enumerate energetic costs in units of numbers of ATP hydrolyses (or their equivalent), which 
is also in keeping with previous efforts (3-8). To remain consistent, we will use the symbol P 
with different subscripts as a shorthand notation to represent an ATP (or an ATP-equivalent) 
hydrolysis event in the context of different energetic cost definitions (8-10). As will be 
discussed below, even with this seemingly straightforward approach, there still remain critical 
subtleties. 
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Cellular structures are assembled from molecular building blocks such as amino acids, 
nucleotides, lipids, and carbohydrates. If not provided by the outside environment, these 
building blocks must be synthesized within the cell by processes requiring carbon skeletons 
and the expenditure of energy. In fact, in the context of the metabolism of many bacteria, all 
building blocks as well as coenzymes and prosthetic groups can be synthesized from a small 
number of precursor metabolites (11). If some building blocks are available externally, the 
biosynthetic costs will be diminished, but there will still be costs of transformation to arrive at 
the full set of internal building blocks (the cost of converting one amino acid to another, for 
example). Here, we will assume that all molecular building blocks are derived from one carbon 
source, namely glucose, and further assume that sources of inorganic nitrogen and other trace 
elements are provided in excess within the growth media. These assumptions are especially 
applicable to growth conditions in the laboratory.  
Moreover, the assembly cost of a cellular structure is obtained by adding up the 
requirements for construction of that structure from its molecular building blocks, e.g., the 
necessities for polymerizing a protein from its constituent amino acids, adding post-
translational modifications, and folding the subsequent chain into the appropriate globular 
form. Finally, there will often be maintenance costs, e.g., accommodation of molecular 
turnover, and identification and elimination of cumulative errors.  
The sum of costs noted above represents the baseline investment that must be made in 
a cellular structure regardless of its benefit to the host cell (Figure 1). Given the near 
universality of many biosynthetic pathways and enzyme-reaction mechanisms, the assembly 
and maintenance costs can generally be calculated from information in the literature. The 
ability to make such calculations is a highly desirable complementary approach to laborious 
experimental approaches (12, 13), such as modifications of gene-expression levels, as these can 
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have additional side effects (e.g., promiscuous binding or aggregation) that are difficult to 
quantify and irrelevant to construction/maintenance costs. What has been summarized in the 
paragraphs above, however, are the direct costs of a cellular structure, which do not fully 
describe the energetic consequences for the cell. We use PD to symbolize the unit of direct 
cost. 
 
Figure 1.  The distinction between direct and opportunity costs associated with 
synthesizing molecular building blocks. As glucose is partially metabolized into 
precursor metabolites, the energy that could have been captured from the 
complete metabolism of glucose is referred to as the opportunity cost of 
precursor metabolites (light green arrow). As precursor metabolites get 
converted to molecular building blocks, the conversion consumes electron 
carrier molecules such as NADH. If not used during the synthesis of 
molecular building blocks, these electron carriers would result in the generation 
of ATP, and thus the conversion of precursor metabolites to building blocks 
incurs additional opportunity cost (dark green arrow). The conversion also 
consumes ATP, which we count as the direct cost of synthesis. The assembly 
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of macromolecules such as proteins from building blocks requires additional 
post-synthesis costs such as the cost of polymerization and maintenance. The 
polymerization costs per nucleotide or amino acid are denoted. Direct costs 
are shown by solid orange arrows, whereas the opportunity costs are denoted 
in shades of green and dotted lines. The same color scheme is used in Figure 2.  
 
The construction and maintenance of a cellular structure represents a drain on 
resources that could otherwise be allocated to other cellular functions. When metabolic 
precursors that can be fully metabolized for ATP production are instead allocated as carbon 
skeletons to the production/maintenance of a particular cellular structure, this diversion 
eliminates their availability for other purposes, a consequence that we refer to as the 
opportunity cost. We use PO to symbolize the unit of opportunity cost. 
Opportunity costs can also be calculated from basic cell-biological knowledge though a 
rigorous definition such as the one provided in the Supplementary Information does not seem 
to have been previously provided (4, 9, 14). Specifically, we estimate the opportunity cost of a 
precursor metabolite as the number of ATPs (or ATP equivalents) that could have been 
generated had the precursor metabolite not been diverted towards the synthesis of molecular 
building blocks (Figure 2A, SI). Figure 2B demonstrates the placement of metabolic precursors 
that are implicated in the synthesis of molecular building blocks across metabolic pathways. In 
arriving at cost estimates for molecular building blocks, we assumed glucose as the primary 
carbon source, so these cost estimates may need to be modified when considering another 
carbon source as input. The estimated opportunity costs for each precursor metabolite in the 
context of bacterial and eukaryotic metabolism are shown in Figure 2C. The difference in 
these costs between eukaryotic and bacterial metabolism stems from the higher efficiency of 
eukaryotic metabolism in producing ≈6 more ATPs per glucose than bacterial metabolism, 
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which generates about 26 ATPs per glucose (15, 16) (see SI). We hope that future studies will 
also reveal these costs in the context of the archaeal metabolism. 
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Figure 2. The energetic cost of molecular building blocks. A) The concept of 
opportunity cost is shown schematically for the situation in which glucose is 
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the sole carbon source. B) The metabolic pathways from which the 
opportunity cost of each precursor metabolite can be estimated. From 
dihydroxyacetone phosphate (dhap) onwards, there are two molecules of each 
precursor metabolite generated. Precursor metabolites that are not implicated 
in the synthesis of building blocks are shown as grey circles. Positive and 
negative signs indicate gains and losses in ATPs or electron carrier molecules 
from the conversion of one precursor metabolite to another. The names for 
each precursor metabolite denoted are as follows: ribose-5-phosphate (r5p), 
erythrose-4-phosphate (e4p, or eryP), alpha-ketoglutarate (αkg), 
dihydroxyacetone phosphate (dhap), 3-phosphoglycerate (3pg), oxaloacetate 
(oaa), phosphoenolpyruvate (pep), pyruvate (pyr), acetyl-CoA (acCoA). C) The 
opportunity cost of each precursor metabolite estimated in the context of both 
heterotrophic bacteria and eukaryotic cells as detailed in the SI. D) The 
opportunity cost of a molecular building block is equivalent to the number of 
precursor metabolites and electron carrier molecules used during its synthesis 
times their respective opportunity costs. The direct cost of synthesizing a 
molecular building block is the number of ATP (or ATP-equivalent) hydrolysis 
events required during the synthesis of each building block (orange). All costs 
shown are estimated in the context of a heterotrophic bacterial metabolism. 
The average direct cost provided for building blocks does not include post-
synthesis costs such as polymerization or maintenance. See SI Dataset 1 for 
further details.  
 
Another source of opportunity cost is the pool of electron carrier molecules used in 
the synthesis of molecular building blocks. If electron carriers such as NAD(P)H were to be 
preserved rather than used in the synthesis of molecular building blocks, they would result in 2 
and 2.5 ATP molecules within the bacterial and eukaryotic electron transport chain, 
respectively (16). To distinguish between these two sources of opportunity cost, we have 
denoted them in two shades of green in both Figures 1 and 2. However, unless denoted 
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otherwise, we will refer to the opportunity cost of a molecular building block as the sum of all 
opportunity costs.  
Moreover, the total cost of producing a trait and diverting structures from alternative 
usage to do so is then the sum of the direct and opportunity costs,  
!! = ! !! + !!!, [1] 
where all costs represent the cumulative expenditures over the entire lifespan of the cell. 
Whereas !! is expected to reflect ATP (and ATP-equivalent) hydrolysis reactions resulting in 
heat dissipation in the cell, !! will not be manifested in heat production, given that the ATP is 
not actually produced or consumed. We have used the symbol PT to denote the number of 
ATP formation/hydrolysis reactions associated with the total cost definition (Figure 2).   
 
2.3 Which is more biologically relevant, the direct or the total cost?   
Depending on the experimental context or question at hand, one of the two 
definitions can be more appropriate than the other. Under the direct cost definition, we 
simply account for the number of ATP hydrolysis events, and ignore the effects of diverting 
molecular building blocks from energy-producing pathways. This cost definition is useful 
when we are comparing direct cost estimates to calorimetric studies or attempting to 
estimate heat production and power generation of a cellular process. It is also of interest in 
scenarios where there is a constrained rate of ATP production, e.g. because of a limited 
amount of membrane real-estate for the respiration machinery (17) or a limitation on the 
amount of glycolytic enzymes. Most of the pioneering studies in bioenergetics have reported 
the costs of molecular building blocks in terms of their direct costs (11). More recent works 
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on cellular energetics, however, have implicitly adhered to the total cost definition, thereby 
including the opportunity costs of molecular building blocks (4, 9, 10, 14, 18).  
The total cost definition is useful when the overall carbon source availability is limiting. 
It also offers the advantage of comparison with results from chemostat experiments as a way 
of determining the cost of a particular biological structure relative to the collective costs of a 
cell at a given growth rate. During a chemostat experiment, the number of glucose molecules 
required per unit time to grow cells at a set growth rate is measured. This number can then be 
converted to an energetic value by assuming that every glucose molecule consumed by the cell 
is fully metabolized. However, not all glucose molecules are used for energy production. In 
fact, as we will briefly discuss in the following section, depending on the growth rate, the 
majority of glucose molecules consumed may be converted to biomass. As a result, the cost of 
a cell as measured through chemostat experiments includes both the direct and the 
opportunity costs of cellular processes, and is inherently a total cost estimate. Thus, when 
considering the energetic burden of a given process on a cell’s energy budget as measured by 
chemostat experiments, the total cost definition provides a more meaningful approach. 
 
2.4 What fraction of a cell’s total cost is direct cost?  
One approach to estimating the total cost of a bacterium is to consider its mass in 
carbon. With a doubling time of 30 minutes, an E. coli cell growing on glucose as its sole 
carbon source will be ≈50% carbon in dry weight which amounts to 0.1 pg (5 x 109 carbon 
molecules) for a cell with an approximate volume of 1 µm3 (19). Considering that every 
glucose molecule contributes 6 carbons, we can deduce that this bacterium’s energy and 
carbon demand is met by ≈109 glucose molecules. Because every glucose molecule can 
generate about 26 ATPs during aerobic respiration in E. coli, we can convert the number of 
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glucose molecules to a total energetic cost of ≈3 x 1010 PT. This estimate for the total cost of 
E. coli is similar to those obtained from growth experiments in chemostats (10).  
 To obtain the direct cost estimate of a bacterial cell, we can make use of the fact that 
translation incurs the greatest cost for cells (5, 9, 10, 14). An E. coli cell with a volume of 1 µm3 
(the size can range between ≈0.5 and 2 µm3 depending on growth rate) contains on the order 
of three million proteins (20). With an average protein length of 300 amino acids (21), an E. coli 
cell of this size will be comprised of 109 amino acids. The direct costs of polymerization (4 PD) 
and synthesis from precursor metabolites (2 PD) (Figure 2) are 6 ATPs per amino acid, and 
thus the direct cost of translation is about ≈6 x 109  PD. We can compare this cost to the direct 
cost of genome replication, ≈ 108  PD, for an E. coli genome that is comprised of 5 x 106  base 
pairs. This is because the direct cost of polymerization (2 PD) and synthesis of nucleotides 
from precursor metabolites (11 PD) amounts to 13 PD per nucleotide. As such, the direct cost 
of translation far outweighs the direct cost of genome replication. The cost of transcription in 
both cellular and viral contexts has also been shown to be lower than the cost of translation (8, 
10). Thus, we will take the direct cost of translation as a proxy for the sum of all direct costs. 
With that assumption, the ratio of direct cost of an E. coli cell (≈6 x 109  PD) to its total cost 
(≈3 x 1010 PT) is 0.2. This estimate suggests that the majority of glucose molecules consumed 
by an E. coli cell during rapid growth are not fully metabolized and instead are used to 
synthesize biomass. 
 
2.5 Energy as one of several possible limiting factors to growth 
Cellular fitness need not always be strongly limited by energy. For example, 
photosynthetic plankton populations often experience an overabundance of energy relative 
to some nutrient such as nitrogen or phosphorus. For microbes growing in laboratory 
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conditions on a defined medium with a single compound providing carbon and energy, the 
growth yield per carbon consumed increases linearly with the substrate heat of combustion 
(which is inversely related to the degree of oxidation) up until a threshold value, thereafter 
leveling off (Figure 3). This suggests that below a critical substrate value of ≈10 kcal/g 
carbon, growth in such conditions is limited by energy, whereas above this threshold the 
food supply contains excess energy relative to carbon content required for growth. Notably, 
the most common substrate used in growth experiments with microbes, glucose, has a heat 
of combustion of 9.3 kcal/g carbon, close to the threshold at which growth is equally limited 
by carbon and energy. Very few commonly used substrates have heats of combustion much 
beyond the apparent threshold (values being 11.0, 13.6, and 14.8 kcal/g carbon for glycerol, 
ethanol, and methanol, respectively).  
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Figure 3. Growth yields per unit carbon consumed as a function of the heats 
of combustion of the carbon substrate (which also serves as the source of 
energy). Results are taken from various sources in the literature; all results for 
eukaryotes involve fungi (mostly yeasts).  
 
Although analyses involving alternative limiting factors will not be pursued here, 
where deemed necessary, they could be implemented in a parallel fashion by altering the 
budgetary currency (e.g., to carbon, nitrogen or some other limiting nutrient). Consider, for 
example, an organism living in an environment plentiful in a carbon/energy source but 
limited by a micronutrient such as iron. In this case, depending on the internal regulatory 
structures of the cell, energy extracted from the food source may be in excess supply, 
resulting in under-utilization of ingested carbon and energy.  In such a case one can choose 
to adopt a framework as described here but define costs in terms of the iron atoms needed. 
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The energetic costs can still be evaluated as given here but their effect on growth will be 
diminished due to the greater impact of iron shortage on growth rate.  
Regardless of the substrates being consumed, all aspects of cellular maintenance and 
growth require energy. Although the yields of microbes (per unit carbon consumed) grown 
on alternative substrates vary substantially with the nature of the substrate, the direct costs 
necessary to build an offspring cell are relatively constant. This is consistent with the positive 
scaling in Figure 3 (except in the above mentioned case of highly reduced substrates such as 
some alcohols and methane), and provides at least partial justification for using ATP as a 
universal currency as opposed to carbon or some other micronutrient.  
 
2.6 The evolutionary implications of the energetic cost of a cellular structure  
Given a value for the total energetic cost of a cellular structure (or modification 
thereof), what are the overall evolutionary implications? To answer that question we need to 
consider two central issues: 1) what is the scaling of the cost of a cellular structure relative to 
the total cost of building and maintaining the cell? and 2) how do we convert the appropriately 
scaled measure of this energetic cost to a corresponding change in fitness. Supposing the cell 
has a baseline total energy budget per cell cycle of !! (which includes the costs of both growth 
and maintenance, with a capital ! denoting a whole-cell cost), the addition of an energetic 
burden to the trait under consideration alters the lifetime energy budget to !!! = !!! !+ !!! . 
Under the assumption that energy availability influences fitness, if the cell-division time is ! in 
the absence of the trait, then we qualitatively expect this additional energetic investment in the 
trait to alter the cell-division time to !!! > !!.  
To understand the total energetic investment in a cellular structure from a fitness 
perspective, we need to define its effects on the cell's reproductive rate relative to that for a cell 
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without such an additional energetic investment. From standard haploid selection theory, the 
selective disadvantage of building a cellular structure in an energy-limited environment is 
defined as 
! = ! !!!!!! !ln 2, [[2!] 
where ! = ln 2 /! denotes an exponential rate of growth. Assuming that!Δ! = !!′− !! ≪!! which we suspect will be valid for most single-gene modifications, we can simplify the 
selective disadvantage to 
! ≃ ! ! !! ln 2. [[2!] 
If we assume that energy is the only limiting factor and further assume that !! ≪ !! so that 
the increment in cell-division time scales proportionally with the increased investment, we can 
write 
!! ≃ !! 1+ ! !!!! . [3] 
This then leads to the simple result that  
s ≃ ! !!!! ln 2,  [4] 
showing that the intrinsic selective disadvantage associated with the energetic cost of a trait 
under energy limited conditions scales directly with the proportional increase in the total 
energy demand per cell cycle.  
It is important to note that there are some caveats with respect to the preceding derivation. 
First, it is assumed that the addition of the trait does not somehow alter the cell's basic 
metabolic makeup in ways that would modify the total baseline energy budget !! . Even if this 
does occur, the result given in Equation 4 will be only slightly modified if the fractional 
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alteration to !! is small, which seems likely for cellular modifications involving just one or two 
genes. Second, we have focused entirely on the bioenergetic costs of producing a trait. There 
may be additional costly side effects, if for example a novel protein promiscuously interacts 
with inappropriate substrates, aggregates with other cellular structures, and/or excessively 
occupies cellular volume or membrane real estate.  
 
2.7 Supplementary Information 
2.7.A Opportunity cost of precursor metabolites in heterotrophic bacteria 
In this section we will use the units of P, without any subscripts, to refer to ATP (and 
ATP-equivalent) hydrolysis events (using the subscripts without having first derived the 
opportunity cost of a metabolite is meaningless). Once we have derived the opportunity cost 
of a precursor metabolite here in this section, we will accompany it with the symbol PO  in later 
figures and tables to clearly mark these costs as opportunity costs. We will estimate the 
opportunity cost of precursor metabolites,!!!""!#!"#$!%, by  !!""!#$%&'$( = !!!"# − !!!"#$%"& , [1] 
where !!"#!represents the net energetic gain from the complete metabolism of a glucose 
molecule into water and carbon dioxide, and !!"#$%"& is the net energetic gain from the partial 
metabolism of a glucose molecule into a precursor metabolite. Under aerobic respiration, !!"# 
is ≈ 26 P in E. coli (15). In the event that there is a net energetic cost from the conversion of 
glucose into a precursor metabolite, !!"#$%"& will be a negative value.  
In the synthesis of lipids, dihydroxyacetone-phosphate (dhap) is used as a precursor. 
This precursor is generated during glycolysis (Figure 2). Each glucose molecule results in the 
production of two dihydroxyacetone-phosphate molecules, with this process having a net 
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energetic cost of 2 P (!!"#$%"& = −2). The opportunity cost of two dihydroxyacetone-
phosphate molecules is 2 P greater than that of glucose, or 28 P (SI Eq. 1). The opportunity 
cost of one dihydroxyacetone-phosphate molecule is therefore ≈ 14 P (Figure 2).  
To simplify the opportunity cost estimates further, we could employ a shortcut. Rather 
than estimating the opportunity cost of each precursor metabolite by calculating the !!"#$%"& 
from glucose as the starting point, we could obtain the opportunity cost of metabolite j, !!""!#$%&'$(! , from the opportunity cost of metabolite i, !!""!#$%&'$(! , by  
!!""!#$%&'$(! = !!!""!#$%&'$(! − !!!"#$%"&!→! , [2] 
where !!"#$%"&!→!  represents the net energetic gain from the conversion of metabolite i to 
metabolite j.  
For example, during glycolysis each molecule of dihydroxyacetone-phosphate is 
converted to a molecule of 3-phosphoglycerate (3pg), resulting in the production of 1 NADH 
molecule and 1 ATP. In E. coli, each NADH molecule results in the production of ≈ 2 ATP 
molecules under aerobic conditions (11); therefore the net energetic gain from this conversion 
is ≈ 3 P. Hence, the opportunity cost of each 3-phosphoglycerate molecule would be ≈ 11 P, 
which is 3 P less than the opportunity cost of a dihydroxyacetone-phosphate molecule (SI Eq. 
2).  
If not used as a precursor, 3-phosphoglycerate is converted to phosphoenolpyruvate 
(pep) in glycolysis (Figure 2). In this process, however, there is zero energy expenditure or 
gain. As such, the opportunity cost of a phosphoenolpyruvate molecule is the same as that of a 
3-phosphoglycerate molecule’s, which is ≈ 11 P. Both of these precursors come before 
pyruvate (pyr) in glycolysis. In converting a phosphoenolpyruvate molecule into a pyruvate 
molecule, there is a net energy gain of 1 P. The opportunity cost of a pyruvate molecule is 
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therefore ≈ 10 P (1 P less than a phosphoenolpyruvate opportunity cost) (Figure 2). Pyruvate 
can be converted to oxaloacetate (oaa) with the expenditure of 1 ATP. The opportunity cost of 
oxaloacetate is ≈ 11 P (10 P + 1 P) (Figure 2). 
Pyruvate is further converted to acetyl-CoA (acCoA), and in the process one molecule 
of NADH is generated, which is equivalent to 2 P (Figure 2). The opportunity cost of acetyl-
CoA is therefore ≈ 8 P (10 P - 2 P) (Figure 2).  One molecule of acetyl-CoA and one molecule 
of oxaloacetate are then eventually converted to alpha-ketoglutarate (αkg) (Figure 2). The sum 
of the opportunity costs of acetyl-CoA (8 P) and oxaloacetate (11 P) is 19 P, and because 1 
molecule of NADH is generated in their conversion to alpha-ketoglutarate, the opportunity 
cost of alpha-ketoglutarate is ≈ 17 P (or, 19 P – 2 P) (Figure 2).  Similarly, alpha-ketoglutarate 
is eventually converted to oxaloacetate, and 2 NADH, 1 GTP, and 1 FADH2 molecules are 
generated (Figure 2). This is a net gain of ≈ 6  (assuming 1 P from each FADH2), reducing the 
opportunity cost of oxaloacetate to ≈ 11 P (17 P – 6 P). Note, this is consistent with the 
opportunity cost of oxaloacetate derived from the anaplerotic pathway described earlier (the 
conversion of pyruvate to oxaloacetate via the pyruvate decarboxylase enzyme).  
Glucose can also be converted to ribose-5-phosphate (r5p) in the pentose phosphate 
pathway, and in the process 2 NADPH molecules are generated, which is equivalent to 4 P 
(Figure 2). We subtract 4 P from the possible 26 P that glucose would be converted to under 
respiratory conditions, and we arrive at 22 P as the opportunity cost of ribose-5-phosphate (SI 
Eq. 1) (Figure 2). The same calculation can be used for erythrose-4-phosphate (e4p), resulting 
in 22 P as its opportunity cost (Figure 2). 
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2.7.B Opportunity cost of precursor metabolites in heterotrophic eukaryotes 
To estimate the opportunity costs of precursor metabolites in heterotrophic 
eukaryotes, we can carry out very similar calculations to those performed for heterotrophic 
bacteria. For eukaryotes, !!!", or the total energetic gain from the complete metabolism of a 
glucose molecule into carbon dioxide and water is higher. This is because each NAD(P)H and 
FADH2 molecule results in a higher number of ATPs within the mitochondrial electron 
transport chain compared to the bacterial electron transport chain. Specifically, each 
NAD(P)H molecule is equivalent to ≈ 2.5 P and each FADH2 molecule corresponds to ≈ 1.5 
P ((16),(22) pages 517-518), resulting in 30-32 P per glucose molecule. Note, the theoretical 
yield of 38 P per glucose molecule has been shown to be an overestimate due to the outdated 
assumptions that each NAD(P)H molecule is equivalent to 3 P and that each FADH2 molecule 
generates 2 P (16). We will therefore use 32 P as !!"#.   
Each glucose molecule results in the production of two dihydroxyacetone-phosphate 
molecules, with this process having a net energetic cost of 2 P. The opportunity cost of two 
dihydroxyacetone-phosphate molecules is 2 P greater than that of glucose, or 34 P (SI Eq. 1). 
The opportunity cost of one dihydroxyacetone-phosphate molecule is therefore 17 P (Figure 
2). As described earlier, in the conversion of dihydroxyacetone-phosphate molecule into a 3-
phosphoglycerate molecule, 1 NADH and 1 ATP molecules are produced. This is equivalent 
to a net energetic gain of ≈ 3.5 P. The opportunity cost of a 3-phosphoglycerate molecule is 
therefore ≈ 13.5 P (17 P – 3.5 P) (SI Eq. 2) (Figure 2).  
The opportunity cost of a phosphoenolpyruvate is the same as that of a 3-
phosphoglycerate, which is ≈ 13.5 P. In converting phosphoenolpyruvate into pyruvate, there 
is a net energy gain of 1 P (1 ATP molecule is formed). The opportunity cost of pyruvate is 
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therefore ≈ 12.5 P. Pyruvate can be converted to oxaloacetate with the expenditure of 1 ATP. 
Hence, the opportunity cost of oxaloacetate will be ≈ 13.5 P. 
Pyruvate is converted to acetyl-CoA, and in the process one molecule of NADH is 
generated. As a result, the opportunity cost of acetyl-CoA is ≈ 10 P (12.5 P – 2.5 P). One 
molecule of acetyl-CoA and one molecule of oxaloacetate are converted to alpha-ketoglutarate 
in the TCA cycle. The sum of the opportunity costs of acetyl-CoA (10 P) and oxaloacetate 
(13.5 P) is 23.5 P, and because 1 molecule of NADH is generated in their conversion to alpha-
ketoglutarate, the opportunity cost of alpha-ketoglutarate is ≈ 21 P (23.5 P – 2.5 P). Alpha-
ketoglutarate is eventually converted to oxaloacetate, and 2 NADH, 1 GTP, and 1 FADH2 
molecules are generated. This is a net gain of ≈ 7.5 P (assuming 1.5 P from each FADH2), 
reducing the opportunity cost of oxaloacetate to ≈ 13.5 P (21 P – 7.5 P). Note, this is again 
consistent with the opportunity cost of oxaloacetate derived from the anaplerotic pathway.  
Glucose can also be converted to ribose-5-phosphate in the pentose phosphate 
pathway, and in the process 2 NADPH molecules are generated, which is equivalent to 5 P. 
The opportunity cost of ribose-5-phosphate is thus ≈ 27 P. The same calculation can be used 
for erythrose-4-phosphate, resulting in ≈ 27 P as its opportunity cost. 
 
SI Dataset 1. A detailed breakdown of the energetic cost of molecular building 
blocks depicted in Figure 2. Provided in a GitHub repository: 
https://github.com/gitamahm/thesis 
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C h a p t e r  I I I  !
Energetic Cost of Building a Virus  
!
 
3.1 Introduction 
Viruses are biological ‘entities’ at the boundary of life. Without cells to infect, viruses as we 
know them would cease to function, as they rely on their hosts to replicate. Though the 
extent of this reliance varies for different viruses, all viruses consume from the host’s energy 
budget in creating the next generation of viruses. There are many examples of viruses that 
actively subvert the host transcriptional and translational processes in favor of their own 
replication (1). This viral takeover of the host metabolism manifests itself in a variety of 
forms such as in the degradation of the host’s genome or the inhibition of the host’s mRNA 
translation (1). There are many other experimental studies (discussed in the SI) (2-6) that 
demonstrate viruses to be capable of rewiring the host metabolism. These examples also 
suggest that a viral infection requires a considerable amount of the host’s energetic supply. 
In support of this view are experiments on T4 (7), T7 (8), Pseudoalteromonas phage (9), and 
Paramecium bursaria chlorella virus-1 or PBCV-1 (10), demonstrating that the viral burst 
size correlates positively with the host growth rate. In the case of PBCV-1, the burst size is 
reduced by 50% when its photosynthetic host, a freshwater algae, is grown in the dark (10). 
Similarly, slow growing E. coli with a doubling time of 21 hours affords a T4 burst size of 
just one phage (11), as opposed to a burst size of 100-200 phages during optimal growth 
conditions.  
These fascinating observations led us to ask the following questions: what is the 
energetic cost of a viral infection, and what is the energetic burden of a viral infection on the 
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host cell? To our knowledge, the first attempt to address these problems is provided through 
a kinetic model of the growth of Qß phage (12). A more recent study performed numerical 
simulations of the impact of a phage T7 infection on its E. coli host, yielding important 
insights into the time course of the metabolic demands of a viral infection (13). 
To further explore the energetic requirements of viral synthesis, we made careful 
estimates of the energetic costs for two viruses with very different characteristics, namely the 
T4 phage and the influenza A virus. T4 phage is a double-stranded DNA (dsDNA) virus 
with a 169 kb genome that infects E. coli. The influenza virus is a negative-sense, single-
stranded RNA virus (-ssRNA) with a segmented genome that is 10.6 kb in total length. The 
influenza virus is a eukaryotic virus infecting various animals, with an average burst size of 
6000, though note that the burst size depends upon growth conditions (14). Similar to many 
other dsDNA viruses, T4 phage infections yield a relatively modest burst size, with the 
majority of T4 phages resulting in a burst size of approximately 200 during optimal host 
growth conditions (15). To determine the energetic demand of viruses on their hosts, the 
cost estimate for building a single virus has to be multiplied by the viral burst size and placed 
in the context of the host’s energy budget during the viral infection.  
Concretely, the costs associated with building a virus can be broken down into the 
following processes that are common to the life-cycles of many viruses: 1) viral entry 2) 
intracellular transport, 3) genome replication, 4) transcription, 5) translation, 6) assembly and 
genome packaging, and 7) exit. Our strategy was to examine each of these processes for both 
viruses in parallel, comparing and contrasting the energetic burdens of each of the steps in 
the viral life-cycle.   
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3.2 Energetic cost units and definitions 
Given that the energetic processes of the cell take place in many different energy 
currencies ranging from ATP and GTP hydrolysis to the energy stored in membrane 
potentials, it is important to have a consistent scheme for reporting those energies. 
Adenosine triphosphate (ATP) serves as the most common energy currency of the cell, a 
function that is universally conserved across all known cellular life-forms (16, 17). Under 
physiological conditions, the hydrolysis of ATP usually releases about -50 kJ/mol (16, 18). In 
addition to ATP, which most commonly serves as the energy currency of the cell, there are 
other nucleoside triphosphates such as GTP that are approximately energetically equivalent 
to ATP. We will refer to these molecules as ATP-equivalent. 
We follow others in their reporting of cellular costs by using the number of ATP 
(and ATP-equivalent) hydrolysis events as a proxy for energetic cost. Similar to Lynch and 
Marinov (19), we will use the symbol P as a shorthand notation to represent an ATP (or an 
ATP-equivalent) hydrolysis event. We will additionally employ subscripts to clearly label the 
results obtained under different energetic cost definitions, which have already been  
introduced in Chapter II (e.g. opportunity cost denoted by PO, direct cost denoted by PD,  
and total cost denoted by PT). Lastly, in reporting some of our final cost estimates we will 
convert the number of ATP (or ATP-equivalent) hydrolysis events to units of Joules and kBT 
by assuming 50kJ of negative free energy change per mole of P at physiological conditions.  
As a reminder of topics discussed in Chapter 2, the distinction between total and 
direct cost definitions is that under the total cost definition, in addition to accounting for 
direct costs, we attribute an energetic cost to the building blocks that are usurped from the 
host during viral synthesis. Both energetic cost definitions have physical significance. For 
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example, the direct cost definition is the more appropriate choice when estimating heat 
production and power consumption of a viral infection (SI sections B, K). The total cost 
definition, on the other hand, is aligned with traditional energetic cost estimates made from 
growth experiments in chemostats, where substrate consumption and cell yield is monitored, 
and allows for a clear comparison between the cost of an infection and the cost of a cell. 
This is because the cost of a cell, derived through chemostat experiments, implicitly includes 
the opportunity cost component, which is the cost of diverting precursor metabolites from 
energy-producing pathways towards the synthesis of molecular building blocks. And while 
our approach would certainly benefit from detailed experimental studies that reveal the 
fluxes in the host metabolome during an infection, the assignment of an energetic value to 
each metabolite allows us to simplify the problem from reporting changes in the 
concentration of hundreds of metabolites to reporting a single energetic value associated 
with the viral infection. This value can then be compared to the cellular energy budget.  
We will generally estimate the cost of a certain viral process for a single virus, and 
then multiply this cost by the viral burst size to determine the infection cost of a given 
process. Subscript v will denote the cost estimates made for a single virus, and the subscript i 
will refer to a cost estimate made for an infection. We relegate the energetic cost estimates 
for all viral processes to the SI sections C through I. 
 
3.3 The energetic costs of T4 and Influenza  
By estimating the energetic costs of influenza and T4 life-cycles, we show that 
surprisingly the cost of synthesizing an influenza virus and a T4 phage are nearly the same 
(Table 1). The outcome of the analysis to be discussed in the remainder of the chapter is 
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viruses, the energetic cost of translation outweighs other costs (Table 1, Figures 1, 2, 3), 
though as we will show at the end of the chapter, since translation scales with the surface 
area of the viral capsid and replication scales as the volume of the virus, for double-stranded 
DNA phages larger than a critical size, the replication cost outpaces the translation cost. 
To get a sense for the numbers, here we provide order-of-magnitude estimates of 
both the costs of translation and replication and refer the interested reader to the SI sections 
C through I for full details. As detailed in the SI Tables 1 and 2, both T4 and influenza are 
comprised of about 106 amino acids. We can estimate the total cost of translation by 
appealing to a few simple facts. First, the average opportunity cost per amino acid is about 
30 PO. Second, the average direct cost to produce amino acids from precursor metabolites is 
2 PD per amino acid (SI Figure 1). Finally, each polypeptide bond incurs a direct cost of 4 PD. 
We can see that the total cost of an amino acid is approximately 36 PT (30 PO + 6 PD). As a 
result, the translational cost of an influenza virus and a T4 phage both fall between 107 to 108 
PT (Table 1).  
 
Table 1. The direct, opportunity and total energetic costs of viral processes 
for T4 and influenza. The T4 infection costs are estimated based on an 
average burst size of 200, and the influenza infection costs are based on an 
average burst size of 6000. Direct costs shown represent the number of 
phosphate bonds directly hydrolyzed during the viral lifecycle (PD), whereas 
the total costs (PT) include both direct costs (PD) as well as opportunity costs 
(PO) incurred during the viral life-cycle (See SI sections C through I). Empty 
entries correspond to viral processes that did not result in an energetic cost 
or were not applicable to the given virus. Note, to obtain the total cost 
estimates, the sum of opportunity and direct costs used exact numbers and 
was then rounded (this is why the sum of the rounded versions of direct and 
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opportunity costs do not exactly match up to the total costs presented in this 
table). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The cost of viral replication can be approximated in a similar fashion: we have to 
consider that the T4 genome is comprised of roughly 4x105 DNA bases and that the 
influenza genome is composed of an order of magnitude fewer RNA bases (≈104). The total 
costs of a DNA nucleotide and an RNA nucleotide, including the opportunity costs as well 
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as the direct costs of synthesis and polymerization, are approximately 50 PT (SI Figure 1, SI 
Dataset 3). As a result of T4’s longer genome length, its total cost of replication (≈107 PT) is 
about an order of magnitude higher than that of an influenza genome (Table 1, Figure 1, 
Figure 2, SI section E).  
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Figure 1. The energetics of a T4 phage infection. The direct and total costs of 
viral processes are denoted and can be distinguished by their units (PD and 
PT, respectively). The energetic requirements of transcription (step 3), 
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translation (step 4), genome replication (step 5), and genome packaging (step 
7) are shown. See SI sections C through I and Table 1.  
 
The cost estimates of different viral processes during T4 and influenza infections are 
summarized in Figures 1-3 and Table 1. The overall cost of a T4 infection is obtained by the 
sum of replication (!!"#/! ), transcription (!!"/!! ), translation (!!"/!! ), and genome 
packaging (!!"#$/!) costs required during the infection (SI sections C-I, Table 1, Figure 1, 
Figure 3). These costs together amount to ≈3 x 109 PD in direct cost and 1 x 1010 PT in total 
cost (SI sections C-I, Table 1, Figure 1, Figure 3, assuming a burst size of 6000). The total 
cost of a T4 infection is also equivalent to the aerobic respiration of ≈4 x 108 glucose 
molecules by E. coli (26 ATP per glucose (20)). Alternatively, it is equivalent to ≈2 x 1011 kBT 
(assuming 1 ATP ≈!20 kBT (21)).  
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Figure 2. The energetics of an influenza infection. The direct and total costs 
of viral processes are denoted and can be distinguished by their units (PD and 
PT, respectively). The energetic requirements of viral entry (steps 2,3), 
intracellular transport (steps 4,5,9), transcription (step 6), translation (step 7), 
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genome replication (step 8) and viral exit (step 10) are shown. See SI sections 
C through I and Table 1.  
 
Similarly, the cost of an influenza infection is obtained by adding up the costs of 
entry (!!"#$%), intracellular transport (!!"#$%&'/!), replication (!!"#/!), transcription (!!"/!), 
translation (!!"/!), and exit (!!"#$/!) required during the infection (SI sections C-I, Table 1, 
Figure 2, Figure 3). These processes have a cumulative cost of ≈8 x 1010 PD and 6 x 1011 PT , 
for the assumed burst size of 200. The sum of costs in an influenza infection (6 x 1011 PT) is 
equivalent to the aerobic respiration of ≈2 x 1010 glucose molecules by a eukaryotic cell (32 
ATP per glucose). It is also equivalent to ≈1013 kBT. It is interesting to note that for both 
viral infections the opportunity cost components are the dominant component of the total 
costs (Table 1).  
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Figure 3. A breakdown of the direct cost (top) and the total cost (bottom) of 
various viral processes during T4 (left) and influenza (right) viral infections 
(normalized to the sum of all costs during an infection, as shown in the 
center of each pie chart). The direct cost of a T4 phage infection is 
approximately 3 x 109 PD (top) while the total cost is 10
10 PT (bottom). The 
direct and total costs of an influenza infection are approximately ~8 x 1010 PD 
and 6 x 1011 PT, respectively. Numbers are rounded to the nearest percent, 
and viral processes costing below 0.5% of the infection’s cost are not shown. 
See SI sections C through I for energetic cost estimates for viral entry, 
intracellular transport, transcription, viral assembly, and viral exit. 
 
Even though individually a T4 phage and an influenza virus have comparable 
energetic costs, because of their different burst sizes, the direct cost of a T4 phage infection 
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is only ≈3% of the direct cost of an influenza infection. Similarly, the total cost of a T4 
phage infection is ≈2% of the total cost of an influenza infection. To contextualize these 
numbers, the host energy budget (or the host energetic cost, depending on the viewpoint of 
a virus versus a cell) during the infection has to be taken into account. The total cost of a cell 
is experimentally tractable through growth experiments in chemostats, in which cultures are 
maintained at a constant growth rate. The number of glucose molecules taken up per cell per 
unit time can be determined. The number of glucose molecules can then be converted to an 
energetic supply by assuming typical conversion ratios of 26 or 32 ATPs per glucose 
molecule depending on the organism (20). This energetic cost estimate will be a total cost 
estimate because not all glucose molecules taken up by the cell are fully metabolized to 
carbon dioxide and water to generate ATPs and are used as building blocks for biomass 
components instead. During the cellular life-cycle, the cell has to double its number of 
building blocks prior to division, and to do so, a fraction of glucose molecules taken up is 
diverted away from energy production towards biosynthesis pathways. As such, cellular 
energetic cost estimates that are derived from chemostat experiments are total cost estimates 
because they report on the combined opportunity and direct costs of a cell.  
Based on chemostat growth experiments (19), the total energy used by a bacterium 
and a mammalian cell with volumes of 1 !"! and 2000 !"!, respectively, are ≈3 x 1010 PT 
and ≈5 x 1013 PT, during the course of their viral infections (SI section J). A simpler estimate 
for arriving at the total cost of E. coli with a 30-minute doubling time is by considering the 
dry weight of E. coli (≈0.6 pg at this growth rate) (22). Given that about half of the cell’s dry 
weight is composed of carbon (22), an E. coli is composed of ≈2 x 1010 carbons, supplied 
from ≈3 x 109 glucose molecules, since each glucose contributes 6 carbons. With the 26 
ATP per glucose conversion for E. coli, this is equivalent to a total cost of ≈7 x 1010 PT, 
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which is similar to the number obtained from chemostat growth experiments (19)(SI section 
J).  
Moreover, we estimate the fractional cost of a viral infection as the ratio of total cost 
of an infection, !!/! , to the total cost of the host during the infection, !!/!. For the T4 
infection with a burst size of 200 virions, !!/! ≈1 x 1010 PT (Table 1) and !!/! ≈3 x 1010 PT, 
therefore the fractional cost of the T4 infection is ≈0.3. Interestingly, a calorimetric study of 
a marine microbial community demonstrated that 25% of the heat released by microbes is 
due to phage activity. (23) If we assume that the majority of the direct cost of a cell is 
associated with translation (19, 21), these calorimetric studies square well with our estimate 
for the ratio of direct costs. In contrast, the influenza infection despite its larger burst size 
(6000 virions) leading to a higher !!/! (≈6 x 1011 PT) has a fractional cost of just 0.01 as the 
host cell is much bigger. Finally, we estimate that the heat release due to the T4 and 
influenza viral infections are approximately 0.2 nJ and 2 nJ, respectively (SI section K). While 
influenza infection results in an order of magnitude more heat, the average power of T4 and 
influenza infections are surprisingly very similar, on the order of 200 fW (SI section K). 
 
3.4 Scaling of viral energetics with size for phages 
While we have concluded that for the influenza virus and the T4 phage the 
translational cost outweighs the replication cost, the ratio of these two costs varies according 
to the dimensions of a virus. In the case of T4 and influenza, these two viruses have 
comparable dimensions and consequently were built from a similar number of amino acids 
(SI Tables 1 and 2). However, because for double-stranded DNA phages, the capsid is 
mostly composed of proteins whereas the virion interior is mostly dedicated to the genetic 
material (24), it follows that with the diminishing surface area to volume ratio of a spherical 
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object as it grows in size, the ratio of translational cost to replication cost also diminishes 
with increasing radius of a spherical capsid. This simple rule governs not just the nucleotide 
or amino acid composition of a virus, but more fundamentally, it governs the elemental 
composition of viruses with spherical-like geometries (24).  
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Figure 4. Generalizing viral energetics. A plot of the genome replication cost 
(!!"#) to translational cost (!!") ratio as a function of the virus inner radius, 
r. The plot uses the geometric parameters of double-stranded DNA viruses 
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with icosahedral geometries (SI Dataset 1, SI section L). The predicted 
numbers of amino acids and nucleotides are derived in SI Dataset 1. Cost 
ratios are shown for both direct and total cost estimates. All viruses shown 
infect bacteria except Sputnik, which is a satellite virus of the giant 
Mimivirus. We have zoomed in on viruses Sputnik (r = 22 nm), P22 (r = 27.5 
nm), T7 (r = 27.5 nm), HK97 (r = 30 nm), and Epsilon15 (r = 31.2 nm). The 
capsid structures for these representative viruses were obtained from the 
VIPERdb (25) and image sizes were scaled based on radii shown in SI 
Dataset 1 to accurately represent the relative sizes of each capsid. The critical 
radii for the total cost (!!"#$!!"#) and the direct cost (!!"#$!!"#) estimates are 
shown. We have also included the mean (!!"#$= 25 nm) and standard 
deviation (gray vertical box, ±6.5 nm) of viral capsid inner radii from 2,600 
viruses collected by the Tara Oceans Expeditions (26). Note, here we have 
subtracted the mean capsid thickness (3 nm) from the mean capsid radius 
reported by Brum et al. to arrive at the mean inner capsid radius. 
 
The full derivation of replication and translational cost estimates as a function of 
viral capsid inner radius,!!, can be found in the SI section L. From these expressions, it is 
clear that the translational cost of a virus scales with !!, whereas the replication cost scales 
with !! (Figure 4). The critical radius at which replication will outweigh translation in cost is 
≈60 nm for total cost estimates, !!"#$!!"#  (Figure 4, SI section L). For the direct cost 
estimates, the critical radius, !!"#$!!"# , is ≈40 nm. Interestingly, a survey of structural 
diversity encompassing 2,600 viruses inhabiting the world’s oceans reveals that the average 
outer capsid radius is 28 nm (26) (25 nm inner radius), which is much smaller than the 
critical radii at which replication becomes the dominant cost (Figure 4). As such, for the 
majority of viruses, we predict translation is the dominant cost of a viral infection.  
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Furthermore, we provide genome replication to translation cost ratios for about 30 
different double-stranded viruses, primarily phages (SI Dataset 1, Figure 4). While we have 
omitted calculations for the virus tails, they can be simply treated as hollow cylinders and will 
further decrease the expected replication to translation cost ratio for the tailed viruses. 
Although we have calculated these ratios for double-stranded DNA phages, similar 
principles can be applied to modeling the energetics of other viral groups.  
 
3.5 Forces of evolution operating on viral genomes.  
Inspired by efforts to consider the evolutionary implications of the cost of a gene to 
cells of different sizes (19, 27), we were curious whether similar considerations might be in 
play in the context of viruses. For example, we asked which evolutionary forces are 
prominently operating on neutral genetic elements that are incorporated into viral genomes, 
either by horizontal gene transfer, gene duplication or other similar types of events. We 
further asked whether the viral size is a parameter of interest in the tug of war between 
different forces of evolution. We will address these topics by assuming that the viral 
infection, consistent with our findings for T4, consumes a substantial portion of the host 
energy budget. We further assume that the energetic cost of a genetic element translates to a 
proportional fitness cost. We believe this assumption to be relevant when the host growth 
condition is energy or carbon substrate limited.     
For a genetic element to remain in the population, regardless of whether it is 
beneficial or not, it must face the consequences of genetic drift which scales with the viral 
effective population size, !! , as !!!!. We follow the treatment of Lynch and Marinov who 
argue that the net selective advantage of a genetic element is !! = ! !! − !!! , where !! and !! 
denote the selective advantage and disadvantage, respectively (Figure 5B). For a genetic 
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element within a viral genome that is non-transcribed and non-translated (Figure 5C), only 
the energetic cost of its replication poses a selective disadvantage. Assuming the genetic 
element provides no benefit to the virus (!! = 0), the net selective advantage can be stated 
as !! = !−!! , the absolute value of which must be much greater than !!!! for selection to 
operate effectively. Following Lynch and Marinov and others (27, 28), we make the 
simplifying assumption that a neutral genetic element’s selection coefficient, !! , is 
proportional to its fractional energetic cost, !!  (Figure 5C). This means that the viral 
infection is energy (or carbon source) limited. Because we assumed that the energetic cost of 
a viral infection is comparable to the total energy budget of a cell, any increase to the cost of 
a virus would necessitate a smaller burst size. Using the viral burst size as a proxy for the 
viral growth rate, we are then able to relate the additional fractional energetic cost of a 
neutral genetic element to a fitness cost.  
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Figure 5. Evolutionary forces acting on genetic elements within viral 
genomes. A) Schematic of a virus as a spherical object, with an inner radius, 
r, an outer radius, R, and a capsid thickness, t. The capsid is composed of 
viral proteins, while the inner volume holds the viral genome. B) Positive and 
negative selective forces (!! and !!) at a tug of war with the force of genetic 
drift, which scales as !!!!, where !! is the viral effective population size. C) 
A schematic of a genetic element within a viral genome. It is assumed to be 
non-functional (!!  = 0) and non-transcribed, resulting in |!!| = !!  = !! , 
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where !! corresponds to the net selection coefficient and !! corresponds to 
the fractional cost of a genetic element. D) The evolutionary forces acting on 
a genetic element within Virus A and Virus B genomes. The fractional cost 
of a genetic element in Virus B, !!_!"#$%& , is 8 times higher than the 
fractional cost of the same element in Virus A, !!_!"#$%&. Note, Virus A has 
twice the radius of Virus B, and therefore its genome is 8 times longer than 
that of Virus B (schematically represented by the number of genetic 
segments). Both viruses are assumed to have radii greater than critical 
radii,!!!"#$!!"# and !!"#$!!"# . E) Log10 !! estimates for non-transcribed and 
neutral genetic elements of different lengths (1 – 10,000 base pairs) within 
the context of 30 dsDNA viruses ranging from ~20 nm to 400 nm in radius 
(SI Dataset 2; viruses with R > 50 nm are hypothetical dsDNA viruses). 
Log10 !!  estimates derived from both direct and total cost estimates are 
included (there is minimal difference between these estimates, which is not 
visible in this figure, see SI Dataset 2). Assuming !! = 105, the region above 
the horizontal dashed line represents a selection-dominated regime, and the 
region below it represents a drift-dominated regime. For comparison, we 
have included the mean (vertical dashed line, 28 nm) and standard deviation 
(gray vertical box, ±6.5 nm) of viral capsid outer radii obtained from 2600 
viruses collected during the Tara Oceans Expeditions (26). 
 
In the case of a non-transcribed genetic element, !! = ! !!"#/!!! , where !!"#/! 
corresponds to its replication cost and !! is the sum of all costs of a virus (Figure 5C). 
Given that replication cost scales as !! the effects of selection relative to genetic drift could 
be different for viruses of different sizes. Consider two viruses with the same burst size, with 
Virus A, having a radius that is two times larger than that of Virus B (Figure 5D). Because 
both viruses are assumed to have radii larger than the critical radius, we imagine the scenario 
in which the cost of genome replication is the dominant cost of synthesizing these viruses. 
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The fractional cost of a genetic element in the smaller virus, !!_!"#$%!  is then equal to 8!!_!"#$%!!, where !!_!"#$%!! is the fractional cost of the genetic element in the larger virus. 
This is because the length of the genome is proportional to !!, and consequently, !! is 
inversely proportional to !! (Figure 5D).  
Figure 5E and SI Dataset 2 provide !! estimates for genetic elements of different 
lengths (1 – 10,000 base pairs) within 30 dsDNA viruses. To illustrate the effect of scaling in 
the example provided above, we made the simplifying assumption that the viruses are large 
enough that their !! are approximately equal to their replication costs. However, for !! 
values in Figure 5E and SI Dataset 2, we provide more precise estimates, treating !! as the 
sum of both the replication cost and the translational cost of a virus. The cost of replicating 
a double-stranded genetic element can be obtained from SI Eq. 3. For a 1 kb element, which 
is about the average length of a bacterial gene, the direct and total costs of its replication per 
virus, !!"#/! ,!are 3 x 104 PD and 9 x 104 PT, respectively. Both direct and total cost estimates 
indicate that the strength of selection acting on a 1 kb, non-transcribed element ranges from 
2 x 10-2 - 7 x 10-6 (SI Dataset 2, Figure 5E) when considering viruses with radii ranging from 
≈20 nm to 400 nm. The difference between direct and total estimates of selection strength is 
minimal within this range of capsid radii and continues to diminish as the capsids grow in 
size.   
To examine whether selection or genetic drift will decide the fate of a genetic 
element we need to assess each virus’s effective population size. This is difficult because the 
effective population size of most viruses is unknown and subject to great variability due to 
several environmental factors (29). The current effective population size estimates regarding 
HIV, influenza, dengue, and measles fall within 101 to 105 (29-31). Based on the wide range 
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of variation in these effective population sizes, it is difficult to make conclusive statements. 
It is, however, apparent that the strength of selection on neutral genetic elements is a non-
linear function of the viral capsid radius and becomes much weaker as viruses get larger 
(Figure 5E). In fact, for giant viruses (with outer radius, R > 200 nm), assuming an !!!! = 
10-5, genetic drift could overpower selection, allowing for the persistence of neutral elements 
of lengths 100 bp or shorter in the population. For the majority of viruses (R = 28 ± 6.5 
nm) (26), however, selection is likely to be the dominant force and drift may only play a role 
for genetic elements that are just a few base pairs long (Figure 5E, SI Dataset 2).  
 
3.6 Discussion  
There have been several experiments that imply that a viral infection requires a 
significant portion of the host energy budget (3, 5, 10, 11, 32-34). Following these 
experimental hints, we enumerated the energetic requirements of two very different viruses 
on the basis of their life-cycles, and thereby estimated the energetic burdens of these viral 
infections on the host cells. According to our total cost estimates, a T4 infection with a burst 
size of 200 will consume a significant portion (about 30%) of the host energy supply. This 
result, demonstrating a significant fraction of the host energy used by an infection, supports 
the experimental findings that the T4 burst size is correlated positively with the host growth 
rate (7, 11). It also lends further credence to the hypothesis that auxiliary metabolic genes 
within phage genomes are not just evolutionary accidents; rather, they have come to serve a 
functional role in boosting the host’s metabolic capacity, which translates into larger viral 
burst sizes (3, 4, 34, 35). These calculations make it all the more interesting to develop high-
precision, single-cell calorimetric techniques to monitor energy usage during viral infections.
 Perhaps the most promising support for T4’s cost estimate is the observation that 
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the maximum T4 burst size is 1,000 virions (15). Using the total cost to make new viruses, at 
a burst size of 1,000, the viral infection would consume 170% of the host normal energy 
supply at a 30 min growth rate, consistent with the observed apparent upper limits on burst 
size. 
It is however important to note that in all of our estimates, we make the assumption 
that the sources of nitrogen, sulfur, phosphorus, and other trace elements are in excess, 
which is typical of culture conditions in the laboratory and from which most burst 
measurements are obtained (SI Section B), but this assumption may not be valid in certain 
natural environments as demonstrated by the phosphorus-limited environments of marine 
ecosystems (36). In such limited environments, phages are shown to carry auxiliary genes 
and to actively rewire the host metabolism (full discussion can be found in the SI Section A). 
It would be interesting to have additional experimental studies that go beyond the ideal 
conditions of a laboratory experiment to fully explore the range of possible limiting factors 
in a viral infection.  
While there are several fascinating studies that explore the link between the host 
metabolism and phage infections (3, 6, 12, 13), similar studies focusing on viruses of 
multicellular eukaryotes are largely lacking. To that end, we chose to estimate the energetic 
cost of a representative virus for this category, namely, the influenza virus. The influenza 
virus and T4 phage are functionally and evolutionarily very different viruses. Yet, they have a 
very similar per-virus cost, regardless of whether the total or the direct cost estimates are 
being considered. This is primarily due to the fact that they have a similar translational cost, 
which dominates all other costs. Their comparable cost of translation is due to the fact that 
these viruses have similar dimensions and are both composed of about a million amino acids. 
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Perhaps even more surprising is that both viral infections have very similar average power 
consumptions, on the order of 200 fW (SI Section K).  
    Even with its higher burst size, an influenza infection has a total cost that is just 1% 
of the total energetic budget of a eukaryotic cell over the characteristic time of the viral 
infection. This is because a typical eukaryotic cell is estimated to have much higher energy 
supply than a typical bacterium under the same growth conditions. So far in our estimates, 
we do not account for the possible inefficiencies at various stages of the viral infection, 
which may drain more of the host energy than we estimated. Specifically, burst sizes are 
typically reported from plaque assays, which count the number of infectious virions that 
create plaques. However, we don’t have a good estimate for the number of non-infectious 
viruses that arise from faulty genome replication, transcription, or viral assembly, for 
example. This point is especially important when considering RNA-based viruses such as 
influenza or HIV, which have higher mutation rates (10-4-10-6 mutations per base pair per 
generation; (37)) compared to dsDNA viruses such as T4 (10-6-10-8 mutations per base pair 
per generation; (37)). As a result of these higher error rates, RNA-based viruses may have 
greater hidden costs associated with aborted viral synthesis or a greater fraction of faulty and 
non-infectious virions.  
Even infectious viruses cannot all be guaranteed to enter the lytic cycle upon 
infecting a host cell. For example, only 10% of influenza-infected host cells have been 
shown to generate infectious virions (38), demonstrating the cumulative inefficiency of an 
influenza infection. Counting plaques to measure viral burst sizes likely underestimates the 
true burst size, and result in an underestimation of the infection cost. As such, single-cell 
studies of viral infection could provide a detailed breakdown of inefficiencies at various steps 
of the viral life-cycle and enable more exact cost estimates.  
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In addition to the energetics of viral synthesis, another burst-limiting metric to 
consider is a volumetric one, namely the fraction of the host volume occupied by viruses 
during an infection. Taking influenza and T4 as our representative viruses, it is clear that they 
both occupy a relatively small percentage of the total host volume (39). A T4 infection takes 
up less than 5% of its host’s total volume. An influenza infection takes up even less space 
(≈0.2% of its host volume). These estimates suggest that 1) for T4, the energy requirement 
is more likely a burst-limiting factor than the volumetric requirement, and 2) for influenza, 
neither energetic nor volumetric factors seem to be limiting the burst size.  
We have already considered several possible causes for the inefficiencies of an 
influenza infection, which have experimentally been shown to result in only one infectious 
virus out of every ten produced (38). Accounting for this inefficiency, boosts the total cost 
of an influenza infection to ≈10% of its host’s. A second consideration that could explain 
the relatively low energy uptake of an influenza infection is the growth state of its host cell. 
Our current estimate assumes that the host cell is under maximal growth conditions. When 
the host cell is not dividing, however, its energy supply could be as low as 1012 PT (estimated 
for a 12-hour infection period, SI section J). In considering both the 10% infection 
efficiency and assuming a slow-growing host cell, the influenza infection’s total cost could 
also be a significant fraction of its host’s total cost.  
Another consideration is that implicit in our original question is the assumption that 
all viruses must conform to producing the maximum burst size allowed by their host 
energetic supply. This assumption, while it appears compatible with our findings for phages, 
may simply not be true for viruses such as influenza. It may be that a eukaryotic virus within 
a multicellular setting has an entirely different growth strategy than a prokaryotic virus 
infecting a single-celled organism. The influenza virus burst size is not only under selection 
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pressure within its host cell, but also within the multicellular organism that serves as its 
secondary host. 
Finally, we will need future experimental studies to test the assumptions underlying 
the relationship between the fractional cost of a neutral genetic element and the strength of 
negative selection acting on the viral population. There is also a great need for estimates of 
the effective population sizes of different viruses within their natural environments. With 
current effective population size estimates for viruses it appears that selection likely 
determines the fate of genetic elements for the majority of viruses, which have on average 28 
nm radii (26) (Figure 5E, SI Dataset 2). However, for larger viruses (R > 200 nm), the 
diminishing, fractional cost of a gene may enable the interference of genetic drift to the 
extent that neutral genetic elements could persist in the viral population. The result of such a 
phenomenon could be genome expansions in the form of gene duplication events, cooption 
of previously noncoding, horizontally transferred elements into functional genes and 
regulatory domains, and perhaps even a trend towards greater autonomy over large 
evolutionary time-scales. This effect may explain the unusual number of duplication events 
in the genomes of giant viruses such as that of the Mimivirus (40, 41).  
 
3.7 Supplementary Information 
3.7.A Viral rewiring of the host metabolism 
Viruses rely entirely on their host as an energy source. Instead of passively exploiting 
the host’s metabolic energy, some viruses appear to augment it (2). A particularly compelling 
example is demonstrated by phages that infect cyanobacteria. Cyanophages carry genes for 
photosystem II, high-light inducible protein, transaldolase, and ribonucleotide reductase, 
which are all transcribed during an infection (3). Given the unprecedented presence of 
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photosynthetic genes in viral genomes and the active expression of these genes during an 
infection, it is proposed that cyanophages carry these genes to increase the host energy 
supply and deoxynucleotide production for their own replication (3). An analogous finding is 
the presence of sulfite reductase genes in genomes of phages that infect deep-sea bacteria, 
which use sulfur as their energy source (34). Here too, these phages are hypothesized to add 
to the host’s metabolic output. It was also shown that large DNA algal viruses encode 
deoxynucleotide synthesis enzymes. For example, PBCV-1 encodes 13 nucleotide 
metabolism enzymes and EsV-1 encodes an ATPase and both subunits of ribonucleotide 
reductase (32). The most recent study on this topic identified more than 200 virus-encoded 
auxiliary metabolic genes such as those used in nitrogen and sulfur metabolism in marine 
viral metagenomes (6).  
Adenoviruses have been shown to reprogram the host’s glutamine metabolism by 
up-regulating glutamine transporters and glutamine catabolism enzymes. Glutamine is a 
critical amino acid used in the synthesis and import of other amino acids. Interestingly, this 
viral rewiring of glutamine metabolism is shown to boost the concentration of certain amino 
acids as well as increase glutamine reductive carboxylation. Together these effects are 
required for optimal viral production not only during an adenovirus infection, but also 
during herpes and influenza viral infections (4). In addition to virus-infected cells, which 
have high demand for molecular building blocks and energy, cancer cells, immune cells, and 
other proliferating cells similarly rewire glutamine metabolism for energy production and 
biosynthesis (42).  
Moreover, several examples from the early years of virology have shown that viruses 
such as Rous sarcoma virus and Feline Leukemia Virus increase their hosts’ glycolytic rate 
upon infection (33). Similarly, the Vaccinia Virus was shown to upregulate mitochondrial 
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genes involved in the electron transport chain, thereby increasing the ATP production within 
its host (5). 
 
3.7.B Energetic cost definitions and assumptions 
Viral synthesis requires the expenditure of the host’s ATP-equivalent molecules as 
well as the usurpation of the host’s monomeric building blocks such as nucleotides, amino 
acids, and in the case of some viruses, lipids. To synthesize these monomeric building blocks 
and generate ATP-equivalent molecules, heterotrophic cells, such as the hosts of T4 or 
influenza, rely on reduced carbon sources from their environment. In calculating the 
energetic cost of a viral infection and its impact on the host energy supply, it is critical that 
we state several assumptions about the host growth conditions. First, we assume that the 
host is growing aerobically at 37°C, with glucose as the sole carbon source. Second, we 
assume that sources of nitrogen, sulfur, phosphorus, and other trace elements are in excess, 
which is typical of culture conditions in the laboratory, and from which burst size 
measurements are commonly obtained. Third, we assume that the growth media contains 
only inorganic sources of nitrogen, requiring cells to synthesize amino acids rather than 
salvaging them from a growth medium supplemented with peptides (although this 
assumption should be modified in the case of a mammalian host cell which cannot 
synthesize all amino acids).  
As the sole carbon source in the growth media, glucose will serve both as a source of 
energy and biomass. SI Figure 1 provides detailed estimates of the opportunity and direct 
costs of precursor metabolites in heterotrophic bacteria and eukaryotes, assuming glucose as 
the sole carbon source.  
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As discussed in Chapter II, in the synthesis of building blocks from precursor 
metabolites there is an additional source of opportunity cost, namely the oxidation of 
electron carrier molecules. Had these electron carriers been preserved for energy production 
rather than being oxidized during biosynthesis pathways, 2 ATP molecules could have been 
generated from each NAD(P)H molecule using the bacterial ETC (43) and 2.5 ATP 
molecules from the eukaryotic ETC (44). The combination of the opportunity cost of 
precursor metabolites and the opportunity cost of building block synthesis from precursor 
metabolites will be referred to as the opportunity cost of a building block, (SI Figure 1). To 
simplify, we will generally refer to the opportunity cost of a building block in our 
calculations.  
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SI Figure 1. A breakdown of direct and opportunity costs associated with  
amino acids, DNA, RNA, and lipids in the context of A) bacterial and B) 
eukaryotic metabolism. Average cost values are reported in the table above 
the chart. See SI Dataset 3 for a detailed derivation of these costs 
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3.7.C Viral entry cost 
The process of viral entry varies extensively across different viral groups. While 
many animal viruses enter their host cell through clathrin-mediated endocytosis or fusion 
with the cell membrane (45), most phages inject their genetic material with the capsid 
remaining outside of the cell. In both cases, however, entry is mediated by the interaction 
between viral entry proteins and host receptors (45).  
For T4, it is the interactions between a minimum of 3 long tail fibers and cellular 
receptors that initiates a cascade of conformational changes (46) (Figure 1, step 1). After this 
preliminary interaction, the base plate is subsequently brought closer to the cell membrane, 
allowing the short tail fibers to interact with their host receptors. The tail sheath contracts, 
resulting in the tail tube puncturing the outer cell membrane (Figure 1, step 2). Then, 
conformational changes in gp5 phage protein activate its lysozyme domains, resulting in the 
digestion of the peptidoglycan layer (Figure 1, step 2). Effectively, the tail tube passes 
through the periplasm. At this point, the phage DNA is passed through the inner membrane 
via the tail tube and is then exposed to the intracellular environment (Figure 1, step 2). In 
general, viral entry proceeds through protein conformational changes and doesn’t rely on 
ATP expenditure (47). In the case of the T5 phage, this point has been explicitly 
demonstrated (48).  
The influenza virus is composed of a capsid that is enveloped by a lipid membrane 
(Figure 2). Inside the capsid reside the ribonucleoprotein complexes, which are composed of 
the segmented viral genome encapsidated by proteins. The viral membrane is decorated with 
hemagglutinin (HA) proteins, which bind to the host sialic acid receptors, thereby initiating 
clathrin-mediated endocytosis (Figure 2, step 1). During endocytosis, a self-assembled 
protein cage composed of clathrin triskelions forms around the inward budding vesicle. 
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Once the clathrin cage has formed, dynamins perform the last stage of endocytosis (Figure 2, 
step 2).  
Dynamin is a mechanochemical GTPase that self-assembles into multimeric spirals 
at the necks of clathrin-coated endocytic vesicles to catalyze membrane fission. The dynamin 
helix wrapped around the neck of an endocytic vesicle forms a protein-lipid tube with an 
inner diameter of 20 nm. In the presence of GTP, the dynamin helix undergoes structural 
changes that result in the reduction of the inner diameter (49). Because the dynamin helix is 
composed of at least 2 turns (35), each turn is composed of 13 dynamins, and each dynamin 
consumes 1 GTP, the energy requirement for vesicle fission can be approximated as 30-100 
PD (Figure 2, step 2).  
Once the vesicle is released from the cell membrane, the clathrin cage has to be 
disassembled. This process requires the expenditure of 3 ATPs per triskelion (50). For a 
clathrin cage composed of 36 triskelions, this is equivalent to about 100 PD (Figure 2, step 3). 
As the endosome matures, the endosomal lumen becomes more acidic. The influenza virus 
has exploited this feature for the uncoating of its lipid membrane as well as the disassembly 
of its capsid. The endosomal pH drop activates the viral transmembrane proton channel, 
M2. The influx of H+ ions from the endosome through M2 leads to the dissociation of the 
viral capsid proteins. The acidic environment also triggers conformational changes that 
expose the viral HA2 fusion peptide, which subsequently fuses the viral and endosomal 
membranes (51). These two events together enable the release of the viral ribonucleoprotein 
complexes into the host’s cytoplasm (52). To summarize, the cost of entry for influenza per 
virion, !!"#$%, falls within the range of 102 to 103 PD. It’s important to note that in our 
estimates we will generally not include the cost of host protein production, unless a protein 
is exclusively produced for viral synthesis. For example, the costs of producing the clathrin 
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cage and dynamin proteins are not included due to the fact that these proteins are recycled 
and produced for the host’s own functions.  
T4 efficiently exposes its genomic material to the host cytoplasm where it can be 
readily transcribed and translated. The influenza virus, however, due to the much larger 
volume and extensive compartmentalization of its eukaryotic host, faces additional obstacles 
in the way of reaching sites of transcription and translation. We will describe these obstacles 
in the next section.  
3.7.D Viral intracellular transport cost 
Replication and transcription of the influenza virus occur inside the nucleus. Like 
other cargo destined towards the nucleus from the plasma membrane, the endosome 
carrying the influenza virus is transported via the action of the dynein motor proteins along 
microtubule tracks (Figure 2, step 4). Unlike the kinesin motor protein, dynein is one that 
takes variable step sizes along the microtubule. As a result of having a hexameric ring of 
AAA+ ATPases (similar to Vps4, described later SI section I), dynein has multiple ATP 
binding sites. For the purposes of our estimates, we assume a step size of 8 nm and the 
expenditure of 1 ATP per step (53). If we assume that the nucleus resides roughly in the 
center of a cell ≈10 !" in diameter (18), this will require approximately 103 dynein steps in 
carrying the endosome. As a result, the cost of transport for the viral genome from the 
vicinity of the cell membrane to the nucleus is approximately 103 PD (Figure 2, step 4). 
The ribonucleoproteins are imported to and exported from the nucleus via nuclear 
localization signals (Figure 2, step 5). The nuclear import of influenza ribonucleoproteins has 
been experimentally demonstrated to be an energy-consuming process (54). To get access to 
the nucleus, these ribonucleoproteins have to pass through the nuclear pore complex. They 
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do so by binding to importins using nuclear localization signals. Each cargo imported into 
the nucleus will require the hydrolysis of one GTP. Whether ribonucleoproteins travel in and 
out of the nucleus separately or together is not definitely known, but there is recent evidence 
suggesting that the eight ribonucleoproteins travel as one cargo (55). As such, we estimate 
that the import of the viral genome will cost 1 PD per virus. 
Once inside the nucleus, the influenza genome is transcribed and replicated, the 
costs of which will be discussed in later sections. The production of the full 
ribonucleoprotein complex is a convoluted process, requiring the transcription of the viral 
genome (Figure 2, step 6), the nuclear export of the resulting transcripts (Figure 2, step 5), as 
well as the translation of viral mRNA transcripts (Figure 2, steps 7). Once the viral proteins 
are generated, some proteins travel back into the nucleus to encapsidate the viral -ssRNA 
genome and form the next generation of ribonucleoprotein complexes (PB1, PB2, NP, and 
PA proteins) (Figure 2, steps 5, 8). Other viral proteins are transported to the cell membrane, 
and together with ribonucleoprotein complexes, which are destined to the same site, bud off.  
Similar to the nuclear entrance, cargo exiting the nucleus must also pay a price. The 
nuclear export cost through the CRM1 export pathway, which is the one used by influenza, 
incurs 1 PD per cargo, similar to the import pathway (55). Considering that on average 6000 
influenza genomes have to leave the nucleus to eventually give rise to 6000 influenza virions, 
we estimate the export of ribonucleoproteins from the nucleus will cost ≈6 x 103 PD. The 
mechanism and energetics of viral mRNA export from the nucleus is not well understood 
(56) though there’s a growing body of evidence implicating the involvement of the nuclear 
RNA export factor 1. We suspect the cost of mRNA nuclear export is on par with the cost 
of ribonucleoprotein nuclear export and estimate the cost of nuclear import and export to be ≈104 PD.  
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Upon exiting the nucleus, ribonucleoproteins have to be transported towards the cell 
membrane where they can co-assemble with other viral proteins and bud off. Their path to 
the cytoplasm starts at the Microtubule Organizing Center (MTOC) and proceeds via 
Recycling Endosomes bound to the RAB-11 GTPase (55). This endocytic transport is 
powered by kinesin motor proteins trekking along microtubules with a step size of 8 nm and 
the hydrolysis of 1 ATP per step (57) (Figure 2, step 9). Assuming the eight 
ribonucleoproteins travel as one cargo – consistent with the reported typical size of an 
endosome (200 nm in diameter) (58) – a 5 !" transport of 6000 ribonucleoproteins from 
the nucleus to the cytoplasm costs ≈3 x 106  PD. Under a similar assumption (i.e. each 
endosome carries the proteins required to build a single virus), the cost of protein transport 
to the apical cell surface is similar to the cost of ribonucleoprotein transport. Considering the 
sum of the costs from nuclear import and export as well as travel along the microtubules, the 
cost of intracellular transport for an influenza infection, !!"#$%&'/! , can be approximated as 6 
x 106  PD.  
The cost of GTPases mediating endosome docking and fusion is likely negligible 
compared to the heavy cost of motor proteins mobilizing the endosomes. This is because 
during endosome trafficking, there are far more steps taken by motor proteins than there are 
endosome fusion or docking events. Yet, each fusion or docking event incurs a similar cost 
to a step taken by a motor protein. More detailed estimates of endosomal trafficking are 
exceedingly difficult due to the unavailability of studies that shed light on 1) the average 
number of proteins carried per endosome, 2) the average number of GTPases needed per 
endosome, and 3) the average length that an endosome travels within the cell, among other 
topics.  
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3.7.E  Viral genome replication cost 
The direct cost. Genome replication is a complex phenomenon requiring many 
different steps, such as the unwinding of the parent helix, RNA primer synthesis, Okazaki 
fragment ligation, and proofreading. Though there are many facets of genome replication in 
cells that require energy expenditure, the direct cost of replication lies primarily in the direct 
synthesis cost of nucleotides from precursor metabolites as well as the polymerization of 
individual nucleotides. The energetic cost of genome replication for a virus with a double-
stranded DNA genome can be approximated as   
!!"#(!"#$%)/!! ≈ !2!!(!! + !!). [3] 
Here, !! corresponds to the genome length and is multiplied by two to account for T4’s 
double-stranded genome. The cost of each DNA nucleotide can be stated as the sum of !! , 
which represents the average direct cost of DNA synthesis from precursor metabolites, and !!, which denotes the cost of chain elongation per base (equivalent to 2 PD, (19)) (Figure 1, 
step 5). The energetic cost of replicating a -ssRNA genome is similarly 
!!"#(!!!"#$)/!! ≈ !2!!(!! + !!), [4] 
where !! represents the average direct cost of RNA synthesis from precursor metabolites. 
The factor of two stems from the fact that a -ssRNA has to first be converted to +ssRNA 
before a second copy of -ssRNA can be synthesized (Figure 2, step 8). !! in the context of 
bacterial metabolism is equivalent to 11 PD (SI Figure 1, SI Dataset 3). The average synthesis 
cost of an RNA base from a precursor metabolite in the context of eukaryotic metabolism is 
10 PD (SI Figure 1, SI Dataset 3). With these values in hand, we estimate the direct cost of T4 
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(!! ≈ 2 x 105) and influenza (!! ≈ 1 x 105) genome replication to be ≈4 x 106 PD and ≈3 x 
105 PD, respectively.  
The opportunity cost.  The opportunity cost of T4 phage replication can be 
estimated as 2!!!!" , where !!" corresponds to the average opportunity cost of a DNA base 
synthesized in bacteria and is approximately 34 PO (SI Figure 1, SI Dataset 3). Note, !!" 
represents the sum of the average opportunity cost of precursor metabolites required for 
DNA synthesis (33 PO) and the average opportunity cost of DNA synthesis from precursor 
metabolites (1 PO).  Under this estimate, the opportunity cost of genome replication for a T4 
phage is ≈1 x 107 PO. Similarly, the opportunity cost of genome replication for an influenza 
virus can be estimated as 2!!!!" , where !!" refers to the average opportunity cost of an 
RNA nucleotide synthesized in a eukaryotic organism, which is ≈!39 PO (SI Figure 1, SI 
Dataset 3). The opportunity cost of influenza genome replication is therefore ≈8 x 105 PO.  
The total cost.  The total cost of T4 phage replication is the sum of opportunity 
and direct costs: 2!!(!! + !! + !!"). Under this estimate, the cost of genome replication 
for a T4 phage is ≈2 x 107 PT. The same logic follows for influenza where the total cost of 
its genome replication can be estimated as 2!!(!! + !! + !!"). The total cost of influenza 
genome replication is therefore ≈1 x 106 PT.  
The replication cost component of an infection.  Further, the replication cost per 
infection is the cost of replication for a virus multiplied by its burst size, !, resulting in 
!!"#/!! ≈ !!!!"#/!. [5] 
The direct, opportunity and total costs of genome replication during a T4 infection with an 
average burst size of 200 are ≈9 x 108  PD, ≈!2 x 109 PO and ≈!3 x 109 PT (Figure 1, step 5). 
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The direct, opportunity and total costs of genome replication during an influenza infection 
with an average burst size of 6000 are ≈ 2 x 109 PD, ≈!5 x 109 PO and ≈!6 x 109 PT (Figure 2, 
step 8).  
3.7.F  Viral transcriptional cost  
As in the case of replication, transcription involves various energy-consuming 
processes, such as transcriptional activation, initiation and termination, as well as 
proofreading and mRNA splicing. However, the dominant cost in transcription is similar to 
that in replication, namely the investment in the synthesis of the nucleotides themselves (19). 
See Figure 1 (step 3) and Figure 2 (step 6).  
The direct cost. The direct cost of transcription is approximately  
!!"/!! ≈ (!!" + !!) !!"!!"!!!! , [6] 
where !!" and !!" represent the length and the copy number of each viral mRNA transcript, 
respectively. The average direct cost of synthesizing an RNA base from precursor 
metabolites is denoted as !! , which is 10 PD (SI Figure 1, SI Dataset 3). The direct cost of 
polymerizing an RNA base is symbolized by !!" , which is equal to 2 PD (19). Because the 
mRNA copy number for each viral gene is largely an unknown parameter, we approximated 
the viral genome as one long gene. This allowed us to eliminate the !! and !! dependence, 
and replace them with constants, !! !and !! , such that !!"/!! ≈ ! (!!" + !!)!!!! . [7] 
The constant !! , corresponds to the length of the mRNA transcript, and thus is equal to the 
length of the genome. The average copy number of this transcript, !! , can be approximated 
by the observed ratio of 1 mRNA transcript per 1,000 resulting proteins both in prokaryotes 
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(18) as well as in mammalian cells (59). The average protein copy number of a virus, !!, can 
be related to its average transcript number according to !! ≈ !!!""". 
To obtain !! we have used available data on viral protein copy numbers. For a T4 
phage, with a total estimated protein count of 5,000 representing 35 structural and 3 lysis 
genes (SI Table 1), the average protein copy number per virus is ≈130. Influenza’s total 
protein count is also approximately 5,000, representing the products of 9 proteins (SI Table 
2). This results in an estimate for the average protein copy number for an influenza virus of ≈550. With these numbers in hand, we estimate !! to be approximately 0.13 for a single T4 
phage and 0.55 for an influenza virus. We note that generally mRNAs are relatively short-
lived and each individual mRNA on average produces between 10 and 100 proteins. 
However, the pool of such proteins is then used to synthesize all the virus particles that 
make up a given burst. 
While it is sufficient to consider only the synthesis and polymerization costs of 
nucleotides in the direct cost estimates for genome replication, the transcriptional cost 
should additionally encompass the cost of mRNA re-polymerization (19). This is because 
mRNA transcripts have a short lifespan and must be regenerated throughout the duration of 
the infection. This cost is perhaps more prominent in bacteria, where the lifetime of a 
transcript is about 3 minutes (18), whereas the lifetime of a mammalian cellular transcript is 
approximately 10 hours (18), and therefore comparable to the lifetime of the influenza 
infection itself. The first step in calculating the mRNA re-polymerization cost is to multiply 
the lifetime of the infection, !, by the mRNA degradation rate, !! .  
The second step is to take into account the average transcript copy number and its 
length to determine the number of RNA bases that have to be re-polymerized during the 
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course of an infection. Effectively, the assumption is that the RNA nucleotides are only 
being re-polymerized, not re-synthesized. The re-polymerization cost of transcription can be 
stated as the number of nucleotides to be re-polymerized, !!!!!!!, multiplied by !!" . The 
direct cost of transcription per virus can then be revised as such: 
!!"/! !≈ ! !!!!(!! + !!!"!!!). [8] 
The lifetime of a T4 infection is ≈30 minutes (60), and the lifetime of an influenza infection 
is roughly 12 hours (14). With these parameters in hand, the direct cost of transcription (per 
virus) for T4 and influenza are ≈7 x 105 PD and ≈7 x 104 PD, respectively (Table 1). 
The opportunity cost. The opportunity cost of transcription can be obtained by !!!!!!" , where !!"  represents the opportunity cost of an RNA nucleotide. !!"  is 
approximately 31 PO in bacteria and 39 PO in eukaryotes (SI Dataset 3, SI Figure 1). Note, 
that in this expression we don’t account for re-polymerization events as RNA nucleotides 
are assumed to be recycled rather than resynthesized. The opportunity costs of transcription 
for a single T4 phage and an influenza virus are thus ≈7 x 105 PO and ≈2 x 105 PO, 
respectively.  
The total cost.  The total cost of transcription can be obtained by !!!!(!!!" +!!! + !!!"!!!), which represents the sum of opportunity and direct costs of transcription. 
According to this estimate, the total costs of transcription for a single T4 phage and an 
influenza virus are ≈1 x 106 PT and ≈3 x 105 PT, respectively (Table 1).  
The transcriptional cost of an infection. The transcriptional cost of an infection is 
the transcriptional cost of a virus multiplied by its burst size, namely,  
!!"/! !≈ !!!!"/!. [9] 
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For T4 with an average burst size of 200 and for influenza with an average burst size of 
6000, the direct cost of transcription at the level of an infection is ≈1 x 108  PD (Figure 1, 
step 3) and ≈4 x 108 PD, respectively (Figure 2, step 6). The opportunity cost of transcription 
for these two infections are ≈1 x 108 PO (T4, Figure 1, step 3) and ≈4 x 108 PO (influenza, 
Figure 2, step 6). Their total costs are ≈3 x 108 PT (T4, Figure 1, step 3) and ≈2 x 109 PT 
(influenza, Figure 2, step 6) (Table 1). 
3.7.G Viral translational cost 
There are important biosynthetic costs associated with proteins just as there are with 
nucleic acids. Here, we attempt to capture the most significant costs in the protein synthesis 
pathway while making some simplifying assumptions that neglect substantially smaller cost 
components such as the costs of translational initiation and termination and post-
translational modifications (19). The estimate for translational cost follows the same 
rationale as the cost calculation for transcription. 
The direct cost.  The direct cost of translating the viral proteome can be estimated 
as  
!!"/!! ≈ ! (!! + !!") !!"!!"!!!! . [10] 
Here we have multiplied the total number of amino acids by the per-amino acid costs of 
synthesis from precursor metabolites, !! , and polymerization, !!" . The arrays !! and !! 
hold values for the length of each protein and its copy number per virus, respectively (SI 
table 1, SI table 2). We show that !!"!!"!!!!  for the influenza virus and the T4 phage are 
about 1.7 and 1.2 million amino acids, respectively (SI table 1, SI table 2). In both bacteria 
and eukaryotes, !!, is on average equal to 2 PD (SI Figure 1, SI Dataset 3) and !!" is 4 PD 
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(21). Due to the relatively slow protein degradation rates for bacteria (!.!!! ) and human cells 
(!.!"!! ) (19, 22) compared to infection lifetimes, we have neglected costs associated with this 
process. Using this information, the direct cost of translation for a T4 phage and an 
influenza virus are ≈7 x 106 PD and ≈1 x 107 PD, respectively (Table 1). This finding stems 
mainly from the fact that both viruses are based on ≈106 amino acids.  
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SI Table 1. T4 bacteriophage structural proteins and their average copy 
numbers per virion. The number of amino acids comprising each virion is 
calculated by the product of the average protein copy number and the length 
of the corresponding protein.  
 
Table S1. T4 bacteriophage structural proteins and their average copy numbers per virion
T4 bacteriophage
Protein Protein length ðLpjÞ
Average protein copy
number ðNpjÞ
Total no. of amino acids in
protein j ðLpjNpjÞ
23* 521 930 484,530
20* 524 12 6,288
24* 427 55 23,485
soc* 80 840 67,200
hoc* 376 160 60,160
22* 269 576 154,944
21* 212 72 15,264
IPIII* 194 370 71,780
IPI* 95 360 34,200
IPII* 100 360 36,000
alt* 682 40 27,280
68* 141 240 33,840
67* 80 341 27,280
3† 176 6 1,056
53† 196 6 1,176
5† 575 3 1,725
6† 660 12 7,920
7† 1,032 6 6,192
8† 334 12 4,008
9† 288 18 5,184
10† 602 18 10,836
11† 219 18 3,942
12† 527 18 9,486
15† 272 6 1,632
18† 659 144 94,896
19† 163 144 23,472
25† 132 6 792
26† 208 Assumed 1 208
27† 391 3 1,173
28† 177 Assumed 1 177
29† 590 6 3,540
48† 364 6 2,184
54† 320 6 1,920
td† 286 3 858
frd† 193 6 1,158
holin‡ 218 20 4,360
endolysin‡ 164 20 3,280
spanin‡ 216 20 4,320
Totals
Pk
j=1Npj = 4,805 proteins
Pk
j=1LpjNpj = 1,225,786 aa
The number of amino acids comprising each virion is calculated by the product of the average protein copy
number and the length of the corresponding protein.
*These genes together compose the phage head.
†These genes are those that make up the tail tube, the tail sheath, and the base plate (table modified from ref.
85).
‡These genes are those that are involved in lysis (76).
Mahmoudabadi et al. www.pnas.org/cgi/content/short/1701670114 11 of 12
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SI Table 2. Influenza A virus proteins and their average copy numbers per 
virion. The number of amino acids comprising each virion is calculated by 
the product of the average protein copy number and the length of the 
corresponding protein (Table modified from (61)).  
 
 
The opportunity cost. The opportunity cost of viral translation is approximately !!" !!"!!"!!!! , where !!" denotes the average opportunity cost of an amino acid, and 
corresponds to 25 PO in bacteria and 30 PO in eukaryotes (SI Figure 1, SI Dataset 3). The 
opportunity cost of viral translation for a T4 phage and an influenza virus are therefore ≈3 x 
107 PO and ≈5 x 107 PO, respectively.  
The total cost.  The total cost of viral translation is the sum of direct and 
opportunity costs of translation. The total cost of viral translation for a T4 phage and an 
influenza virus are therefore ≈4 x 107 PT and ≈6 x 107 PT, respectively (Table 1).  
The translational cost component of an infection.  The translational cost of an 
infection is simply the cost of translation per virion multiplied by its burst size, namely,  
!!"/! !≈ !!!!"/!. [11] 
Table S2. Influenza A virus proteins and their average copy numbers per virion
Influenza A virus
RNA segment lengths
(no. of nucleotides) Protein product
Protein
length ðLpjÞ
Average protein
copy number ðNpjÞ
Total no. of amino acids
in protein j ðLpjNpjÞ
1 (2,341) Polymerase PB2 759 45 34,155
2 (2,341) Polymerase PB1 757 45 34,065
3 (2,233) Polymerase PA 716 45 32,220
4 (1,778) Hemagglutinin 566 500 283,000
5 (1,565) Nucleoprotein 498 1,000 498,000
6 (1,413) Neuraminidase 454 100 45,400
7 (1,027) Matrix protein M1 252 3,000 756,000
Matrix protein M2 97 40 3,880
8 (890) NS1 230 0 0
NS2 121 165 19,965
Totals
Pk
j=1Npj = 4,940 proteins
Pk
j=1LpjNpj = 1,706,685 aa
The number of amino acids comprising each virion is calculated by the product of the average protein copy number and the length
of the corresponding protein (table modified from ref. 86).
Dataset S1. The detailed breakdown of opportunity and direct costs of building blocks across heterotrophic bacterial and eukaryotic
metabolisms (using glucose as the sole carbon source). All references are provided as notes in the Excel sheets
Dataset S1
Dataset S2. A list of viruses and their associated costs used to estimate replication to translation cost ratios shown in Fig. 4
Dataset S2
Dataset S3. A list of direct and total fractional cost estimates, Eg, for genetic elements of lengths 1, 10, 100, 1,000, and 10,000 bp across
30 dsDNA viruses (Fig. 5). Genetic elements are assumed to have no functional benefit to the virus and to be nontranscribed. Viruses A, B,
and C correspond to hypothetical viruses
Dataset S3
Mahmoudabadi et al. www.pnas.org/cgi/content/short/1701670114 12 of 12
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The direct, opportunity and total translational costs for a T4 infection with a burst size of 
200 are ≈1 x 109 PD, 6 x 109 PO and 8 x 109 PT (Figure 1, step 4). For an influenza infection 
with a burst size of 6000, these costs are ≈ 6 x 1010  PD, 3 x 1011 PO and 4 x 1011 PT (Figure 2, 
step 7)(Table 1). 
Protein folding and quality control.  Just as in any other biological process, 
protein folding is subject to errors. To correct for such errors and prevent the aggregation of 
misfolded proteins, cells from all three domains of life have evolved elaborate mechanisms 
for the detection of misfolded proteins. Through various ATP-dependent (e.g. Hsp90, 
Hsp70, and Hsp60) and ATP-independent processes, a triage is carried out in which some 
proteins are re-folded and others are degraded (62-64). From an energetic standpoint, 
protein quality control mechanisms are likely to cost substantially less than the cost of 
translation. As shown above, a protein with an average length of 300 amino acids (22) will 
have a direct translational cost of 1,800 PD and a total cost of 9,300 PT in bacteria and 10,800 
PT in eukaryotes, respectively. On the other hand, the energetic cost of various protein 
quality control pathways can range from a few ATPs (65) to a few hundred ATPs per 
protein (66), which is required for protein degradation. Thus, it is likely that protein quality 
control will be a fractional cost compared to the translational cost of a protein. A similar 
conclusion was drawn in the context of cellular protein cost (19). Because we were unable to 
ascertain the fraction of viral proteins that may be degraded, and because different proteins 
require different quality control pathways (67), any more detailed estimates are difficult to 
make. Future experimental studies would be needed to determine any substantial costs 
incurred by protein quality control or translation at large that may be missing from our 
estimates.  
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Another very interesting experimental avenue would be to explore the consequences 
of the quality control mechanisms as they are being partially recruited towards maintaining 
the viral proteome. Particularly in the context of a host cell that survives the infection, how 
the cell responds to the additional burden from viral protein production and maintenance 
would be a fascinating topic of study. Constructed from roughly 5000 proteins (SI Table 2), 
and with an average burst size of about 6000, the influenza infection will produce about 3 x 
107 viral proteins. Considering that a human cell will harbor more than 109 proteins (68), we 
would expect the extra load from viral proteins on the quality control machinery to be 
minimal. For a T4 phage, composed of roughly 5000 proteins (SI Table 1) and with a burst 
size of roughly 200, the total number of viral proteins during an infection would be 
approximately 106. This is comparable to the number of bacterial proteins, which is 
estimated to be 106 per cubic micron (69), or the approximate volume of an E. coli cell. As 
such, in the case of a T4 infection, the viral quality control pathways are likely to more 
heavily affected than in the case of an influenza infection.   
3.7.H Assembly and genome packaging cost 
Upon translation, the influenza viral proteins and ribonucleoproteins travel towards 
the cell membrane via Rab-bound endosomes that are carried by kinesins on microtubules. 
Interactions of the matrix protein M1 with ribonucleoproteins and the viral transmembrane 
proteins, namely HA, NA, and M2, result in the assembly of the influenza virus (70). 
Though the kinetics of the assembly steps remain to be delineated, influenza virus assembly 
and genome packaging are not regarded as energy-consuming processes. In general, virus 
assembly is described as an energetically favorable process, typically driven by the burial of 
hydrophobic surfaces (71, 72), and therefore independent of host energy expenditure. As an 
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example, the assembly of hepatitis B virus is shown to occur spontaneously through weak 
protein-protein interactions (73).  
While the assembly of the T4 capsid is spontaneous, the packaging of the genome 
inside the capsid is not (Figure 1, step 7). The cost of genome packaging for a T4 phage is 
!!"#$/! = !!!!, [12] 
where the cost to package a base pair, !!, is 2 PD (74). For the 169 kb genome of T4, this 
cost is ≈3 x 105 PD.  
Genome packaging cost of an infection. The packaging cost of a T4 infection is 
simply the cost of packaging for a single T4 phage multiplied by the T4 burst size: 
!!"#$/! = !!!"#$/!. [13] 
For T4, with a burst size of 200, the contribution of packaging to the total cost of infection 
is ≈7 x 107 PD (Figure 1, step 7) (Table 1).  
3.7.I Viral exit cost 
Viruses use two primary exit strategies. Generally, enveloped viruses such as 
influenza and HIV bud off from the host membrane. Phages, on the other hand, generally 
lyse their host cells. For T4, the cost of exit is primarily the production cost of proteins that 
together break down the cell wall. We have already included the cost of lysis proteins in our 
translational cost estimates. The lysis proteins include holin, endolysin, and spanin proteins. 
The holins create holes in the host inner membrane, enabling the endolysins to reach the 
peptidoglycan layer. The spanins fuse the inner and the outer membrane as a requirement 
for lysis of gram-negative bacteria (Figure 1, step 9, only holins and endolysins are shown). 
Considering that T4 holin, endolysin, and spanin proteins are 218, 164, and 216 amino acids 
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in length, respectively, and each have a copy number of about 4,000 per infection (or 
approximately 20 per virus considering a burst size of 200) (75), the contribution of lysis 
proteins to the translational cost of an infection is negligible.   
In the case of influenza, the exocytosis of virions is energy-consuming. However, the 
exact mechanism remains a mystery, with influenza M2 protein so far serving as the most 
likely agent for mediating exocytosis (76). Three separate costs exist: 1) the cost to locally 
bend the membrane outward, 2) the cost to scisse the budding virion from the cell 
membrane, and the cost of the cellular membrane that becomes part of the viral membrane 
(Figure 2, step 10). The cost to bend the membrane into the shape of a sphere of any size, is 
equivalent to 25 PD (21). One way to estimate the cost of scission is to assume that it incurs a 
comparable cost to the HIV scission process, which, similar to several other enveloped 
viruses, is mediated through the ESCRT-III (endosomal sorting complexes required for 
transport) assembly. ESCRT-III complex self-assembles into filaments around the neck of a 
budding vesicle (similar to dynamin), and its disassembly requires the expenditure of 6 PD via 
the Vps4 ATPase (77). The sum of these two costs results in the usage of 31 PD as one 
influenza virus leaves the cell. Because 6000 virions exit the cell on average, exocytosis costs 
approximately 2 x 105 PD.  
An alternative, order-of-magnitude estimate could be made with the assumption that 
the cost of membrane scission during endocytosis equals the cost of membrane scission 
during exocytosis. In estimating the influenza entry cost, we showed that the cost of 
membrane scission during influenza endocytosis via the dynamin polymer is ≈30 PD. 
Together with the cost of membrane bending, ≈25 PD, this exit estimate is slightly higher (55 
PD per virus) than the previous (31 PD per virus). Under this estimate, the cost of exocytosis 
for all 6000 influenza virions amounts to ≈3 x 105 PD.  
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The primary cost of viral exit for influenza, however, is the cost of lipids that are 
taken from the host cell to form the viral membrane. The cost of lipids per virus can be 
estimated by the number of lipid molecules needed per virion multiplied by the cost of a 
lipid molecule, !! : 
!!"#$/! = !!!!! !!! . [14] 
In SI Eq. 14 the numerator represents twice the viral surface area (accounting for the bilayer) 
and the denominator, s, denotes the surface area of a lipid head group, which is 
approximately 0.5 nm2 (22, 78). With an average radius of 50 nm, the influenza virus is 
comprised of ≈ 105 lipid molecules. The direct, opportunity and total cost of a lipid molecule 
in a eukaryotic cell are 18 PD, 264 PO and 282 PT, respectively (SI Dataset 3, SI Figure 1). As 
a result, the direct, opportunity and total costs of lipids per influenza virus are 2 x 106 PD, 3 x 
107 PO and 4 x 10
7 PT, respectively.  The exit costs of an influenza infection can be derived by !!"#$/! = !!!"#$/!,  [15] 
and are approximately 1 x 1010  PD, 2 x 10
11  PO and 2 x 10
11 PT for an infection with a burst 
size of 6000 (Table 1).  
3.7.J Estimating the total host energy budget  
The total basal and growth metabolic requirements of various organisms have been 
shown to correlate with the cellular volume (19). We have used SI Eqs. 16-18 presented by 
Lynch and Marinov (19) to estimate the energetic budget of hosts considered in this study. 
Basal metabolic requirement of a cell scales with the cell volume according to !! = 0.39!!.!!, [16] 
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where !, represents the cell volume in units of !"!, and !! is in the units of 109 ATP per 
cell per hour. The growth metabolic requirement of a cell similarly scales with the cell 
volume according to  !! = 27!!.!", [17] 
where !!  is in the units of 109 ATP per cell.  The total energy requirement of a cell is simply 
the sum of the basal and growth energy requirements, 
!! = !! + !!!! , [18] 
where ! is the cell-division time in the units of hours.   
 
For a bacterial cell with a volume of 1 !"!, the maintenance metabolic cost is ≈108 PT in 
the duration of a T4 phage infection which lasts about 30 minutes. A mammalian cell, on the 
other hand, with a characteristic volume of 2000 !"!, has a basal metabolic cost of ≈1012 PT 
over the course of a 12-hour influenza infection. The total energetic cost of a cell should also 
encompass the cost of cellular growth. The total energetic cost of a bacterium and a 
mammalian cell with the dimensions highlighted above are therefore ≈3 x 1010 PT and ≈5 x 
1013 PT, respectively, during the course of their viral infection. The correlation between 
cellular volume and metabolic capacity is supported by the observation that larger E. coli cells 
produce higher T4 burst sizes (79). 
3.7.K Heat production and power consumption of a viral infection 
In our estimates for heat production and power consumption of a viral infection, we 
will not consider the total cost of an infection as it contains the opportunity costs; by 
definition, these opportunity costs do not represent direct usage of ATP (and ATP-
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equivalent) molecules; rather, they represent the ATP (and ATP-equivalent) molecules that 
could have been generated in the absence of a viral infection. For these estimates we will rely 
on the direct costs. 
To estimate the amount of heat that is generated due to a viral infection, we have to 
consider the inefficiency of aerobic metabolism. The burning of glucose results in the 
production of approximately 2800 kJ/mol of heat (80). The same reaction takes place inside 
our cells, with the difference being that cells are capable of harnessing a fraction of the free 
energy that would otherwise be liberated as heat. When glucose is aerobically metabolized 
into water and carbon dioxide, a fraction of the free energy is used to convert ADP into 
ATP, while the remaining free energy is dissipated as heat. By assuming physiological 
conditions, the free energy change of ATP hydrolysis can be approximated as -50kJ/mol 
(16). In bacterial metabolism, 26 ATPs are generated from each glucose molecule; hence the 
free energy captured by the conversion of ADP into ATP is approximately -1300 kJ/mol of 
glucose. As a result, in this simple estimate, we consider that about 50% of the energy from 
the aerobic metabolism of glucose is dissipated as heat: 1− !"## !"!"#!"## !"!"# !×!100% . For 
eukaryotic cells, with 32 ATPs generated per glucose molecule, about 40% of the energy 
stored in glucose is dissipated as heat. 
The T4 infection has a direct cost of 3 x 109 PD (Table 1). Because each glucose 
molecule results in 26 ATPs in the bacterial metabolism, T4 infection’s direct cost would 
require the complete metabolism of 108 glucose molecules. The influenza infection’s direct 
cost is about an order of magnitude higher than that of T4 (Table 1), and is equivalent to the 
aerobic metabolism of approximately 109 glucose molecules. Based on the number of glucose 
molecules required to cover the direct costs of each infection, the free energy stored in 
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glucose (-2800 kJ/mol), and the percentage of the energy released as heat during the aerobic 
metabolism of glucose (≈ 40-50%), we can conclude that the heat generated during T4 and 
influenza infections are approximately 0.2 nJ and 2 nJ, respectively.  
In half an hour, the T4 infection results in the hydrolysis of ATP-equivalent 
molecules at an average rate of 2 x 106 PD per second. In half a day, an influenza infection 
also has an average ATP-hydrolysis rate of 2 x 106 PD per second. Put in terms of the more 
familiar units of Watts (by assuming -50kJ/mol of free energy change per PD), the power of 
both viral infections is on the order of 200 fW. 
3.7.L Generalizing viral energetics for double-stranded DNA phages 
Figure 5A.1 shows how we can generalize the estimates presented here by thinking 
of dsDNA phages as approximately spherical objects with an outer layer of thickness, t. In 
this model, the inner volume of a virus containing the viral genome is given by !!!!! , which 
can be used to estimate the viral genome length (24). The total cost of genome replication 
for a double-stranded DNA genome can be obtained from SI Eq. 3 (Figure 4). However, 
instead of using the viral genome length directly, we can divide the capsid inner volume by 
the volume of a base pair, !! (approximately 1 nm3 ) (22):  
!!"#(!"#$%)/!! ≈ 4!!!3!! ! !! + !!!+!!!" . [19] 
Because for many dsDNA phages only about half of the capsid is filled with the viral 
genome (24), the cost of a DNA base was not multiplied by a factor of 2 (even though the 
genome is double stranded) as the two multipliers cancel each other out. The direct cost of 
replication can be obtained similarly by the exclusion of the opportunity cost of a DNA base 
or !!"  (in bacteria) from SI Eq. 19. Moreover, the translational cost of a virus can be 
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obtained from a modification of !! + !!" + !!!" !!"!!"!!!! ,  derived previously (SI 
section G). The total cost of viral translation,  
!!"/! ≈ ! !!(!!!!!)!!! ! !! + !!" + !!" , [20] 
can be obtained from multiplying the total number of amino acids by the total cost of an 
amino acid. The number of amino acids is estimated by dividing the outer capsid volume 
(denoted by the shaded blue region in Figure 5A), !!(!!!!!)! , by the volume of an amino 
acid, !!, which can be approximate as 0.1 nm3 (81). This expression can be further simplified 
by replacing the outer radius, !, with ! + ! (Figure 4): 
!!"/! ≈ !4!((! + !)! − !!)3!! ! !! + !!" + !!!" ≈ !4!!!!!! ! !! + !!" + !!" . [[21] 
The direct translation cost of a virus can be similarly obtained from Eq. 21 by 
excluding the average opportunity cost of an amino acid, !!". The critical radius, !!"#$, at 
which translation and replication will have equal cost can be obtained by setting Eqs. 19 and 
21 equal and solving for ! (Figure 4). Because capsid shell thickness is relatively conserved 
across icosahedral viruses studied to date, it can be treated as a constant equal to 3 nm (82). 
The critical radius for total cost estimates, !!"#$!!"#, is 59 nm. For the direct cost estimates, 
the critical radius, !!"#$!!"# , is 42 nm (Figure 4). 
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SI Dataset 1. A list of viruses and their associated costs used to estimate replication to 
translation cost ratios shown in Figure 4.  Provided in a GitHub repository: 
https://github.com/gitamahm/thesis 
 
 
SI Dataset 2. A list of direct and total fractional cost estimates, !!, for genetic elements of 
lengths 1, 10, 100, 1000, and 10,000 base pairs across 30 dsDNA viruses (Figure 5). Genetic 
elements are assumed to have no functional benefit to the virus and to be non-transcribed. 
Virus A, B, and C correspond to hypothetical viruses. Provided in a GitHub repository: 
https://github.com/gitamahm/thesis 
 
 
SI Dataset 3. A detailed breakdown of opportunity and direct costs of building blocks across 
heterotrophic bacterial and eukaryotic metabolisms (using glucose as the sole carbon source). 
Provided in a GitHub repository: https://github.com/gitamahm/thesis 
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C h a p t e r  I V   
A Comprehensive and Quantitative Exploration of 
Thousands of Viral Genomes 
 
 
4.1 Introduction 
There are an estimated 1031 virus-like particles inhabiting our planet, outnumbering 
all cellular life forms (1, 2). Despite their presence in astonishing numbers and their impact 
on the population dynamics and evolutionary trajectories of their hosts, our quantitative 
knowledge of trends in the genomic properties of viruses remains largely limited with many 
of the key quantities used to characterize these genomes either scattered across the literature 
or unavailable altogether. This is in contrast to the growing ability exhibited in resources 
such as the BioNumbers database (3) to assemble in one curated collection the key numbers 
that characterize cellular life forms. Our goal has been to complement these databases of key 
numbers of cell biology (3-6) with corresponding data from viruses. With the advent of high-
throughput sequencing technologies, recent studies have enabled genomic and metagenomic 
surveys of numerous natural habitats, untethering us from the organisms we know and love 
and giving us access to a sea of genomic data from novel organisms (7). Such advances allow 
us to appreciate the genomic diversity that is a hallmark of viral genomes (7-12) and now 
make it possible to assemble some of the key numbers of virology.  
In contrast to cellular genomes, which are universally coded in the language of 
double-stranded DNA (dsDNA), genomes of viruses are remarkably versatile. Viral genomes 
can be found as single or double-stranded versions of DNA and RNA, packaged in 
segments or as one piece, and present in both linear and circular forms. Additionally, based 
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on their rapid infectious cycles, large burst sizes, and often highly error-prone replication, 
viruses collectively survey a large genomic sequence space, and comprise a great portion of 
the total genomic diversity hosted by our planet (13, 14). Recently, through a large study of 
metagenomic sequences, the known viral sequence space was increased by an order of 
magnitude (7), and much more of the viral “dark matter” likely remains unexplored (15).   
In analyzing an increasing spectrum of sequence data, we are faced with a 
considerable challenge that is unique to viruses, namely, how to find those features within 
viral genomes that might reveal hidden aspects of their evolutionary history. To put this 
challenge in perspective, when analyzing non-viral data, universal markers from the 
ribosomal RNA such as 16S sequences are used to classify newly discovered organisms and 
to locate them on the evolutionary tree of life (16). Virus genomes on the other hand are 
highly divergent and possess no such universally shared sequences (17). 
In the absence of universal genomic markers, viruses have historically been classified 
based on a variety of attributes, perhaps most notably morphological characteristics, 
proposed in 1962 by the International Committee on Taxonomy of Viruses or ICTV (18), or 
based on the different ways by which they produce mRNA, proposed by David Baltimore in 
1971 (19) (see SI and Figure 1 for a detailed description of the ICTV and the Baltimore 
classification categories). Given the prevalence of these viral classification systems in the 
categorization of viruses today, it is worth remembering that their inception predates the 
sequencing of the first genome in 1976. With the fastest and cheapest rates of sequencing 
available to date, we live at an opportune moment to explore viral genomic properties and 
evaluate these existing classification systems in light of the growing body of sequence 
information.  
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Figure 1. Schematics of several viral classification systems explored in this 
study. A) The Baltimore classification divides all viruses into seven groups 
based on how the viral mRNA is produced. DNA strands are denoted in red 
(+ssDNA in darker shade of red than -ssDNA). Similarly RNA strands are 
denoted in green (+ssRNA in darker shade of green than -ssRNA). In the 
case of Baltimore groups 1, 2, 6, and 7, the genome either is or is converted 
to dsDNA, which is then converted to mRNA through the action of DNA-
dependent RNA polymerase. In the case of Baltimore groups 3, 4, and 5, the 
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genome is or is converted to +ssRNA, which is mRNA, through the action 
of RNA-dependent RNA polymerase. B) Nucleotide type classification 
divides viruses based on their genomic material into DNA and RNA viruses. 
Baltimore viral groups 1, 2, and 7 are all considered DNA viruses, and the 
remaining viral groups are considered RNA viruses. C) Host Domain 
classification groups viruses based on the host domain that they infect. Three 
groups are formed: eukaryotic, bacterial and archaeal viruses. 
 
In addition to the ICTV and the Baltimore classifications (see SI) we used a simple 
classification system based on the host domain information, and divided viruses into 
bacterial, archaeal and eukaryotic viruses (Figure 1). The underpinning motivation behind 
this kind of classification is the Coevolution Hypothesis (20, 21). Viruses are obligate 
organisms unable to survive without their host, and as a corollary it is hypothesized that they 
have coevolved with their hosts as the hosts diverged over billions of years to form the three 
domains of life (20, 21). A possible piece of supporting evidence for this hypothesis is that 
there are to date no reported infections of hosts from one domain by viruses of another 
observed. We also explored a minimal classification system that divides the virus world into 
two groups based on their nucleotide type (RNA and DNA), here termed “Nucleotide 
Type” classification (Figure 1). This classification is introduced as a simplified version of the 
Baltimore classification system. In practice, we have assigned Baltimore groups 1, 2, and 7 to 
the DNA viral category, and the remaining Baltimore groups to the RNA viral category. 
Although many viruses are uncharacterized, at the time of the analysis of the data 
presented here, there were 4,378 completed genomes available from the NCBI viral genomes 
resource (22) (data acquired in August, 2015). However, large-scale analyses of genomic 
properties for these viruses are generally unavailable. This stands in stark contrast to the in-
depth analyses performed on partially assembled viral genomes or viral contigs derived from 
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metagenomic studies (7, 23). Although these studies have uncovered many important aspects 
of viral ecology with relatively little bias in sampling, they are limited by the fact that 
metagenomic studies typically do not result in the full assembly of genomes. An interesting 
example that illustrates the difficulty of complete genome assembly from metagenomic 
studies is the crAssphage genome, which despite taking prominent fractions of reads across 
various metagenomic datasets, had gone undetected and remained unassembled (24).  
Without complete viral genomes, it is difficult to develop systematic understanding 
of key aspects of viral genomic architecture. To address this problem at least in part, we set 
out to provide a large-scale analysis of various genomic metrics measured from complete 
viral genomes. To perform a comprehensive analysis on complete viral genomes, we first 
explored the diversity of known viruses and their hosts within the NCBI database (see 
Methods). We then created distributions on a number of metrics, namely genome length, 
gene length, gene density, percentage of noncoding DNA (or RNA), functional gene 
category abundances, and gene order. We have provided brief introductions to these metrics 
in the following subsections.   
Viral genome length, gene length and gene density. Genomes are replete with 
information about an organism’s past and present. A central and revealing piece of 
information is the genome length. As more and more complete genomes have become 
available, we have learned that genome lengths of cellular organisms vary quite extensively, 
specifically by six orders of magnitude (4, 25). Because these studies focused on cellular 
organisms, and because genome length information is generally inaccessible through 
metagenomic studies, large-scale analyses that systematically capture viral genome length 
distributions in light of different classification systems and in relation to other genomic 
parameters are lacking. One such genomic parameter is the number of genes that are 
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encoded per genome, also referred to as gene density (26, 27). Another set of missing 
distributions involves gene lengths, and here too, it is important to see how they vary across 
different viral classification categories.  
The noncoding percentages of viral genomes. One of the most surprising 
discoveries of the past several decades was the rich and enormous diversity of noncoding 
DNA in the human genome (28). Though originally thought of as “junk DNA”, the 
noncoding regions of our genomes were later shown to be of great functional importance. 
Noncoding DNA is an umbrella term for very different elements, for example functional 
RNAs such as micro RNAs (miRNA), regulatory elements such as promoters and enhancers, 
and also transposons and pseudogenes.  
Moreover, genomes vary widely in their noncoding percentages. While multicellular 
eukaryotic genomes such as plants and vertebrates have 50% or more of their genomes filled 
with noncoding regions, single-cell eukaryotic genomes have 25-50% of their genomes 
present as noncoding regions and prokaryotic genomes have even lower percentages of 
noncoding DNA, generally 15 to 20% (29-31). As such, the noncoding percentage of the 
genome is thought to correlate with the phenotypic complexity of the organism, and 
consequently, much of the investigation into noncoding fractions of genomes has been 
focused on higher eukaryotes. However, the discovery of the bacterial immunity against 
phages and other sources of foreign DNA, otherwise known as CRISPR/Cas system 
(Clustered Regularly Interspaced Short Palindromic Repeats), as well as the discovery of a 
new class of antibiotics targeting bacterial noncoding DNA (32) demonstrate the level of 
biotechnological impact and scientific insight that the study of noncoding elements in 
bacteria can provide. Even less is known about the noncoding fraction of viral genomes.  
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The literature on viral noncoding DNA or RNA is relatively sparse but highly 
intriguing. The first viral noncoding RNAs were discovered in adenoviruses, dsDNA viruses 
that infect humans, and were ~160 base pairs long (33-35). These sequences were shown 
responsible for viral evasion of host immunity by inhibition of protein kinase R- a cellular 
protein responsible for the inactivation of viral protein synthesis (36). In ovine herpesvirus, 
miRNAs have been shown to maintain viral latency (37). These are just several examples in 
which viral noncoding elements have been shown to enable viral escape from host 
immunity, as well as regulate viral life-cycle and viral persistence (34). Despite many 
interesting studies exploring the topic of cellular noncoding DNA (29-31), there are no 
studies, to our knowledge, that reveal the statistics of noncoding percentage of viral 
genomes. 
Viral functional gene categories. There are detailed studies on the counts of 
cellular genes belonging to each broad functional category (38, 39). These studies have 
helped us better understand the scaling of functional categories across different clades of 
organisms. In fact there was an intriguing conclusion that for prokaryotic genomes, there 
exists a universal organization which governs the relative number of genes in each category 
(38). Such depictions of viral genomes, however, are largely lacking. Thus, we set out to 
better understand how viral genes are distributed across different functional categories and 
how these distributions might differ across various viral groups.  
Viral genome organization. Viral genome organization is a topic that has great 
depth but limited breadth. There exist highly detailed genome-wide diagrams that illustrate 
the location, direction, and predicted function of viral genes, which are then compared to 
similar illustrations from a small number of viral genomes (40-43). While this highly detailed 
approach is indispensible for studying individual viruses, a simplified illustration of genome 
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organization is a requirement of any high-throughput visualization and comparison of 
genomes. The latter approach could help us uncover general rules governing genomic 
organization, in the same way that synteny, or conserved gene order, has been used to 
compare animal genomes (44, 45). 
 
4.2 Exploring the NCBI viral database 
 We used the largest available dataset of completed viral genomes available from the 
National Center for Biotechnology Information (NCBI) viral genomes resource (22), 
containing a total of 4,378 complete viral genomes at the time of data acquisition (August, 
2015). After implementing several manual and programmed steps towards curating the data, 
a total of 2,399 viruses (excluding satellite viruses) could be associated with a host using 
NCBI’s documentation (see Methods). These viruses were included for further analysis, and 
unless noted otherwise, will constitute our dataset in this study. By examining these viruses 
through different classifications (Figure 2), it is clear that they are largely DNA viruses 
(Figure 2.B4), and more specifically, they are primarily double-stranded DNA (dsDNA) 
viruses (Figure 2.C4). This is in contrast to the RNA viruses, which are mostly single-
stranded (Figure 2.B4 and Figure 2.C4).  
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Figure 2. A census of all viruses with complete genomes reported to NCBI 
that were matched to a host (N= 2399). A) Percentage of viruses infecting 
hosts from the three domains of life. 1) Eukaryotic, 2) bacterial, and 3) 
archaeal viromes are further classified according to the B) Nucleotide Type, 
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C) Baltimore, and D) ICTV classification systems. E) Distributions of host 
phyla (or supergroups) infected by the 1) eukaryotic, 2) bacterial, and 3) 
archaeal viruses is shown. As in the case panel F, the host taxonomic 
identification is derived from the NCBI Taxonomy database (see Methods). 
F) Histograms of the number of known viruses infecting host species. 
Median and mean number of viruses infecting a host species is provided in 
each plot. The full-range of x-values for the bacterial and eukaryotic 
histograms extends beyond n=20 (see virusHostHistograms.ipynb).            
 
We further observed that eukaryotes host nearly an equal number of DNA and RNA 
viruses (Figure 2.B1). In contrast to prokaryotes, which are predominantly host to viruses 
with double-stranded genomes, eukaryotes are host to a higher number of viruses with 
single-stranded genomes. Why are double-stranded DNA viruses, despite their high 
prevalence in the bacterial and archaeal world, only the third largest group of viruses in 
eukaryotes? One explanation proposed is the physical separation of transcriptional processes 
from the cytoplasm by way of the eukaryotic nucleus (46). This physical separation is 
thought to impose an additional barrier for DNA viruses in gaining access to the host’s 
transcriptional environment.  
 More than half of viruses with complete genomes have not been assigned to any viral 
orders under the ICTV classification (Figure 2.D4). About one third of all known viruses are 
assigned to the Caudovirales order, while the other orders are in the minority. The vast 
majority of the bacterial viruses are categorized as part of the Cauodvirales order (Figure 
2.D2), but the majority of archaeal and eukaryotic viruses remain unassigned to any order.  
Before any further exploration of this dataset, we aimed to assess its diversity and 
possible sources of bias (Figure 2.E-F, SI Figure 1). It was immediately clear, for example, 
that archaeal viruses were heavily undersampled. In contrast, bacterial viruses infect hosts 
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from a diverse array of bacterial phyla (Figure 2.E2). However, even for bacterial viruses, 
there are host phyla whose viruses are entirely missing from the database, for example 
Synergistes and Acidobacteria, whose members are typically unculturable soil bacteria. Given 
that the isolation and characterization of archaeal and bacterial viruses has traditionally been 
dependent on the culturing of their hosts, the majority of viruses with unculturable hosts 
remain unexplored. Moreover, the eukaryotic viruses in the database infect hosts primarily 
from the Viridiplantae or the Opisthokonta supergroups (Figure 2.E1). Among Viridiplantae, the 
majority of hosts belong to the Streptophytina group (land plants), and within the Opisthokonta 
supergroup, the majority of viruses are metazoan. We further examine the distribution of 
viruses from the Opisthokonta supergroup in SI Figure 1.  
We continued to explore host diversity at a finer resolution and mapped out the 
number of viruses that infect each host species (Figure 2.F). As expected, organisms such as 
Staphylococcus aureus, Escherichia coli, and Solanum lycopersicum, which are host species with either 
medical, research or agricultural relevance, have many known viruses and are outliers in the 
skewed distributions shown in Figure 2.F. However, the median number of viruses known 
to infect a eukaryotic or a prokaryotic host species is approximately 1 (Figure 2.F). This 
signifies that even for host species that are already represented in our collection, the number 
of known viruses is likely an underestimate considering the larger numbers of viruses known 
to infect the more heavily studied host species.  
 
4.3 Viral genome lengths, gene lengths and gene densities 
Genome lengths for all fully sequenced viral genomes varied widely by three orders 
of magnitude (Figure 3.A, Table 1). According to the Host Domain classification, 
prokaryotic viruses tend to have longer genomes than eukaryotic viruses (SI Table 1, SI 
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Figure 2). However, this difference can be better explained by the Nucleotide Type 
classification, as the median RNA virus genome length is four times shorter than the median 
DNA virus genome length. Thus, the comparison between prokaryotic and eukaryotic viral 
genome lengths is confounded by the fact that the prokaryotic virome is primarily composed 
of DNA viruses, whereas the eukaryotic virome is only half composed of DNA viruses 
(Figure 2.C4).  
With respect to viral genome lengths, the Baltimore classification seems to offer the 
most explanatory power. Knowing whether a viral genome is DNA- or RNA-based already 
provides a strong indication about viral genome length, especially for RNA viruses where the 
standard deviation is just a few kilobases (SI Table 1). However, by distinguishing between 
ssDNA, dsDNA and dsDNA-RT viruses, the Baltimore classification offers a more 
complete view of genome length distributions compared to the binary Nucleotide Type 
classification (Figure 3.A). Across all Baltimore groups, dsDNA viruses have genome lengths 
that have the largest standard deviation, however considering the limited range of genome 
lengths associated with other Baltimore groups, it is very likely that a larger viral genome will 
be composed of dsDNA (Figure 3.A). We provide a more detailed view of genome length 
distributions by layering different classification systems, first applying the Baltimore 
classification, followed by the Host Domain and the ICTV family classifications (Figure 3.B, 
SI Table 1).  
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Figure 3. Describing viral genomes through distributions of genome length, 
gene length and gene density. A) Box plots of genome lengths (Log10) across 
all viruses included in our dataset (top), further partitioned based on the 
Baltimore classification categories (bottom). The number of viruses included 
in each group is denoted by N. B) A closer examination of dsDNA and 
ssDNA viral genome lengths through the overlay of Host Domain and ICTV 
classification systems. Distributions of genome lengths associated with 
eukaryotic, bacterial and archaeal viruses are shown in salmon, blue, and teal, 
respectively. ICTV viral families with only a few members are omitted. 
Distributions of genome lengths across different classification systems along 
with various statistics are shown in SI Figure 2 and SI Table 1. Note that the 
bimodal distribution of eukaryotic ssDNA viruses, which also appears in the 
next figure, arises from the Begomoviruses, which are plant viruses with 
circularized monopartite and bipartite genomes (47). C) Median gene length 
is plotted against the number of genes for each genome for all genomes in 
our dataset, color-coded according to different classification systems. D) 
Number of genes per genome length (gene density) for dsDNA viruses based 
on the overlay of Host Domain (bottom) and ICTV family classification 
categories (top) (Pearson correlations and their statistical significance are 
denoted).  
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Table 1. Viral genomic statistics based upon different classification systems. 
Only median values are reported in this table. A more complete version of 
these statistics can be found in SI Table 1- SI Table 3. Genome length data is 
rounded to the nearest kilobase. N corresponds to the number of viruses 
from which data is obtained.  
 
 
In viewing the relationship between median gene length and number of genes per 
viral genome (Figure 3.C), two different coding strategies become apparent. Namely, 
N
Genome'
length'(kb)
Percent'
noncoding'
(DNA/RNA)
Median'gene'
length'
(bases)
Eukaryota)Viruses) 1384 8 10 1055
Bacteria)Viruses) 969 43 9 408
Archaea)Viruses) 46 24 10 400
Group)I)(dsDNA)) 1211 44 9 429
Group)II)(ssDNA)) 431 3 14 588
Group)III)(dsRNA) 123 8 8 2291
Group)IV)(+ssRNA) 482 9 5 2366
Group)V)(EssRNA)) 101 12 7 1353
Group)VI)(ssRNAERT)) 14 8 16 1799
Group)VII)(dsDNAERT) 37 8 11 558
DNA)Viruses) 1679 38 10 444
RNA)Viruses) 720 9 6 2072
Caudovirales) 879 44 9 408
Herpesvirales) 55 159 19 1107
Ligamenvirales) 11 37 12 372
Mononegavirales) 71 12 8 1266
Nidovirales) 35 27 3 672
Picornavirales) 89 8 11 7056
Tymovirales) 73 8 4 693
All)Eukaryotic)dsDNA)viruses 271 33 11 990
All)Bacterial)dsDNA)viruses) 899 44 9 408
All)Archaeal)dsDNA)viruses) 41 28 10 396
All)Eukaryotic)ssDNA)viruses) 375 3 14 732
All)Bacterial)ssDNA)viruses) 51 7 14 348
Classification
ICTV'(orders)
Combinations'of'
different'
classifications
Host'Domain
Baltimore
Nucleotide'Type
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compared to DNA viruses, RNA viruses exhibit a large range of gene lengths. This trend is 
at least in part reflective of the challenges faced by RNA viruses when encountering the 
requirements of their host’s translational machinery (48). For example, many of the RNA 
genomes we examined closely contained genes that encode polyproteins, ribosomal slippage 
(frame-shifting) or codon read-through events, among other non-canonical translational 
mechanisms.  
As in the case of genome lengths, by examining only the ICTV or the Host Domain 
classifications it would be difficult to draw meaningful conclusions about the observed 
patterns, and in the case of the Host Domain classification, our conclusions would be 
confounded by the disproportionate ratio of RNA to DNA viruses that are known to infect 
each host domain. However, the layering of these classification systems offers new insights, 
which we will discuss in the following paragraphs.   
We follow others (26, 27) in defining the gene density of a genome as the number of 
genes divided by the genome length (Figure 3.D). We further partitioned dsDNA viruses 
according to the Host Domain and subsequently the ICTV (family) classifications. We 
observed a strong linear correlation between dsDNA viral genome lengths and the number 
of genes encoded by these genomes (Figure 3.D). The mean (and median) gene densities for 
bacterial, archaeal and eukaryotic dsDNA viral genomes are approximately 1.4, 1.6 and 0.9 
genes per kilo basepairs. As illustrated by the slopes of the regression lines, as well as 
through a nonparametric statistical test performed on eukaryotic and bacterial dsDNA viral 
gene densities (one-sided Mann-Whitney U test, P < 0.001), bacterial dsDNA viruses have 
significantly higher gene densities than their eukaryotic counterparts.   
A closer examination of median gene lengths more clearly reveals the significantly 
longer gene lengths of RNA viruses compared to DNA viruses (one-sided Mann-Whitney U 
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test, P < 0.001) (Figure 4, Table 1). By focusing on DNA viruses, and further dividing these 
viruses based on Baltimore, Host Domain and ICTV (family) classifications, we arrive at an 
interesting trend. Namely, eukaryotic viruses, whether dsDNA or ssDNA, have significantly 
longer gene lengths compared to bacterial viruses from the same Baltimore classification 
category (Figure 4, SI Table 2) (one-sided Mann-Whitney U test, P < 0.001). This trend 
follows what we see across cellular genomes, since prokaryotic genes and proteins are shown 
to be significantly shorter than eukaryotic ones (5, 49).  
 
Figure 4. Normalized histograms of median gene lengths (log10) across all 
complete viral genomes associated with a host. Instead of showing absolute 
viral counts on y-axes, the counts are normalized by the total number of 
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viruses in each viral category (denoted as N inside each plot). The mean of 
each distribution is denoted as a dot on the boxplot. For all histograms, bin 
numbers and bin widths are systematically decided by the Freedman-
Diaconis rule (35). Viral schematics are modified from ViralZone (38). Key 
statistics describing these distributions can be found in Table 1 and SI Table 
2. 
 
4.4 Noncoding percentages of viral genomes 
So far we have primarily focused on the coding fractions of viral genomes. Thus, we 
created distributions of noncoding percentage of viral genomes (see Methods, Figure 5, 
Table 1, SI Table 3). In general, DNA viral genomes contain about 10% noncoding regions 
which is even lower than the noncoding percentage of bacterial genomes (29, 30). With a 
median noncoding percentage of just 6%, RNA viral genomes have significantly lower 
noncoding percentage compared to DNA viruses (one-sided Mann-Whitney U Test, P < 
0.001). A notable exception to the RNA viral group is the ssRNA-RT with a median 
noncoding percentage of 16%. Interestingly, both retroviral groups had relatively high 
noncoding DNA percentages. This is likely due to the presence of defunct retroviral genes. 
For example, the Xenopus laevis endogenous retrovirus (NCBI taxon ID 204873) belonging to 
the ssRNA-RT group has a noncoding percentage of 93%. This high noncoding percentage 
can be explained by the fact that this virus genome contains three pseudogenes previously 
coding for env, pol, and gag proteins.  
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Figure 5. Normalized histograms of noncoding DNA/RNA percentage 
across all complete viral genomes associated with a host. The counts of 
viruses are normalized by the total number of viruses in each viral category 
(denoted as N inside each plot). The mean of each distribution is denoted as 
a dot on the boxplot. For all histograms, bin numbers and bin widths are 
systematically decided by the Freedman-Diaconis rule (35). Viral schematics 
are modified from ViralZone (38). Key statistics describing these 
distributions can be found in Table 1 and SI Table 3.  
 
4.5 Viral functional gene categories  
We categorized viral genes according to several major functional categories, 
including structural genes such as capsid and tail genes, metabolic genes, informational 
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genes, which we define as those involved in replication, transcription or translation of the 
viral genetic code, among other categories (Figure 6, see Methods). In addition to the 
fraction of viral genes that we were able to assign to these functional categories, there still 
remains what we will refer to as an “unlabeled” fraction that contains hypothetical genes or 
genes with poor annotation (see Methods). When reporting the relative abundance of 
different functional gene categories, we will normalize the number of genes belonging to 
each functional category by the total number of labeled genes.  
RNA, dsDNA, and ssDNA viruses, despite differences in the detailed categorization 
of their genes (Figure 6.B) share similar general features (Figure 6.A). For example, across all 
three viral groups, roughly half of all genes are structural. Similarly, dsDNA viruses of 
eukaryotes and bacteria, in contrast to having different genomic properties and 
morphologies surprisingly have very similar distribution of gene functional category and 
subcategory abundances. The major difference between these two viral groups, as expected 
from our knowledge of viral morphologies, is that a larger portion of eukaryotic dsDNA 
viral genes are envelope and matrix genes, whereas a greater portion of bacterial dsDNA 
genes are portal and tail-associated genes. By further zooming in on bacterial dsDNA 
viruses, it is again interesting to see that Myoviridae, Siphoviridae, and Podoviridae viral groups, 
with their different morphologies and wide range of hosts, having very similar functional 
gene category abundances even at the level of subcategories.  
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Figure 6. Normalized abundance of functional gene categories across 
different viral groups. A) Abundances of functional gene categories across 8 
viral groups normalized to the number of labeled genes in each viral group 
(the number of labeled genes in each viral group is shown above the panel). 
B) Abundances of functional gene subcategories across 8 viral groups: RNA, 
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ssDNA, and dsDNA viral groups (top plot); eukaryotic and bacterial dsDNA 
viral groups (middle); Siphoviridae, Myoviridae, and Podoviridae viral groups 
(bottom). A few examples of the types of genes contained as part of each 
functional subcategory are provided.  
 
4.6 Viral genome organization  
To explore viral genome organization we developed a coarse-grained method for 
visualizing a large number of genomes in one snapshot. We first defined genome 
organization as the order in which genes appear across a genome. We then symbolized each 
gene by a letter, indifferent to the gene’s length or its orientation on the genome. Genes with 
similar functions are grouped and are represented by the same letter (Figure 7). Therefore 
each viral genome, analogous to a nucleotide sequence, is compactly described by a sequence 
of letters that represent its gene order (Figure 7), which we will refer to as the gene order 
sequence. Because we aimed to study gene order sequences across different viral groups, we 
focused on genes whose functions are universally required, namely structural genes. SI text 
file 1 provides the structural gene order sequences for all viruses (see Methods for filters 
applied), though the script developed can be easily modified to visualize the placement of 
any number of genes or user-defined gene groups.   
Furthermore, by focusing on bacterial dsDNA viruses, we were able to identify the 
most common gene order patterns across this virome (see Methods). One particular gene 
order pattern and its variations exist across various types of dsDNA bacterial viruses. We 
will refer to it as gene order pattern A, or pattern A for short (Figure 7.A). In pattern A, gene 
packaging, portal and capsid-related genes are mostly tightly clustered and are followed by 
tail-associated genes. Interestingly, this pattern occurs at the beginning of the genome for 
some viruses, and for others it seems to have been shifted further down on the genome. 
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Pattern A occurs across viruses from five different host phyla. The other two most common 
gene order patterns (patterns B and C) occur across viruses with more limited host range and 
morphologies.  
To further examine the extent to which gene order sequences in a given pattern may 
be related at the sequence level, we used BLASTN to identify genomes in pattern C that 
share any regions of homology. We have shown examples of genomes (see SI) with very 
little sequence similarity, which due to having similar gene order sequence were grouped into 
the same gene order pattern, suggesting that at least for some viral genomes the gene order 
can remain conserved in time.   
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Figure 7. Alignment of the most common gene order patterns for dsDNA 
bacterial viruses. Each genome is summarized by a sequence of letters, with 
each letter corresponding to a gene, positioned in the order that it appears on 
the genome. As an example, the gene order sequence for Salmonella phage FSL 
SP-004 is shown. Note the letters shown serve to only denote genes with 
similar functions. Structural genes are assigned colors, whereas other genes 
are denoted in black. Across all three panels, each row corresponds to the 
gene order sequence for a given virus, and thus, the length of the sequence 
denotes the number of genes within a given genome. The left two columns 
accompanying each panel provide further information on hosts and viral 
morphologies. Panel A, B, and C, represent gene order patterns A, B, and C, 
respectively. Geneious global alignment (37) was used to align gene order 
sequences (see Methods). 
 
4.7 Discussion  
The motivation for conducting a large-scale study of viral genomes was above all to 
provide the distributions of key numbers that characterize viral genomes. Furthermore, 
implicit in this aim was to compare different viral classification systems. Because viral 
classification systems were constructed prior to the emergence of sequencing, we were 
interested to see how well they can describe genomic trends. Based on a comparison of 
classification systems across various genomic metrics, the Baltimore classification and in 
some cases its more minimal form (Nucleotide Type classification) seem to provide the 
clearest explanation for the observed trends. We suspect that this is due to the Baltimore 
classification’s discernment of RNA, ssDNA, and dsDNA genomes, which have striking 
physical differences.  
The greater stability of dsDNA compared to RNA (50) and ssDNA is thought to be 
an important factor in the observed variations in genome lengths. The 2’-hydroxyl group in 
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RNA makes it more susceptible to hydrolysis events and cleavage of the backbone compared 
to DNA. It has been shown that for bacteria and viruses, the mutation rate and the genome 
length are inversely correlated (51, 52), and it is therefore hypothesized that the lack of 
proofreading mechanisms in RNA replication and the resulting higher mutation rates 
compared to DNA replication (52) imposes length limits on RNA viral genomes. In support 
of the suspected link between mutation rates and genome length, it has been shown that 
long RNA viruses (above 20 kb) contain 3’-5’ exonuclease, which is a homolog of the DNA-
proofreading enzymes (53).  
Similarly, the hydrolysis of cytosine into uracil occurs two orders of magnitude faster 
in ssDNA genomes than in dsDNA genomes (54). This may explain the high mutation rates 
of ssDNA viruses, which is within the range of RNA viral mutation rates, despite using 
error-correcting host polymerases to replicate. In contrast to genome length in which 
ssDNA and RNA viruses have similar distributions, it was interesting to see that ssDNA 
viruses are actually more similar to dsDNA viruses in terms of their gene lengths and 
noncoding percentages.  
While the Baltimore classification serves as a meaningful coarse-grained classification 
system, it can be expanded by the addition of subcategories. As is shown by gene length 
distributions (Figure 4), the additional layer of categorization provided by the Host Domain 
classification offers new insight. For example, dsDNA and ssDNA viruses of eukaryotes 
have much longer gene lengths compared to their prokaryotic counterparts, an observation 
that may be hinting at the coevolution of host and viral genomes and proteomes since the 
eukaryotic genes and proteins are also shown to be significantly longer than prokaryotic ones 
(49, 55, 56). It is well known that certain eukaryotic viral genomes, similar to their hosts’ 
genomes, contain genes with introns (57-59), which may explain the longer median gene 
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length for eukaryotic viruses. In fact mRNA splicing was discovered for the first time in a 
study of adenovirus mRNA expression (60). Virus proteomes are also shown to be tuned to 
their hosts’ proteomes by having similar codon usage and amino acid preferences (61). 
However, future studies are needed to further ascertain the mechanisms responsible for the 
differences in eukaryotic and prokaryotic viral gene lengths.  
The ICTV classification also offers some supporting data (e.g. viral morphology or in 
some cases host information), perhaps as the final layer of classification, but it is limited by 
the fact that it leaves many viruses unclassified and, more importantly, that it lacks truly 
systematic classification criteria. As our exploration of viruses shifts its basis from culturing 
of viruses to sequencing of viruses from their natural habitats, morphological data is likely to 
become more and more scarce. As a result, ICTV will need to adapt its classification system 
to operate exclusively on genomic data, a viewpoint that is broadly shared by many experts 
in the field (10).  
In this work, we have described our attempt at providing a comprehensive and 
quantitative view of fully sequenced viral genomes. Similar to earlier work on biological 
numeracy, as exemplified by the BioNumbers database (3), we have identified a number of 
interesting trends associated with viral genomes that will be helpful in gaining a broad 
overview of vastly different viral groups.  
 
4.8 Materials and Methods 
Data acquisition and curation. All genomic data was retrieved from the NCBI 
Genome FTP server (retrieved July 2015) (Brister, 2015). Matching viruses to their hosts was 
done by parsing ASN files from the NCBI Genome FTP server while searching for the term 
“nat-host”. All other taxonomic data, including host and viral lineages, was retrieved from 
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NCBI’s Taxonomy database using the NCBI Taxa class of the ETE Toolkit (62). Once we 
had the “nat-host” name of organisms in English, we retrieved their taxids using ETE 
Toolkit. These were in turn used to identify the host’s taxonomic lineage. Hosts with 
complete genomes were identified by searching the assembly reports of the NCBI Genome 
FTP server for assemblies labeled “Complete Genome”, then using the associated FTP 
address to download the _assembly_stats.txt files and _protein.faa files. Only viruses that 
could be matched to a host were included for further analysis. Additionally, various quality 
checks were manually performed to ensure that viruses with improper annotations were 
excluded from further analysis. For example, we found viruses and hosts with incomplete or 
incorrect taxonomic information which we excluded from further analysis. The list of 
excluded viruses can be found in our code (see next section).   
Data and code availability. We have compiled all scripts (in the format of Jupyter 
Notebooks) used to write this manuscript in a GitHub repository 
(https://github.com/gitamahm/VirologyByTheNumbers), and invite others to explore our 
methods. viromePieChartsVF.ipynb and virusHostHistogramsVF.ipynb were used to create 
Figure 2. The code for Figure 3 through Figure 5 can be found in genomeLengthsVF.ipynb, 
geneLengthsVF.ipynb, and percentNoncodingVF.ipynb, respectively. Finally, the code for 
Figure 6 and Figure 7 is provided in geneOrderAndGeneAbundanceVF.ipynb. SI text files 1 
through 6 can also be found in this repository.  
Genome length and gene densities. Genome lengths were extracted from .ptt files 
and _assembly_stats.txt files for viruses. The .ptt files were parsed to find “complete genome 
- 1..” which is followed by the length of the genome. The _assembly_stats.txt files were 
parsed to find the first instance of “total-length”, which is followed by the length of the 
genome. For segmented genomes, the total length of the segments is reported as the genome 
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length. The number of protein-coding genes, which was used in calculating gene densities, 
was found by parsing .faa files using the BioPython Seq class. For gene length histograms, 
we first obtained the gene lengths for each virus, and then create a histogram based on the 
median gene length associated with each virus. To have a systematic scheme for determining 
the number of bins needed for each histogram, we employ the Freedman-Diaconis' rule (63) 
for all histograms shown in this paper. 
Noncoding DNA/RNA percentages. To extract the percent of the genome that 
is noncoding, we could not merely subtract the lengths of the genes from the length of the 
genome, as this would not take overlapping genes into account. Instead, we used the .ptt 
files to identify where each gene began and ended in the genome, then added all indices 
between protein-coding genes to a set. We then could subtract the size of this set from the 
genome length to arrive at the number of noncoding bases, which is then turned into a 
percentage. 
Decomposition of Viral Genes into Functional Categories. To obtain the 
abundance of various gene functional categories, we collected the COG product annotations 
(64) accompanying each gene from .ptt file(s) provided for each virus. Based on the most 
frequent COG product names, we constructed a dictionary of search terms to query viral 
genes and measure the abundance of various functional categories (by measuring abundance, 
we are referring to the number of genes that belong to a given functional category). To 
determine the most common search terms, we derived the unique set of COG product 
annotations for different viromes. We used the annotations shared between viromes to 
exclude problematic search terms with multiple meanings. As a result we avoided search 
terms with multiple functional associations such as “gp41”, which in the context of HIV 
  
IV-30 
signifies a transmembrane glycoprotein, and in the context of Mycobacterium phage Bxb1 
denotes a 3’-5’ exonuclease involved in DNA replication. 
While the dictionary constructed contains many key words that capture essential 
gene functional categories common to many viruses, it does not account for COG 
annotations that are non-descriptive (e.g. “phage protein” or “Z protein”). Additionally, 
there is typically a large number of genes that code for “hypothetical proteins”. Together, 
these two fractions make up the unlabeled component, which we do not include for further 
analysis. Despite the limitations introduced by these unlabeled genes, there are still a large 
number of genes (~105) that are included in our analysis. In constructing the relative 
abundances of different gene functional categories (Figure 6), we divide the abundance of a 
gene functional category by the total number of labeled genes (denoted at the top of Figure 
6.A for each viral group).    
Gene Order. In visualizing gene order we employed a similar search strategy to the 
one explained in the previous section. To detect potentially conserved patterns in gene order 
across vastly different viral genomes, we searched only structural genes as they are essential 
to any virus. We used .ptt files to determine gene order since they contain the beginning and 
end indices of genes. The code developed uses .ptt files as input, and outputs a string of 
characters per viral genome, which we have referred to as the gene order sequence. Each 
character represents a viral gene in the order that it appears on the genome (without 
distinguishing between the strand of DNA on which the gene is located).  All genes 
belonging to the same functional category, for example all tail-related genes, are represented 
by the same character. All unlabeled genes (i.e. non-structural, hypothetical, or poorly 
annotated genes) are also represented by the same character. Each gene order sequence, 
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analogous to a nucleotide sequence, can be aligned against other gene order sequences by 
existing alignment software.  
Though it would be ideal to calculate a pairwise distance matrix between gene order 
sequences and to quantitatively define a gene order pattern based on gene order sequence 
similarity (akin to defining an Operational Taxonomic Unit), this effort would require the 
development of appropriate alignment algorithms and inference methods fit to process gene 
order sequences. In the meantime, we used existing alignment software as a guide and 
grouped gene order sequences based on generally shared features 
We used Geneious software (65) to align gene order sequences using global 
alignment with free end gaps and identity cost matrix (with default gap open and extension 
penalties). Using Geneious global alignment as a guide, we further manually improved the 
alignment by aligning similar characters, without introducing any gaps. This step was 
necessary because any alignment algorithm will aim to maximize the alignment between 
unlabeled genes, unable to distinguish between these characters and the more meaningful 
characters corresponding to labeled structural genes. Moreover, because of the high fraction 
of genes that have “hypothetical protein” COG annotation, we had to impose filters to 
extract gene order sequences that are not entirely composed of unlabeled genes. To generate 
the alignments shown in Figure 7, we imposed that at least 15% of characters in a gene order 
sequence have to correspond to labeled genes, and that the gene order sequence has to be at 
least 40 characters long. For the gene order sequences shown in SI text file 1 the sequence 
order length limit was not imposed.  
To further explore gene order pattern C, we used BLASTN and accession numbers 
shown in SI Figure 3 to BLAST all genomes in pattern C against each other. We have 
summarized these results in SI Figure 3.A, wherein orange boxes correspond to homologous 
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relationships (E values < 10-5). All non-homologous relationships are shown in blue. We 
then used protein-protein BLAST to identify relationships between genomes that had no 
homology to any other genomes in pattern C. We targeted tail tube A, tail tube B, capsid, tail 
fiber, and large terminase proteins (SI Figure 3.B). The BLASTP reports are provided as SI 
text file 2- SI text file 6. 
  
4.9 Supplementary Information  
Virus classifications. The ICTV classifies viruses into seven orders: Herpesvirales, 
large eukaryotic double-stranded DNA viruses; Caudovirales, tailed double-stranded DNA 
viruses typically infecting bacteria; Ligamenvirales, linear double-stranded viruses infecting 
archaea; Mononegavirales, nonsegmented negative (or antisense) strand single-stranded RNA 
viruses of plants and animals; Nidovirales, positive (or sense) strand single-stranded RNA 
viruses of vertebrates; Picornavirales, small positive strand single-stranded RNA viruses 
infecting plants, insects, and animals; and finally, the Tymovirales, monopartite positive single-
stranded RNA viruses of plants. In addition to these orders, there are ICTV families, some 
of which have not been assigned to an ICTV order. Only those ICTV viral families with 
more than a few members present in our dataset are explored.  
The Baltimore classification groups viruses into seven categories (Figure 1): double-
stranded DNA viruses (Group I); single-stranded DNA viruses (Group II); double-stranded 
RNA viruses (Group III); positive single-stranded RNA viruses (Group IV); negative single-
stranded RNA viruses (Group V); positive single-stranded RNA viruses with DNA 
intermediates (Group VI), commonly known as retroviruses; and the double-stranded DNA 
retroviruses (Group VII).  
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Comparing the sequence similarity of genomes found in Gene Order Pattern 
C. We wanted to examine the extent to which gene order sequences in a given pattern may 
be related at the sequence level, so we used BLASTN to identify genomes in pattern C that 
share any regions of homology. While the majority of sequences share at least a small degree 
of homology across their genomes (see Methods, SI Figure 3), genomes of Acinetobacter phage 
Petty, Lelliottia phage phD2B, and Synechococcus phage S-CBP4 do not share any significant 
homology at the nucleotide level with any other genome in pattern C (SI Figure 3). When we 
examined several structural proteins from these viruses using protein-protein BLAST, we 
found that they have homologous large terminase and tail tube B proteins. However, they 
have weak to nonexistent homology across their capsid, tail fiber, and tail tube A proteins 
(see Methods, SI Figure 3, SI text file 2- SI text file 6). This finding demonstrates that at least 
for some viruses despite limited homology across their nucleotide sequences, genome 
organization could still be detectably similar.  
 
 
SI Figure 1. Further exploration of the largest fraction of the eukaryotic 
virome: viruses of Opisthokonta supergroup (animals). The x-axis 
corresponds to the number of viruses infecting each host group. In a 
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recursive fashion, the host group with the largest number of known viruses is 
further zoomed in on (host groups infected by only a few known viruses are 
not shown). The host classification was obtained from the NCBI taxonomic 
database. 
 
SI Figure 2. Histograms of genome length (Log10) across all complete viral 
genomes associated with a host. Histograms are grouped according to four 
viral classification systems: A) Baltimore classification, B) Nucleotide type 
classification, C) Host Domain Classification, and D) ICTV classification. 
Instead of showing absolute viral counts on the y-axis, the counts are 
normalized by the total number of viruses in each viral category (the total 
counts of viruses in each category is denoted as N inside the plots). The 
mean of each distribution is denoted as a dot on the boxplots. The relevant 
statistics for each distribution is provided in SI Table 1. In each histogram 
the number of bins and their width is set by Freedman-Diaconis rule (35).  
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SI Figure 3. Exploring homology across genomes and proteins in gene order 
pattern C. A) Qualitative depiction of BLASTN results, wherein orange 
boxes correspond to homologous genomes (E value < 10-5), and blue denote 
non-homologous genomes. The genome number can be used to identify the 
genome name and its NCBI accession number. B) Gene order sequences for 
Acinetobacter phage Petty, Lelliottia phage phD2B, and Synechococcus phage S-CBP4, 
which are viruses with genomes that have no homology to any other 
genomes in pattern C. We compared their tail tube A, tail tube B, capsid, tail 
fiber, and large terminase proteins using protein-protein BLAST. SI text file 
2- SI text file 6 provide the BLASTP results. 
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SI Table 1. Genome length statistics for viral groups across different 
classification systems (rounded to the nearest kilobase).  
           
 
 
 
 
 
 
Classification Classification+Categories Min Max
25th+
Percentile
Median 75th+
Percentile
Mean Stdev.
Eukaryota)Viruses)(N)=)1384) 1.3 2473.9 4.9 7.5 11.1 27.7 110.5
Bacteria)Viruses)(N)=)969) 2.9 617.5 37.3 43.4 65.8 63.4 55.7
Archaea)Viruses)(N)=)46) 7.0 95.7 15.7 24.4 40.9 31.7 21.9
Group)I)(dsDNA))(N)=)1211) 4.8 2473.9 35.5 43.6 77.7 75.9 121.4
Group)II)(ssDNA))(N)=)431) 1.3 11.7 2.7 2.8 5.3 4.0 1.8
Group)III)(dsRNA))(N)=)123) 1.8 29.1 4.8 8.1 14.0 10.6 7.0
Group)IV)(+ssRNA))(N)=)482) 2.6 33.5 6.6 8.5 10.1 9.6 5.5
Group)V)(HssRNA))(N)=)101) 8.9 19.2 11.1 11.9 15.4 13.0 2.6
Group)VI)(ssRNAHRT))(N)=)14) 4.3 10.3 7.5 8.4 9.5 8.3 1.5
Group)VII)(dsDNAHRT))(N)=)37) 3.0 8.8 7.3 7.5 7.8 6.8 1.8
DNA)Viruses)(N)=)1679) 1.3 2473.9 5.5 38.3 56.6 55.9 108.0
RNA)Viruses)(N)=)720) 1.8 33.5 6.6 9.3 11.5 10.2 5.5
Caudovirales)(N)=)879) 11.6 358.7 39.1 44.5 70.2 67.9 52.5
Herpesvirales)(N)=)55) 119.5 295.1 144.9 159.2 211.5 177.0 45.1
Ligamenvirales)(N)=)11) 20.9 41.2 31.8 36.9 40.4 34.7 6.5
Mononegavirales)(N)=)71) 8.9 19.2 11.4 12.0 15.5 13.4 2.5
Nidovirales)(N)=)35) 12.1 33.5 20.1 26.7 31.0 25.8 5.6
Picornavirales)(N)=)89) 6.6 14.3 7.8 8.4 9.8 8.9 1.4
Tymovirales)(N)=)73) 5.5 9.4 6.7 7.9 8.5 7.6 1.0
All)Eukaryotic)dsDNA)viruses)(N)=)271) 4.8 2473.9 7.3 33.0 152.7 109.0 232.5
Baculoviridae)(N)=)22) 84.3 176.7 108.6 127.6 151.1 127.2 23.9
Poxviridae)(N)=)12) 150.0 307.7 170.6 237.2 282.9 233.1 56.2
Herpesvirales)(N)=)55) 119.5 295.1 144.9 159.2 211.5 177.0 45.1
Papillomaviridae)(N)=)73) 7.0 8.3 7.3 7.6 7.7 7.6 0.3
Adenoviridae)(N)=)31) 26.3 45.8 31.6 35.1 43.4 36.1 6.0
Polyomaviridae)(N)=)51) 4.8 6.2 5.0 5.1 5.3 5.1 0.2
All)Bacterial)dsDNA)viruses)(N)=)899) 10.1 617.5 39.0 44.4 69.8 67.8 55.5
Siphoviridae)(N)=)435) 14.3 280.0 38.0 43.1 53.1 50.5 30.5
Podoviridae)(N)=)200) 11.7 145.9 39.2 42.5 50.4 47.2 19.5
Myoviridae)(N)=)232) 11.6 358.7 47.4 136.4 164.0 118.1 69.2
All)Archaeal)dsDNA)viruses)(N)=)41) 8.1 95.7 17.4 28.3 41.2 34.5 21.6
All)Eukaryotic)ssDNA)viruses)(N)=)375) 1.3 8.1 2.7 2.8 5.2 3.5 1.4
All)Bacterial)ssDNA)viruses)(N)=)51) 4.4 11.7 5.8 6.8 7.8 6.8 1.5
Combinations+
of+different+
classifications
Host+Domain
Baltimore
Nucleotide+
Type
ICTV+(orders)
Genome+Length+Statistics+(kb)
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SI Table 2. Median gene length statistics for viral groups across different 
classification systems (rounded to the nearest base). It is important to clarify 
that the median values of this table represents the median of median gene 
lengths.   
    
 
 
 
 
 
Classification Classification+Categories
Min Max
25th+
Percentile
Median
75th+
Percentile
Mean Stdev.
Eukaryota)Viruses)(N)=)1384) 272 22173 702 1055 2129 2192 2770
Bacteria)Viruses)(N)=)969) 204 5100 366 408 456 429 192
Archaea)Viruses)(N)=)46) 195 762 324 400 462 412 119
Group)I)(dsDNA))(N)=)1211) 195 1577 380 429 555 539 269
Group)II)(ssDNA))(N)=)431) 204 2777 404 588 774 692 419
Group)III)(dsRNA))(N)=)123) 453 22173 1638 2291 3978 4148 4409
Group)IV)(+ssRNA))(N)=)482) 297 17715 828 2366 6372 3742 3266
Group)V)(GssRNA))(N)=)101) 648 5052 1167 1353 1568 1448 633
Group)VI)(ssRNAGRT))(N)=)14) 362 3530 1154 1799 2103 1805 921
Group)VII)(dsDNAGRT))(N)=)37) 368 6537 477 558 915 873 998
DNA)Viruses)(N)=)1679) 195 6537 393 444 708 586 354
RNA)Viruses)(N)=)720) 297 22173 1014 2072 4812 3452 3360
Caudovirales)(N)=)879) 224 972 369 408 456 419 76
Herpesvirales)(N)=)55) 669 1382 978 1107 1200 1092 151
Ligamenvirales)(N)=)11) 315 462 342 372 429 384 45
Mononegavirales)(N)=)71) 648 1896 1055 1266 1367 1218 275
Nidovirales)(N)=)35) 297 4920 537 672 1056 1045 1007
Picornavirales)(N)=)89) 3375 10041 6372 7056 8232 6963 1580
Tymovirales)(N)=)73) 402 5103 554 693 1014 1183 1138
All)Eukaryotic)dsDNA)viruses)(N)=)271) 272 1577 714 990 1179 958 271
Baculoviridae)(N)=)22) 582 843 647 672 711 680 57
Poxviridae)(N)=)12) 614 762 650 695 729 691 45
Herpesvirales)(N)=)55) 669 1382 978 1107 1200 1092 151
Papillomaviridae)(N)=)73) 272 1577 1170 1209 1338 1231 187
Adenoviridae)(N)=)31) 510 999 636 681 771 706 104
Polyomaviridae)(N)=)51) 639 1320 797 990 1055 930 158
All)Bacterial)dsDNA)viruses)(N)=)899) 224 972 369 408 456 419 78
Siphoviridae)(N)=)435) 248 644 366 401 429 402 57
Podoviridae)(N)=)200) 231 972 378 426 480 438 100
Myoviridae)(N)=)232) 224 678 372 419 483 431 76
All)Archaeal)dsDNA)viruses)(N)=)41) 195 762 315 396 459 405 120
All)Eukaryotic)ssDNA)viruses)(N)=)375) 300 2777 404 732 806 741 426
All)Bacterial)ssDNA)viruses)(N)=)51) 204 653 303 348 404 352 84
Combinations+
of+different+
classifications
Median+Gene+Length+Statistics+(bases)
Host+Domain
Baltimore
Nucleotide+
Type
ICTV+(orders)
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SI Table 3. Percent noncoding DNA (or RNA) for viral groups across 
different classification systems (rounded to the nearest percentage). 
     
 
 
 
 
 
Classification Classification+Categories
Min Max 25th+
Percentile
Median 75th+
Percentile
Mean Stdev.
Eukaryota)Viruses)(N)=)1384) 0 93 5 10 15 11 9
Bacteria)Viruses)(N)=)969) 3 92 7 9 11 10 6
Archaea)Viruses)(N)=)46) 3 21 7 10 13 10 4
Group)I)(dsDNA))(N)=)1211) 2 92 7 9 12 11 7
Group)II)(ssDNA))(N)=)431) 1 91 10 14 24 17 10
Group)III)(dsRNA))(N)=)123) 0 47 5 8 12 9 8
Group)IV)(+ssRNA))(N)=)482) 0 43 3 5 9 7 5
Group)V)(GssRNA))(N)=)101) 2 20 4 7 10 8 4
Group)VI)(ssRNAGRT))(N)=)14) 7 93 15 16 19 24 23
Group)VII)(dsDNAGRT))(N)=)37) 0 31 9 11 14 11 6
DNA)Viruses)(N)=)1679) 0 92 8 10 14 12 8
RNA)Viruses)(N)=)720) 0 93 4 6 10 8 7
Caudovirales)(N)=)879) 3 92 7 9 11 10 5
Herpesvirales)(N)=)55) 2 38 16 19 22 19 6
Ligamenvirales)(N)=)11) 8 21 9 12 17 13 4
Mononegavirales)(N)=)71) 2 20 4 8 10 8 4
Nidovirales)(N)=)35) 1 8 2 3 5 4 2
Picornavirales)(N)=)89) 2 23 9 11 12 11 4
Tymovirales)(N)=)73) 2 13 3 4 4 4 2
All)Eukaryotic)dsDNA)viruses)(N)=)271) 2 86 8 11 16 14 9
Baculoviridae)(N)=)22) 6 24 8 10 12 11 4
Poxviridae)(N)=)12) 6 22 7 10 13 11 5
Herpesvirales)(N)=)55) 2 38 16 19 22 19 6
Papillomaviridae)(N)=)73) 5 51 8 9 12 11 8
Adenoviridae)(N)=)31) 4 18 6 7 11 8 3
Polyomaviridae)(N)=)51) 4 31 9 11 14 12 5
All)Bacterial)dsDNA)viruses)(N)=)899) 3 92 7 9 11 10 5
Siphoviridae)(N)=)435) 3 39 7 9 11 10 5
Podoviridae)(N)=)200) 3 55 7 9 10 10 6
Myoviridae)(N)=)232) 3 92 7 9 11 10 6
All)Archaeal)dsDNA)viruses)(N)=)41) 3 21 7 10 13 10 4
All)Eukaryotic)ssDNA)viruses)(N)=)375) 1 80 10 14 24 17 10
All)Bacterial)ssDNA)viruses)(N)=)51) 4 91 8 14 19 16 14
Percent+Noncoding+(DNA/RNA)
Host+Domain
Baltimore
Nucleotide+
Type
ICTV+(orders)
Combinations+
of+different+
classifications
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SI text files  
SI text files are included as part the SI Text Files folder at the following GitHub repository:  
https://github.com/gitamahm/VirologyByTheNumbers 
 
SI text file 1. Gene order sequences for all viruses whose genomes contained 
at least 15% labeled genes. Letters I, C, E, and Q correspond to capsid-
related, portal-related, tail-related, and genome packaging-related genes, 
respectively. All other genes are denoted by the letter A.  
 
SI text file 2. BLASTP report for the tail tube A protein found in Acinetobacter 
phage Petty, Lelliottia phage phD2B, and Synechococcus phage S-CBP4 genomes.  
 
SI text file 3. BLASTP report for the tail tube B protein found in Acinetobacter 
phage Petty, Lelliottia phage phD2B, and Synechococcus phage S-CBP4 genomes.  
 
SI text file 4. BLASTP report for the tail fiber protein found in Acinetobacter 
phage Petty, Lelliottia phage phD2B, and Synechococcus phage S-CBP4 genomes.  
 
SI text file 5. BLASTP report for the capsid protein found in Acinetobacter 
phage Petty, Lelliottia phage phD2B, and Synechococcus phage S-CBP4 genomes.  
 
SI text file 6. BLASTP report for the large terminase protein found in 
Acinetobacter phage Petty, Lelliottia phage phD2B, and Synechococcus phage S-CBP4 
genomes.  
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C h a p t e r  V   
Human Phageprints: Commensal phage communities reveal 
individual-specific and temporally-stable signatures 
 
 
5.1 Introduction 
The study of bacteriophages (phages) often relies on culturing the bacterial hosts. 
Because the vast majority of microbes are currently unculturable, we have only recently 
become aware of the overwhelming presence of phages in natural environments through 
metagenomic and imaging studies (1, 2). These recent studies collectively paint phages not 
only as the most numerous and diverse biological entities on our planet, but also as 
regulators of microbial ecosystems through rapid infection cycles and horizontal gene 
transfer events (3-7). Yet, compared to their bacterial hosts, and despite their medical, 
biogeochemical and agricultural importance, environmental phages remain largely under-
sampled and poorly characterized (8-12).      
One of the defining features of phage genomes (and viruses in general) is the lack of 
the ribosomal RNA sequence that has remained highly conserved across cellular genomes. 
The 16S ribosomal RNA sequence (18S in eukaryotic genomes) is used as a universal 
marker, and its sequence variation across genomes can be used to draw conclusions about 
cellular classification and evolution (13-15), as well as geographical distribution and 
community composition (16, 17). This marker-based approach to microbiology is 
indispensible, as it enables a high coverage depth of the 16S region via PCR-amplification 
and high-throughput sequencing. This depth of coverage provides a precise and 
reproducible depiction of bacterial community composition across space and time (18-20). 
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Given current sequencing technology, the trade-off for coverage depth is the coverage 
breadth, as only a small region in the genome can be sequenced (Figure 1). 
 
Figure 1. Comparison of A) metagenomic sequencing and B) targeted 
sequencing approaches. A) Metagenomic sequencing offers high breadth of 
coverage, spanning genomes from many different organisms, however it 
suffers from low depth of coverage (shown here by the incomplete assembly 
of phage genomes). B) Targeted sequencing approaches, such as 16S 
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sequencing, which use PCR to amplify a specific genomic region, exchange 
breadth of coverage for depth. Targeted sequencing studies, due to their 
greater depth of coverage, provide much higher resolution for constructing 
the community composition by equating coverage depth with relative 
abundance of species or strains.   
 
In comparison to the targeted marker-based approach, metagenomic studies provide 
much greater breadth in coverage (Figure 1). Typically, these studies obtain genomic 
sequences from many different organisms, but the coverage depth remains comparatively 
low. Assuming an equal distribution of species or variants within a sample, coverage depth 
can be estimated as ! = ! !"! , where ! represents sequencing read length, ! represents the 
total number of reads, and ! represents the total length of genome(s) or genetic segment(s) 
of interest (21). For example, using 100 million, 150-bp Illumina HiSeq reads to sequence a 
marker of length 150 bp, would provide a coverage depth of  !"#!!×!!"!!"#  or 108x. This would 
mean that each base pair along the makrer’s length would be sequenced 108 times. On the 
other hand, if the same sequencing conditions are used for metagenomic sequencing of a 
sample hypothetically composed of 100 different bacterial genomes (assuming an average 
bacterial genome length of 106 bp (22)) the coverage depth would drop to just !"#!!×!!"!!""!×!!"!  = 
150x. Natural environments are often far more complex, containing many different species 
and strains of organisms with varying abundances (23). One of the manifestations of this 
problem is that de novo assembly of genomes from natural environments through current 
metagenomic techniques remains a significant challenge (24), even for the most abundant 
members of an environment with relatively short genome lengths (25).  
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 Moreover, the coverage depth of a genome through metagenomics varies greatly 
across the length of the genome. Even for complete genome assemblies from metagenomic 
samples, the assemblies represent consensus genomes (average representation of highly 
similar genomes within an environment). In these studies, it is typical to see genomic 
segments with ~100x coverage depth that are islands in the sea of low coverage depth 
regions (< 10x) (26-28). However, when a variant appears 1 in 1000 sequences, 100x 
coverage does not provide adequate resolution needed to assess the sequence diversity of 
this genomic region. Because of this limitation of metagenomics, the marker-based 
exploration of microbial community composition often provides a more reliable and 
accurate approach (29-31).  
Due to the lack of a 16S-analog within viral genomes, the study of environmental 
phages has typically relied on metagenomic studies (5, 32-34). While these studies have 
unveiled intriguing facets of environmental phage biology, insufficient coverage depth fails 
to provide a detailed view of phage community composition. Thus, to explore 
environmental phage communities at a higher resolution than is typically offered through 
metagenomics, we decided to take a targeted, marker-based approach. We hypothesized that 
due to the immense sequence diversity of phage genomes (35-37), a high-resolution view of 
their communities could provide novel insights.  
Considering the lack of universal markers for phages, we aimed to discover 
environment-specific phage markers so that we could study previously unexplored phage 
families (we will provide a more precise description of this term later in this section). As we 
will demonstrate, this marker-based approach reveals phage community composition with a 
resolution that cannot be achieved through typical metagenomic approaches. Specifically, we 
will follow others (38, 39) in using the term “community composition” to refer to the 
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relative abundance profile of members within a phage family. We will further demonstrate 
that at this resolution, phage community composition can serve as a fingerprint, or a 
“phageprint” – highly unique to an environment and apparently stable over time.  
In our search for candidate phage markers, we combined the advantages of 
metagenomic and marker-based approaches. Namely, to study previously unexplored phage 
families, we first used existing metagenomic datasets to identify candidate phage families, 
and then by targeting these families using degenerate primers and PCR, we were able to 
explore them with high coverage depth (see Methods). We limited our bioinformatic and 
later experimental search for ubiquitous phage families to those inhabiting the human oral 
cavity. Our motivation to study phages within the human oral environment was rooted in 
this environment’s diversity of microbial inhabitants, key role in human health and disease, 
feasibility of sample collection, and the wealth of existing oral metagenomic datasets (40-43).  
Briefly, to arrive at markers representing ubiquitous oral phage families, we imposed 
several guidelines: 1) candidate marker sequences should be unique to phages; 2) candidate 
phage markers should be present across different metagenomic datasets so to increase the 
likelihood that the markers will represent core (though not necessarily abundant) members 
of the human oral environment; and 3) candidate markers representing different phage 
families should not share any significant sequence similarity.  
To meet the first criterion, we focused our search on the terminase large subunit 
(TerL) sequences, which are shown to be unique to phages (44, 45). To meet the second 
criterion, we used two metagenomic datasets, the Xie (46) and the Mira (47) datasets, to 
identify potentially ubiquitous phage makers based on their presence in both datasets. Using 
two larger metagenomic projects, namely the HOMD (43) and the HMP (48), we confirmed 
the presence of candidate phage markers across a greater number of human oral samples. In 
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meeting the third criterion, pairwise sequence similarity analysis was performed to exclude 
markers that share any sequence similarity to each other (see Methods). Finally, by designing 
degenerate primers for the candidate phage markers, we experimentally confirmed marker 
presence in human oral samples, and developed a marker-based survey of phage 
communities with high resolution. In the absence of a taxonomic convention for viral 
genomic data, we use the term “phage family” to refer to phages that share homologous 
TerL sequences.  
 For the bulk of our sample collection, we took a citizen science approach. By 
creating instructional videos and sample collection kits (see Methods), volunteers collected 
~700 oral samples (representing ~100 individuals). Using this large collection of samples, we 
were able to explore phage communities as a function of space (Figure 3, Figure 5, Figure 6, 
Figure 12) and time (Figure 9, Figure 10, Figure 11). By examining phage communities at 6 
different oral sites, and by comparing phage communities of individuals living across the 
globe, we were able to study the effect of spatial separation, ranging from several millimeters 
to thousands of kilometers. We found that the spatial separation of just a few centimeters 
(the distance between the gingival sites and the hard palate, for example) can already result in 
highly distinct phage communities. For larger distances, spanning the phage communities of 
different individuals, we did not observe any correlation between spatial distance and phage 
community composition. In other words, individuals residing in the same city did not have 
any more similar phage communities than individuals living on different continents.  
Additionally, we found that neither genetics nor cohabitation played a role in the 
relatedness of phage communities across individuals. Cohabitating siblings and even identical 
twins did not have phage communities that were any more similar than those of unrelated 
individuals (Figure 12). The only factor we observed that contributes to phage community 
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relatedness is direct exchange of saliva between individuals, as is demonstrated by the 
similarity between phage communities of couples (Figure 11, Figure 12).  
By exploring phage communities across the span of a month, we observed highly 
stable communities (Figure 8, Figure 9, Figure 10, Figure 11). These studies consistently 
point to the existence of remarkably diverse and personal phage families that are stable in 
time.  
 
5.2 Results 
5.2.A Discovery of phage families ubiquitous across humans  
To test our bioinformatics predictions regarding the presence of ubiquitous phage 
families, we designed degenerate primers (see Methods). We then tested to see if the primers 
would be able to amplify the candidate phage marker sequences from oral samples 
previously collected from 10 individuals and 6 oral sites (40). We found that many samples 
were positive for the phage families that were targeted via four of the primer sets (Figure 2). 
To further explore these phage families, we developed instructional videos and collection 
kits to recruit volunteers for our study (see Methods). 700 additional oral samples from 100 
different individuals were collected, the results of which will be discussed in later sections. 
We will focus our discussions on the most ubiquitous phage families, namely HA, HB1 and 
PCA2.  
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Figure 2. A qualitative depiction of phage family presence in oral samples 
collected from 10 healthy individuals and 6 different oral sites. Filled-in 
circles indicate presence of a phage family, and blank circles correspond to 
absence of that phage family.  
 
5.2.B An exploration of three phage families reveal the presence of highly personal 
phage communities with varying degrees of conservation across different oral 
sites 
 As previously defined in the introduction, due to the high depth of coverage 
afforded through targeted sequencing, the relative abundance of OTUs provides a highly 
reproducible snapshot of the phage community composition (see SI). As shown in Figure 3 
and Figure 4, phage community composition is highly skewed towards one or two dominant 
OTUs. However, there are also many other OTUs with abundance values that are consistent 
across space (different oral sites) and time. Generally, the dominant OTUs are not the same 
across different individuals, and the presence of numerous other OTUs with stable relative 
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abundances, gives rise to phage community compositions that appear highly personal. 
Therefore, we sometimes use “phageprint” as shorthand to refer to a community 
composition plot.  
 
Figure 3. HA phage community compositions (phageprints) across 4 
different oral sites in subject 16. Each phageprint is derived from the analysis 
of 4000 sequences (see SI). OTUs are defined at 98% sequence similarity and 
OTUs with less than or equal to 0.1% relative abundance across all 
phageprints were filtered out (see SI). 
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Figure 4. HA Phage community compositions (phageprints) from subject 37 
at two different time points. Samples were collected from the tongue 
dorsum.  A) Subject 37’s phageprint at 0th time point, collected right after 
brushing tongue dorsal and teeth surfaces. B) Subject 37’s phageprint 24 
hours after the initial time point (no brushing in between time points). Each 
phageprint is derived from the analysis of 4000 sequences (see SI). OTUs are 
defined at 98% sequence similarity. 
 
To further quantify the differences between phage community compositions, we 
depict each pairwise comparison of community compositions by their Pearson correlation 
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coefficient (r-value). In comparing any pair of communities, there were ! OTUs. Pearson 
correlation coefficient of community compositions ! and !, was calculated according to 
(!!!!!!!! !)(!!!!!)(!!!!!! !!)! (!!!!!! !!)! . Here, !! ! and !! ! are relative abundance values of !"#!  in 
community compositions !  and ! , respectively, and !  and !  are average OTU relative 
abundances for community compositions ! and !. A ! by ! matrix of Pearson correlation 
coefficients was created and shown as a heatmap for each phage family, with ! representing 
the number of phage community compositions.  
 Figure 5 summarizes the Pearson correlation matrix for the HB1 phage family 
across 9 individuals and 4 different oral sites. An immediately recognizable pattern is that the 
phage community compositions of an individual are highly correlated. In stark contrast are 
the correlations between the phage community compositions of different individuals. 
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Figure 5. Pearson correlation coefficient matrix of HB1 phage community 
compositions spanning 9 subjects and four oral sites. Each community 
composition is derived from the analysis of 4000 sequences associated with 
an individual and a particular oral site. OTUs are defined at 98% sequence 
similarity and OTUs with less than or equal to 0.1% relative abundance 
across all phageprints were filtered out (see SI). Phageprints are color-coded 
based on the individual they originate from. Community compositions that 
have been replicated at least twice and averaged have an asterisk next to them 
(see SI).  
 
As in the case of the HB1 phage family, there is low to non-existing 
correlation between the HA phage community compositions of different individuals 
(Figure 6), reinforcing the notion of highly personal phage communities. However, 
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unlike HB1, not all oral sites within the same subject are highly or even moderately 
correlated (see subjects 3, 12, and 17).  In subject 12 for example, the tongue dorsum 
has a correlation close to zero with supra-gingiva and sub-gingiva sites, which are 
nearly perfectly correlated. Similarly, in subject 3, the hard palate and the tongue 
ventral surface have nearly identical phage community compositions while they have 
a very low correlation with the community at the tongue dorsum. However, unlike 
subject 12, the tongue dorsum in subject 3 seems to be an intermediate community, 
having a moderate correlation with all other sites that are distinct from each other. In 
subject 17 as well, buccal mucosa serves as the intermediate community, having a 
moderate correlation with the disparate communities of sub-gingiva and the hard 
palate.  
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Figure 6. Pearson correlation coefficient matrix of HA community 
compositions encompassing 11 subjects and six oral sites. Each community 
composition is derived from the analysis of 4000 sequences associated with 
an individual and a particular oral site. Samples are color-coded based on the 
individual they originate from. Oral sites shown are the tongue dorsum (TD), 
buccal mucosa (BM), supra-gingiva (SP), sub-gingiva (SB), hard palate (HP), 
and ventral surface of the tongue (TV). Samples whose community 
composition has been replicated at least twice and averaged have an asterisk 
next to them (see SI).  
 
 SI Figure 1 represents yet another phage family’s Pearson correlation coefficient 
matrix. As with the HA and HB1 phage families, PCA2 phage community compositions 
appear specific to individuals, and in some cases they are even specific to an individual’s oral 
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site. While subject 16 and subject 25 have highly correlated phage community compositions 
across different oral sites, subjects 10 and 12 have uncorrelated phage communities 
separated by intermediate communities similar to subjects 3 and 17’s HA phage communities 
(Figure 6).  
In contrast to the other phage families, which were found across all oral sites, the 
HB1 phage family is absent from the hard palate and the tongue ventral surfaces. The HB1 
communities at the gingival sites and the buccal mucosa tend to be highly correlated, and the 
buccal mucosa community is moderately correlated with the tongue dorsum community (SI 
Figure 2). Similarly, the HA phage communities at the gingival sites are highly correlated (SI 
Figure 2).  
Using bipartite network diagrams (Figure 7, SI Figure 3, SI Figure 4, SI Figure 5) we 
can further examine phage communities. For example, the HB1 phage family network 
degree distribution appears to fit a power-law model, with the majority of OTUs occurring 
only in one subject. Using these networks we can begin to see the differences between the 
community compositions at different oral sites that were identified as only moderately 
correlated using the Pearson correlation matrices. In viewing the HB1 phage family network 
(SI Figure 5), we can see that in subject 16, in addition to OTU 5, which is abundant on the 
tongue dorsum and the buccal mucosa, OTU 8 has exclusively thrived on the buccal 
mucosa, while OTU 11 is only pervasive on the tongue dorsum. Similarly, subjects 17 and 3 
each have a second-abundant OTU that is exclusive to the buccal mucosa surface, 
distinguishing this site from the phage communities at gingival sites, which they are 
moderately correlated to.  
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Figure 7. HB1 phage-host network and degree distribution. A) Two types of 
nodes exist: OTU nodes (purple), and subject nodes. Subject nodes and 
0.3
140
32
9
208
132 6
2
20
2
80
273
82
165
229
4
231
1
206
87
256 48
24
9
86
117
22
1
122
2
29
16
2
54
255
10
233
20
3
14
77
21
272
15
16
1 26
34
241
257
44
19
5
197
216
20
7
24
18
12
67
118
21
8
59
60
265
261
10
9
5
176
220
222
51
30
184
7
242
33
264
14
9
13
250
123
22
274
10
4
1962
25
42
259
238
36
38
46
210
23
7
27
6
178
50
262
75
21
3
112
170
164
72
227
245
8111
8
260
166
189
128
71
19
68
13
4
236
142
106
40
25
10
3
17
0
37
3
90
89
183
HB1$Network$Degree$Distribu2on$
Subject(node(ID(and(color1code$
3 6 12 16 17 31 35 37 38
A$ B$
Subject$nodes$
1 2 3 4 5 6 7 8 9
0
0.1
0.2
0.3
0.4
0.5
 
 
Degree$
Fr
ac
2o
n$
of
$O
TU
$n
od
es
$ General$model$Power1:$$$$$$f(x)$=$a*x^b$
Coeﬃcients$(with$95%$conﬁdence$
bounds):$
$$$$$$$a$=$$$$$$$0.554$$(0.4994,$0.6087)$
$$$$$$$b$=$$$$$$X1.815$$(X2.155,$X1.474)$
Goodness$of$ﬁt:$
$$SSE:$0.003785$
$$RXsquare:$0.9838$
$$RMSE:$0.02325$
HB1$phage$clade$with$a$
broad$microbial$host$range$
Rhodococcus(equi(phage$(ReqiPepy6)$
Rhodococcus(equi(phage$(ReqiPoco6)$
Clostridium(symbiosum(phage$
Clostridium(scindens$phage$$
Clostridiales(VE202903(phage$
Clostridium(hathewayi$phage$
Ruminococcus(torques(phage$
Ruminococcus(sp(CAG:17$phage$
Ac3nobacteria(
Firmicutes,(Lachnoclostridium(
Firmicutes,(Ruminococcus(
HB1$phage$clade$with$
conﬁned$microbial$host$
range$
C$
HB1(microbial(host((color1coded(
  
V-17 
edges are color-coded based on the individual they represent. Each directed 
edge connects an individual to a phage OTU that he/she harbors, and the 
edge weight is proportional to the relative abundance of the OTU in that 
individual’s oral community. OTU node sizes and labels are proportional to 
the number of individuals the OTU is present in. For OTU nodes, the node 
ID is the OTU ID, which can be matched to IDs in SI Table 1 and SI Table 
2 for obtaining taxonomic information regarding each OTU’s representative 
sequence. Refer to SI Figure 5 to see a similar network that shows OTUs 
present at different oral sites. B) The degree distribution of HB1 phage 
network. This distribution was obtained by making a histogram of OTU in-
degrees, or the number of individuals that each OTU is present in. C) 
Maximum Likelihood phylogenetic tree of OTU representative sequences 
(see SI Figure 7 for their nucleotide alignment) for the HB1 phage family. 
Red circles are placed next to OTUs that are prevalent (appear in multiple 
samples). Branches are color-coded based on the organism in whose genome 
the closest homolog of the OTU representative sequence was found (see SI 
Table 1, SI Table 2).  
 
In all of our analysis so far, we have used the Pearson correlation because it allows 
for a coarse-grained depiction of differences between phage communities, as it is dominated 
by the most abundant OTUs. We will also use other distance metrics to explore different 
facets of phage communities in later sections. Moreover, we have carefully explored the 
effects of sequence similarity thresholds when defining OTUs, and we discovered that the 
phage community compositions, as represented by pairwise Pearson correlation coefficients, 
are highly robust to sequence similarity thresholds used for defining OTUs (see SI). 
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5.2.C A bioinformatic search for the bacterial hosts 
Because we aimed to study previously uncharacterized phages, the bacterial 
hosts for the phage families in this study have not yet been cultured or 
identified. However, using homology search we can identify candidate host 
species. Figure 7 (right panel) demonstrates organisms that were found to 
have terminase sequences homologous to HB1 sequences found in the 
human mouth. Each OTU’s most abundant sequence served as its 
representative sequence and was used as a query for BLASTx homology 
search. With the exception of a few sequences tagged as “putative proteins”, 
all resulting homologs were terminase sequences with very low E-values (less 
than 10-19) (SI Table 1). This was true for the HA and the PCA2 marker 
sequences as well (SI Table 3 and SI Table 5  
SI Table 5).  
The majority of HB1 homologs belonged to ReqiPepy6 phage isolated from 
Rhodococcus equi, a member of the Actinobacteria phylum. Recognized as a major pathogen in 
foals and an emerging pathogen in immunocompromised humans, R. equi inhabits soil as 
well as a diverse range of organisms such as cattle and pigs (49). Other OTU homologs were 
matched to ReqiPoco6, another R. equi phage, and six species spread across two different 
families of the Firmicutes phylum.  
In the phylogenetic tree composed of HB1 OTU representative sequences (Figure 
7), two major clades have formed. The first clade is entirely composed of sequences that are 
ReqiPepy6 phage terminase homologs. The second clade contains a mixture of sequences 
with homologs captured from phages of two different host phyla and three different 
families. Despite the great diversity and host range observed in sequences from the second 
clade, red circles placed next to prevalent OTUs (those that appear in multiple individuals) 
(Figure 7) reveal that the majority of these OTUs belong to the first clade. Moreover, the 
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HA phage family infects only a single genus of Firmicutes (Streptococcus), but appears 
embedded in the genomes of many different species within this genus (SI Table 4). 
 
5.2.D Oral phage community temporal dynamics in the span of 30 days 
We have so far demonstrated the highly personal nature of phage communities 
residing in the human mouth. To better understand the temporal stability of these phage 
communities, 10 subjects collected one sample per day (from tongue dorsum) for 30 days. 
The HB1 community composition as it evolved over 30 days inside subject 1 is depicted in 
Figure 8. Here, to provide a more detailed view of this community, we cluster the reads into 
OTUs based on 100% similarity (hence the 10,000 OTUs that are listed). These OTUs are 
shown in Figure 8 ordered based on their phylogenetic distance.  
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Figure 8. A 3D surface plot depicting the HB1 phage community 
composition as it evolves over 30 days on subject 1’s tongue dorsum. The x-
axis contains ~10,000 OTUs ordered according to the depicted phylogenetic 
tree of the OTU sequences (the phylogenetic tree is provided largely to serve 
as a schematic since it is hard to visualize the details of this tree). Each OTU 
is composed of identical sequences (i.e. 100% sequence similarity threshold). 
The y-axis depicts the relative abundance of each OTU, and the z-axis shows 
the fluctuations in relative abundance of each OTU in time. (Note, the colors 
shown correspond to an abundance-based heatmap, which provides 
redundant information since the y-axis provides this information, however 
the colors are kept because they allow for a better visualization of 
fluctuations in low-abundant OTUs.)   
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Surprisingly, over 30 days, the main features of the HB1 community composition is 
preserved, though there are also interesting fluctuations that are well above the experimental 
error and detection threshold (see SI). Figure 9 demonstrates different degrees of temporal 
stability and phylogenetic diversity across individuals. However, a global trend is that the 
dominant OTUs remain dominant over the span of 30 days in all subjects.  
 
Figure 9. Depictions of HB1 phage community evolution in different 
subjects over 30 days. The format of the plots is the same as that of Figure 8, 
and the order of OTUs is based on their phylogenetic distance and identical 
across all plots. All samples are collected from the tongue dorsum. Note that 
subject 2 and 4 are a couple, and their phage community compositions share 
some main features. 
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To further examine the phage community dynamics, we used several distance metrics 
to create pairwise comparisons within and between phage community compositions (Figure 
10).  The first metric explored is binary Jaccard distance, which is equal to one minus the 
ratio of the intersection to the union of two samples’ OTUs: 1− ! |!∩!|! ! ! !|!∩!|. Here, ! and ! represent the OTUs that are present in sample 1 and 2, respectively. This is a binary 
method of comparing samples simply based on the presence/absence of the OTUs. In 
addition to the Pearson distance (1- Pearson correlation), we chose two other abundance-
based distance metrics, namely abundance-weighted Jaccard and Bray-Curtis. Abundance-
weighted Jaccard, which is equal to 1− ! !"!!!!!" (50), is similar to Jaccard but here ! and ! 
represent the sum of relative abundances of OTUs shared between samples 1 and 2, 
respectively. Bray-Curtis dissimilarity (51) is defined as  
|!!"!!!!"|!!"!!!!" , where !!"  and !!" 
correspond to the relative abundance of OTU ! in samples ! and !.  
Lastly, we explored unweighted Unifrac, a phylogenetic distance metric (52). The 
Unifrac algorithm operates on a phylogenetic tree containing sequences from all samples. It 
proceeds to create pairwise comparisons between samples by identifying the branch lengths 
that are shared between two samples, as well as the branch lengths that are unique to each 
sample. The Unifrac distance is then defined as the unshared branch lengths divided by the 
total branch lengths, where total branch lengths is the sum of shared and unshared branch 
lengths. If two samples are identical, the fraction of the tree’s branch lengths that is unique 
to one sample or the other will be zero, and thus, the Unifrac distance will be zero.  
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Figure 10. HB1 phage community temporal dynamics (previously shown 
graphically in Figure 9) depicted here by pairwise distance metrics: A) 
Peason, B) Binary Jaccard, Abundance Jaccard, Bray Curtis and unweighted 
Unifrac. The heatmap scale applies to all heatmaps shown. Subjects 02 and 
04 are a couple. Samples from each subject are chronologically ordered.  
 
All distance metrics explored paint similar pictures of the HB1 phage communities, 
depicting them as highly personal and stable over time. Because phage communities in 
different individuals have such distinct composition (Figure 9) abundance-based metrics are 
especially suitable for describing them. However, even the binary Jaccard and weighted 
Unifrac distance metrics demonstrate a similar message, which is consistent with HB1 
network’s degree distribution (Figure 7). Figure 11 further demonstrates the intra-and -
interpersonal distances as measured through these various distance metrics. As is expected 
from the heatmaps shown in Figure 10, the intra-personal distances are markedly different 
from the inter-personal, with the notable exception being subject 2 and 4, who are the 
couple in the study.  
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Figure 11. Intra-and inter-personal distances between HB1 phage 
communities from 10 subjects, over the span of 30 days (further quantifying 
the heatmaps from Figure 10). Box-plots depict distances from pairwise 
comparisons made using the following metrics: A) Binary Jaccard, B) 
Abundance Jaccard, C) Bray-Curtis, D) Pearson, and E) unweighted Unifrac. 
The outliers defined as those outside of the 1.5 x IQR (inter-quartile range) 
are denoted by “+”. The box-plots corresponding to the comparisons 
between the couple in this study are highlighted.  
 
5.2.E Phage community comparisons across siblings, couples, and non-related 
individuals residing across the globe 
 Given the ubiquitous presence of the phage families across subjects residing in the 
U.S. we wondered whether phage families (HA and HB1, specifically) are globally 
distributed, and whether subjects residing in the same country would have more similar 
phage communities. We discovered that phage families were in fact found in individuals 
from various ethnicities, nationalities, and ages. Surprisingly, neither from abundance-based 
nor phylogenetic distance comparisons did we find an indication that people residing in the 
same country share more similar phage communities (Figure 12). We found individuals 
typically have highly unique phage communities.  
 Even siblings who were either living in the same household or had previously, do not 
have any more similar phage communities than unrelated individuals. In fact, one of the four 
sibling groups with uncorrelated phageprints are identical twins (Figure 12). However, 3 out 
of 4 couples in this study exhibited highly similar phage communities. These results suggest 
that genetics and cohabitation do not significantly impact a person’s oral phage community. 
The more impactful factor appears to be direct oral contact with another person. To further 
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test these trends, larger studies encompassing a greater number of individuals and regions in 
the world are required. 
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Figure 12. HB1 phage community across 61 individuals residing across 
different parts of the globe. Samples are obtained from the tongue dorsum. 
A) Pearson distance (1 – Pearson correlation) is shown as a heatmap. A 
subset of individuals residing in the U.S. are either couples or siblings. Green 
and red boxes are drawn around samples from each sibling group and 
couple, respectively. B) Intra- and inter-country distances from pairwise 
comparisons made using Bray-Curtis and unweighted Unifrac distance 
metrics. The outliers are denoted as points outside of the 1.5 x IQR (inter-
quartile range). Siblings and couples are excluded from this analysis.  
 
5.3 Discussion 
Our method for finding ubiquitous human oral phages relied on a relatively small  
metagenomic dataset, which contained sequences from 6 individuals residing in Spain (47). 
Yet, on the basis of markers designed from this small dataset we were able to identify the 
same phage families in at least 10 times as many individuals from across the globe. This 
finding seems to suggest that despite the great sequence diversity that has been revealed 
through viral metagenomic surveys, there exist certain phage families that are a stable feature 
of the human oral microbiome. Studies of phages from various natural environments (e.g. 
marine, soil, lakes) also report the finding of phage families that are distributed across similar 
types of habitats despite vast geographical distances and barriers that exist between these 
habitats (9, 53, 54). The discovery of core bacterial members within the human microbiome 
(40, 55, 56) that are present globally (42) further support our discovery of globally distributed 
phage families. Similar to our findings for phages, the oral bacteria of individuals from the 
same part of the world was as different from each other as they were to individuals from 
other parts of the world (42).  
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The ubiquitous presence of the identified phage families in individuals, together with 
their temporal stability, seems to suggest that they likely play important roles in this 
environment. The observed temporal stability of these phage families over the span of a 
month is supported through metagenomic studies of oral phages (57, 58) as well as 16S 
sequencing of bacterial communities inhabiting various sites in the human body (55, 59, 60). 
Our study represents one of the largest studies of human oral phages. As a comparison, the 
most recent version of the Human Microbiome Project, contains samples from 265 
individuals (61). However, future studies are required to more systematically account for diet, 
ethnicity, and other parameters across tens of thousands of individuals across the globe.  
A particularly important aspect of our study is that it combined the advantages of 
metagenomics with targeted sequencing to not only identify core phage families inhabiting 
the human oral cavity, but to also characterize their communities with a resolution that is 
unavailable through metagenomic studies of phages. This detailed view allowed us to clearly 
observe the highly complex, and personal nature of phage community compositions. 
Moreover, the emergence of phageprints is directly the result of the remarkable phage 
sequence diversity that we were able to capture via targeted sequencing. For example, we 
observed a few hundred HB1 OTUs (defined at 97% sequence similarity). This is a 
staggering number when considering that this is about the same number as the total number 
of bacterial OTUs (defined at 97% sequence similarity) in the human mouth (47, 55). Even 
though the HB1 phage family is only one of many oral phage families, it by itself contains 
the same level of sequence diversity as the entire bacterial population in the human mouth. 
This perhaps explains the need to use highly elaborate algorithms applied onto 16S and 
metagenomic sequences from all bacterial strains to be able to identify a person based on 
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his/her microbiome with a similar level of accuracy as our method, which only employs 
sequences from one phage family (62).  
Because of the great diversity of sequences associated with just one phage family, in 
our study of about 60 individuals we found only one case where unrelated individuals whose 
phageprints had similar correlation coefficients. This may be due to experimental error or 
due to the course-graining associated with Pearson correlation matrices. However, if we 
conservatively assume that each phage family can provide only 50 unique patterns, then the 
combination of phageprints from just 6 phage families would already provide a greater 
number of possible patterns than the size of the current human population. This is assuming 
that these phage families will be physiologically independent of each other. Future studies 
are needed to test the long-term stability of the human phageprints especially with regard to 
perturbations such as exposure to antibiotics. To our knowledge, this is the first study that 
demonstrates the potential application of phage sequences for human identification.  
 
Figure 13. An estimate for the number of additional globally-distributed 
phage families needed to achieve the number of possible phageprint patterns 
that surpass the current human population. Assuming that phageprints from 
each phage family can provide 50 unique patterns, there would only be 3 
additional globally distributed phage families needed.  
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5.4 Materials and Methods 
Materials and Methods (an overview).  This section will comprise a condensed 
description of phage marker discovery, experimental methods such as sample collection, 
barcoded PCR, sequencing, and experimental reproducibility analysis, as well as 
bioinformatic methods such as sequence quality control measures, sequence demultiplexing 
and clustering. Figure 14 provides a schematic summary of some of the main experimental 
and bioinformatic methods employed.  
 
 
Figure 14. A schematic summary of the main experimental and bioinformatic 
methodologies presented in this chapter: 1) Discovery of ubiquitous phage 
families by examining large terminase sequences that occur across different 
metagenomic datasets, 2) sampling, 3) DNA extraction from oral biofilm 
samples, 4) PCR using barcoded primers followed by PCR clean-up, 5) 
paired-end Next Generation Sequencing, 6) joining paired-end reads to 
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eliminate sequencing errors, 7) various additional quality control steps to 
further eliminate errors, 8) demultiplexing of reads based on their barcode 
sequence and tagging sequence names by the sample they originate from, 9) 
gathering reads from all samples and clustering them based on sequence 
similarity (OTUs), 10) counting the number of sequences belonging to each 
OTU from each sample (i.e. constructing an OTU table), and rarefying the 
table so that each sample is represented by the same total number of 
sequences, and 11) performing various down-stream diversity analysis (e.g. 
community composition plots or phageprints) using the constructed OTU 
table as the basis.  
 
 Phage marker discovery. Focusing on the oral cavity, we applied a metagenome 
clustering program called MetaCAT (63) to eight oral metagenomes obtained from six 
human subjects with varying degrees of oral hygiene (47). MetaCAT reports the most 
abundant genes in a metagenome based on an annotated reference library provided by the 
user. As a reference library we used the viral RefSeq database (v48) (64) containing 2727 
distinct viral taxonomic IDs, spanning 96713 viral gene records. Applying MetaCAT to the 
eight Mira metagenomes yielded 8757 known RefSeq viral genes. This list was manually 
screened for RefSeq genes containing the case insensitive keywords “terL”, “terminase”, or 
“packa” in the definition of the known reference gene or in the features field of the GenPept 
file provided by MetaCAT. From the 1.9×106 contigs, 119 contained TerL genes, which 
when cross-BLASTed against a second oral metagenomic dataset obtained from a healthy 
individual (46), reduced to eleven candidate markers.  
After removing redundant markers using additional alleles recovered from public 
genomic oral datasets we found seven full length TerL genes representing unrelated lineages 
(maximum percent identity < ~30%), labeled HA, HB1, HB2, PCA1, PCA2, AB1, and AB2, 
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all present in a context of phage-related genes. The labels were made according to the 
database from which each marker was identified (H=healthy, PC=past caries, A=active 
caries, C=cavities), followed by the patient index (patient A or B for the given dental 
category), and a counter of the TerL solution found in the given metagenome. Moreover, in 
order to derive markers that span the full length of the TerL gene we applied a 
bootstrapping approach in which the seven TerL+ contigs were used as hooks to recover 
additional alleles from several datasets. This was achieved by BLASTing the amino acid 
sequence of the seven representative contigs against the Xie, Mira, HOMD (Human Oral 
Microbiome Database)(43) and the HMP (Human Microbiome Project) (48) datasets. After 
identifying markers and designing degenerate primers against them, we began to test for their 
presence in a variety of samples.  
Measures against contamination. A common source of contamination in PCR 
originates from previously amplified template sequences that enter new PCR reactions. To 
prevent contamination this type of contamination, four physically separated workstations 
were developed for DNA extraction (station A1), PCR preparation (station A2), PCR 
and gel electrophoresis (station B1), and PCR cleanup (station B2). A and B specify two 
different buildings at Caltech while 1 and 2 refer to two different rooms within the same 
building. The flow of materials was from building A to B and never the vice-versa. Every 
station had its own set of lab equipment, materials, and storage space. Disposable lab coats 
(Sigma-Aldrich®) were worn and disposed of at the end of every procedure to ensure that 
DNA was not carried between stations via clothing. Facemasks (Fisher Scientific) were also 
worn at all times to prevent any oral or nasal droplets from entering reactions. Prior to the 
start of every DNA extraction, lab equipment and bench tops were cleaned using sterile 
wipes and DNA AWAY™ (Thermo Scientific), a surface decontaminant that eliminates 
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DNA and DNAses. PCR preparations and aliquoting of reagents were carried out in a PCR 
flowhood (AirClean® Systems) equipped with a UV light and laminar airflow capabilities. 
Lab equipment required for PCR preparation was designated to the PCR preparation 
flowhood. At the end of every experimental session and when introducing new equipment 
into the flowhood, all surfaces were first wiped with DNA AWAY™ solution and then 
exposed to UV radiation for 60 minutes. Prepackaged, sterile gloves were used for PCR 
preparation. To prevent sample-to-sample contamination during DNA extraction, PCR 
preparation, and PCR cleanup, gloves were frequently exchanged. Most importantly, 5 No 
Template Control (NTC) reactions accompanied every PCR run. Similarly, to test the 
presence of contaminants in extraction reagents, for every extraction experiment, 3 reactions 
were carried out without the addition of any sample. PCR using phage primers was 
performed on these extraction control reactions.  
DNA Extraction (Station A1). DNA extraction of human oral samples was done 
according to the manual from MoBio PowerBiofilm® DNA Isolation Kit. The advantage to 
using this kit for DNA extraction and purification is that it combines the use of chemical 
and mechanical (bead-beating) treatments for an increased efficiency in biofilm disruption, 
lysis, and removal of inhibitors such as humic acid. The final concentrations of DNA were 
measured using Nanodrop. The concentration range of the total extracted genomic DNA 
was typically between 5 to 50 ng/µL.  
PCR preparation (Station A2) and PCR (Station B1). Each PCR reaction 
contained 12.5 µL of PerfeCTa® qPCR SuperMix, ROX™ (Quanta Biosciences), a premix 
containing AccuStart™ Taq DNA polymerase, MgCl2, dNTPs, and ROX reference dye for 
qPCR applications. Additionally, each reaction contained 10.5 µL of RT-PCR Grade Water 
(Ambion®) which is free of nucleic acids and nucleases, 1 µL of extracted DNA at 1 ng/µL, 
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0.5 µL of forward and 0.5 µL of reverse primers, each at 50 ng/µL (synthesized by IDT). A 
higher than recommended primer concentration was used because the phage primers used 
are 32-64 fold degenerate. The thermocycling protocol was made according to PerfeCTa 
qPCR SuperMix recommendations: 1) a 10-minute activation of AccuStart™ Taq DNA 
polymerase at 95°C, 2) 10 seconds of DNA denaturation at 95°C, 3) 20 seconds of annealing 
at 60°C, and 4) 30 seconds of extension at 72°C, 40 cycles repeating steps 2 to 4, followed by 
5 minutes of final extension at 72°C.  
Gel electrophoresis (Station B1) and PCR cleanup (Station B2). Phage PCR 
products were visualized using 2% agarose in TAE buffer. After gels were cast, 5 µL of each 
PCR product was mixed with 1 µL of 6X loading dye and loaded into a well. 5 µL of 100 
base-pair ladder was used, and the gel electrophoresis instrument was set to run for 30 
minutes at 100V. Phage PCR positive hits were purified using the QIAquick PCR 
Purification Kit (QIAGEN). 20µL of PCR products were used and purified according to the 
QIAquick PCR Purification manual. 
Illumina sequencing. Upon PCR cleanup, double stranded DNA concentration in 
each sample was measured using Qubit instrument. Qubit measurements were performed in 
Building C due to practical considerations rather than a necessary treatment for preventing 
contamination. Samples were combined into one reaction (~2 µg dsDNA) and submitted to 
GENEWIZ, Inc for library preparation and MiSeq 2x300bp Paired-End sequencing.   
DNA barcodes for multiplexed sequencing. To enable multiplexing, unique 
DNA barcodes (Table 1) were appended onto the forward primer sequences (Table 3) used 
to amplify each phage marker. These barcoded primer sequences were synthesized by IDT. 
Using this scheme, ~100 samples were submitted per MiSeq sequencing run (Table 1) and 
  
V-37 
by matching the barcode sequence to the sample ID, information about who and where the 
sample came from was accessible. More specifically, Hamady error-correcting 8-letter 
barcodes (65) were used. Hamady DNA barcodes are an example of Hamming code wherein 
the addition of parity bits allow for detection and correction of errors within the barcode 
sequence. In the case of Hamady barcodes, up to 2 errors in the barcode sequence can be 
detected and one error can be corrected.  
Error-detecting barcode design. Because we were unable to use Hamady barcodes 
to amplify PCA2 marker sequences under various PCR conditions, 4-letter error-detecting 
DNA barcodes were designed. The general scheme used is that the last letter of the barcode 
sequence (Table 4) serves as a parity base and contains information about the preceding 
letters, enabling a check on single-base sequencing errors occurring in the barcode sequence. 
More specifically, in designing four-letter barcodes the first three letters in the barcode 
sequence together are set to represent a number between 1 and 64 written in base 4, and 
converted to DNA bases using the following assignments: 0 = A, 1 = C, 2 = G, and 3 = T. 
For example, to generate a barcode representing the number 60, we re-write 60 as 3 × 42 + 3 ×!41 + 0 × 40, and convert the coefficients to DNA bases. As such, 60 can be coded as 
TTA. To enable error detection, the fourth letter in a barcode represents !"#$$%!%#&'(!! "#!4, which is the remainder of the sum of the coefficients divided by 4. 
The full sequence of barcode #60 is TTAG. Although using 4 letters and 3 positions 64 
barcode sequences are possible, certain barcode sequences were excluded due to repetition 
of bases and/or high GC content, for example barcode #42 (GGGG) and barcode #41 
(GGCC). Note that barcode numbers 1 through 21, 24, 32, 33, 36, and 48, !"#$$%!%#&'(!! "#!4 result in fractions, and had more barcodes been necessary for our 
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experiments it would be simple to include additional assignments for conversion of fractions 
into DNA bases.   
Barcode verification. To verify the efficacy of all barcodes used in the experiments, 
PCR was once performed on each sample using non-barcoded primers (Table 1), and once 
again using barcoded primers. We were unable to use Hamady barcoded primers to amplify 
the PCA2 marker; therefore shorter, 4-letter error-detecting barcodes were designed and 
experimentally verified (Table 2).  
The sample collection kit and measures against sampling contamination. To 
obtain samples, we developed a sample collection kit and prepared kit contents within the 
PCR flowhood. Before and after every kit preparation session, the flowhood surfaces and 
pipettes were wiped using sterile wipes, DNA AWAY™, and 95% ethanol. At the end of 
each session the surfaces were also UV-sterilized (60 minutes). Each kit contains plastic 
tongue scrapers (Yellow CeraSpoon Safe Ear Curettes, Bionix) that were first autoclaved and 
then UV-sterilized for 60 minutes, 1.5 mL gamma-sterilized and pre-packaged collection 
tubes certified as pyrogen- RNase- DNA- and ATP-free (VWR), each containing 200 uL 
sterile 1X PBS buffer (VWR), along with pre-packaged sterile gloves (VWR). Each collection 
tube and tongue scraper pair was placed inside a sterile bag and the bags were placed in 
another bag. The next steps were performed outside of the flowhood. Each collection bag 
was put inside a Styrofoam box along with ice gel packs. Ice gel packs and Styrofoam boxes 
were not reused to prevent cross contamination between individuals in case of a spill, which 
would already be highly unlikely due to multiple layers of packaging. Upon arrival of 
samples, collection tubes were taken out of their original bags, wiped with 95% ethanol and 
DNA AWAY™ using sterile wipes and placed into a new sterile bag. Gloves were frequently 
exchanged both during this step and before proceeding to the next collection tube to 
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prevent cross contamination. In addition to standard lab attire such as gloves and lab coat, a 
facemask was worn to prevent contamination during kit preparation and sample storage.   
Subject recruitment and sample collection. We made an educational video to 
introduce a diverse audience to the fascinating world of phages, explain our study and to 
recruit volunteers. We also created an instructional video for prospective volunteers on 
subject disqualifying criteria and subject rights, and to provide a step-by-step demonstration 
of sample collection, storage, and shipment. Among other exclusion criteria, subjects could 
not have taken antibiotics for the preceding 3 months and subjects could not have active 
cavities or gum disease. Qualified subjects were sent a kit and were asked not to brush their 
teeth or tongue for a minimum of 8 hours prior to sample collection to allow for a 
substantial build up of plaque on the tongue dorsum. Put simply, subjects were instructed to 
1) wear gloves, 2) scrape their tongue (dorsal surface) several times using the tongue scraper, 
3) deposit their sample into the collection tube, 4) place the tube back into the bag, and 5) 
store the bag in their freezer along with ice gel packs prior to an over-night shipment of their 
samples. They were also instructed to report any sources of error that occurred at any step, 
and to send their samples along with their signed consent form and questionnaire. Our 
sample collection and processing protocols were approved by Caltech Institutional Review 
Board (IRB protocol 14-0430) and Institutional Biosafety Committee (IBC protocol 13-198).  
Subject recruitment and sample collection (Bik e t  a l . samples). 10 subjects 
included in this study are those included in a previous study of oral microbial diversity by Bik 
et al. (40). Briefly, samples were collected from 10 individuals by a dentist who examined 
subjects for their oral health, thereby excluding subjects with active cavities, gingivitis, or 
periodontal disease. For each of the 10 individuals, samples from 6 different oral sites were 
collected using sterile curettes and deposited separately in 1.5 mL collection tubes containing 
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PBS buffer. The 6 oral sites sampled include plaque from tongue dorsum, tongue ventral, 
buccal mucosa, hard palate, supra-gingiva, and sub-gingiva.  
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Table 1. List of non-barcoded phage primer sequences used to amplify 
markers HB1, PCA2, HA, and PCA1.  
Markers 
Forward Primer Sequence        
(5' to 3') 
Reverse Primer Sequence              
(5' to 3') 
HB1 CCGATCTGTCICARGGIGAYGA GTTACGAACTCTTTGGCRTTRTAIGGRTC 
PCA2 GTGCGGCAACWAARCARGAICA CTGATTATTTGGGTGTGCRTGWARYTCRTC 
HA CGTGATGGCTGYCTWGARTTYGAYGA CGTAAGGAGTGCTYTCRTCCARCATIGG 
PCA1 CCTTTGYTTGGCITGGTTYGARGA CAGCRACICCCCAYTCRCC 
 
 
Table 2. A list of 4-letter error-detecting barcodes designed for multiplexed 
sequencing of PCA2 marker sequences from various samples.  The barcode 
number dictates the first three letters in the barcode sequence according to 
base 4 arithmetic. The last letter in the barcode sequence is a parity letter and 
allows for detection of errors within the barcode sequence (See Error-
detecting Barcode Design). 
Barcode 
Number 
Barcode Sequence  
(5' to 3') 
63 TTTC 
62 TTGA 
61 TTCT 
60 TTAG 
59 TGTA 
58 TGGT 
57 TGCG 
56 TGAC 
55 TCTT 
54 TCGG 
53 TCCC 
52 TCAA 
51 TATG 
50 TAGC 
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Quality control steps to eliminate sequencing errors. We used Illumina MiSeq’s 
2x300bp paired-end configuration (GENEWIZ, Inc). Each sequencing run produced about 
20-25 Million paired-end reads. Paired-end reads were joined using join_paired_ends.py script 
from QIIME (Quantitative Insights Into Microbial Ecology) package, and unless noted 
otherwise scripts used in this chapter are part of QIIME (66). When a base is confirmed by 
both reads, higher Phred score is increased by up to 3 points. If paired reads had any 
mismatches across their overlapping bases, the paired reads was eliminated from any further 
analysis (QC step #1). Taking one of the sequencing runs as an example, this step reduced 
the number of paired reads from ~21Million to ~6.3Million joined reads (Figure 1), but it 
also likely reduced the probability of sequencing error in the surviving reads. For markers 
49 TACA 
47 GTTA 
45 GTCG 
44 GTAC 
43 GGTT 
40 GGAA 
39 GCTG 
37 GCCA 
35 GATC 
31 CTTT 
30 CTGG 
29 CTCC 
28 CTAA 
27 CGTG 
25 CGCA 
23 CCTC 
22 CCGA 
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HB1, PCA2, and HA the overlap between the paired reads entirely covers the marker 
sequence, hence eliminating many sequencing errors.  
Upon joining reads and eliminating those with mismatches in the region of overlap 
seqQualityFilters.py, an in-house script, was used to preform QC step #2: taking joined reads 
from QC step #1, and eliminating any sequences that have one or more bases marked by a 
Phred score below 30. At this step the number of sequences was reduced from ~6.3Million 
to ~6.0 Million, reflecting the fact that QC step #1 already ensures that the majority of 
surviving reads have high Phred scores across their bases (Figure 1). Excluded from QC step 
#2 were the first two bases in the beginning and end of each sequence, which for majority of 
reads have much lower quality scores.  
Using seqQualityFilters.py, sequences were placed in 4 different bins according to their 
primer sequences, and any sequence that did not have the correct barcode length, or the 
correct primer sequences at the expected positions, was eliminated (QC step #3). 
Additionally, nearly half of remaining sequences had to be reverse complemented so that all 
sequences were oriented in the 5’ to 3’ direction. Using the same script, primer and barcode 
sequences were removed, and barcode sequences were written to a separate file (to be used 
as input to split_libraries_fastq.py). At this point sequences that did not have the correct length 
were filtered out (QC step #3). Sequences were demultiplexd using split_libraries_fastq.py and 
reads with errors in the barcode sequence were eliminated (QC step #4).  
Phage community composition plots (“Phageprints”). After demultiplexing 
quality-controlled reads, sequences were clustered according to a specified sequence 
similarity threshold using UCLUST de novo clustering algorithm (67) used in pick_otus.py 
script. Using make_otu_table.py, OTU tables were generated. An OTU table summarizes 
counts of sequences assigned to each OTU across each sample. We refer to this per-sample 
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sequence count as the OTU size. As long as an OTU of size 1 or greater exists in at least one 
sample, it is included in the OTU table. In this way, the counts of OTUs for samples 
containing the same marker remains the same, though their size could vary widely across 
different samples. Later we will demonstrate the effects of noise filters applied to the OTU 
table. The relative abundance of each OTU within each sample was calculated via 
processOtuTable.py, another in-house script. In plotting the relative OTU abundance values for 
different samples, we arrived at complex, individual-specific patterns. We dubbed these 
phage community composition plots as “phageprints”.  
Examining the effect of OTU sequence similarity threshold on Pearson 
correlation coefficient matrices. In analyzing 16S sequences, clusters or Operational 
Taxonomic Units (OTUs) are conventionally defined at 97% sequence similarity threshold. 
To examine the effect of sequence similarity threshold for phage OTU formation, we tested 
OTU sequence similarity thresholds of 98%, 97%, 95%, 90%, and 80%. Figure 15 is a matrix 
of Pearson correlation coefficients calculated during the pairwise comparison of HB1 
community compositions using different sequence similarity thresholds for defining OTUs. 
Very similar Pearson correlation matrices are obtained as the sequence similarity threshold is 
lowered from 98% to 80%. However, because the number of cluster is reduced as we reduce 
the sequence similarity threshold, with lower sequence similarity thresholds, the chance that 
individual-specific variations are lumped into the same cluster is increased. If noise-induced 
sequence variations are effectively accounted for, higher sequence similarity thresholds for 
defining OTUs can enable a more accurate and detailed depiction of a person’s phage 
community composition. For this reason, we used a sequence similarity threshold of 98% for 
the study of different oral sites, and later we used a 100% sequence similarity threshold for 
the temporal and the global study.   
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Figure 15. Pairwise Pearson correlation coefficient values calculated for HB1 
phage community compositions as a function of A) 98%, B) 97%, C) 95%, 
D) 90%, and E) 80% sequence similarity thresholds for OTU formation. 
Sample IDs can be decoded as before: subject ID precedes oral site ID. Oral 
sites 1-6 correspond to tongue dorsum, hard palate, buccal mucosa, ventral 
tongue, supra-gingiva, and sub-gingiva respectively (e.g. 3.3 corresponds to 
subject 3 community composition derived from the buccal mucosa, and 3.5 
is subject 3 supra-gingiva community composition). The number of OTUs 
generated at 98%, 97%, 95%, 90%, and 80% sequence similarity thresholds 
are 210, 181, 172, 170, and 80, respectively.  
 
Rarefaction. One common observation when analyzing sequence diversity is that it 
is dependent on the number of sequences analyzed. Rarefaction is typically performed to 
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illustrate the minimum number of sequences needed to entirely capture sequence diversity in 
a given environment. Because both PCR and sequencing are error-prone processes, they 
contribute noise-induced sequence variation and result in an over-estimation of natural 
sequence diversity. To resolve this issue, we present a comparison of rarefaction plots in 
Figure 16 and Figure 17.  
 
Figure 16. Rarefaction plot for HB1 marker using data from 3 samples, 
belonging to subject 6 supra-gingiva (red), subject 12 buccal mucosa (purple), 
and subject 17 sub-gingiva (blue). The y-axis contains the number of OTUs 
(defined at 98% sequence similarity) that contain one or more sequences. 
The x-axis demonstrates the number of sequences analyzed per sample. 
Trend lines demonstrate a logarithmic relationship between number of 
OTUs and the number of sequences analyzed per sample. 
 
Figure 16 is a rarefaction plot of HB1 marker present in three different 
environments: subject 6 supra-gingiva (red), subject 12 buccal mucosa (purple), and subject 
17 sub-gingiva (blue). By randomly selecting x number of sequences from each environment 
and plotting the number of observed OTUs, y, at each value of x, the relationship can be 
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modeled as y=ln(x). From this plot, one might conclude that even 10,000 sequences are 
insufficient to entirely capture sequence diversity within each environments. This result 
would place significant limits on the number of samples that reads from a sequencing run 
can be divided into. It also provides no insight for identifying OTUs that are either noise-
induced or so naturally low in abundance that practically they would not be reproducible 
using current sequencing technologies. However, if we stratify OTUs based on their relative 
abundance, we arrive at a more meaningful picture.  
Figure 17 shows HB1 rarefaction plots of the same subjects as in Figure 16: subject 6 
supra-gingiva (panel A), subject 12 buccal mucosa (panel B), and subject 17 sub-gingiva 
(panel C). As in Figure 16, OTUs are defined at 98% sequence similarity threshold. In Figure 
17.A OTUs have been binned into 5 categories: Empty OTUs, which are present in other 
samples or are non-empty at higher values of x, but have zero sequences associated with 
them in this sample; below-threshold OTUs that are present in less than 0.1% of population 
x; rare OTUs which are present in 0.1-1%; common OTUs with 1%-10% presence; and 
finally, abundant OTUs which take up anywhere from 10% to 100% of reads.  
As we increase x from 500 to 10,000, the number of abundant OTUs remains 
constant. The number of common OTUs fluctuates between 6 and 7, and the number of 
rare OTUs decreases from 32 to 25. At x =1500, OTUs below 0.1% of population emerge 
and they are OTUs defined by a single sequence. As x increases previously empty OTUs 
transform into below-threshold OTUs defined by 1 to 10 sequences. However, as the 
number of below-threshold OTUs continues to increase the rare, common, and abundant 
OTU counts begin to stabilize and have nearly exact values at x=4000 as they do at 
x=10,000.  
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In Figure 17.B and C, we have combined counts of rare, common, and abundant 
OTUs and together call them above-threshold OTUs. Below-threshold OTU counts 
continue to increase as a function of x while above-threshold OTU counts have the same 
value at x=4000 as they have at x=10,000. We have limited our analysis to a maximum of 
10,000 sequences because only a few samples are represented by more than 10,000 
sequences. By rarifying the OTU table multiple times and creating an average OTU table at 
different values of x, the count of above-threshold OTUs could stabilize at even a smaller 
value of x. While it’s possible that some below-threshold OTUs are highly rare species in the 
population, they are more likely OTUs that arose as a result of sequencing and/or PCR 
errors. From this exercise we have taken away two useful parameters: the minimum number 
of sequences to analyze per sample, and the relative abundance threshold for detection, 
which we will further demonstrate in the following subsections. 
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Figure 17. Rarefaction plots of HB1 marker segmented based on OTU 
relative abundance. Samples are analyzed at rarefaction intervals ranging 
from 500 to 10,000 sequences. A) Subject 6 supra-gingiva rarefaction plot. 
OTUs that are present in other samples but have zero sequences associated 
with them in this sample are shown in light pink, below threshold OTUs 
with a relative abundance of less than 0.1% but greater than zero are in 
darker pink, Rare OTUs (0.1%-1%) are in blue, followed by Common OTUs 
(1%-10%) in green, and Abundant OTUs ( >10%) in purple. The count of 
OTUs for rare, common, and abundant OTUs are depicted. Rarefaction 
plots for B) subject 12 buccal mucosa and C) subject 17 sub-gingiva. The 
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count of Rare, Common and Abundant OTUs are summed and shown in 
yellow as above-threshold OTUs (0.1%-100% relative abundance). The 
counts of above-threshold OTUs are shown. 
 
Quantifying experimental noise. How reproducible is a phage community 
composition plot? Figure 18 summarizes the sources of noise from all experimental 
processes performed during this study. First, it’s important to capture sampling variation. 
How consistently can we capture a phage community from an individual’s oral site given that 
we are sampling different clumps of biofilm each time? Another factor that could contribute 
to sampling variation are the personal differences in the rate of biofilm mass accumulation 
on the tongue dorsum. Secondly, we need to ask whether processes of lysis and DNA 
extraction allow for the availability of the same template DNA sequences in the same relative 
abundances across different extraction runs.  
Third, we need to evaluate the OTU abundance variations that could result in PCR 
due to both errors as well as other stochastic events. For example, it’s possible that very rare 
template sequences are left out of the initial cycles of PCR and their relative abundance at 
the end of PCR is lower than their relative abundance prior to PCR. In this hypothetical 
scenario PCR could serve as a biased amplifier. PCR purification is similar to extraction and 
sampling in that it does not introduce sequence errors; however it is unlike these processes 
because after PCR billions of template copies are created and it’s unlikely that the loss of a 
fraction of templates during PCR purification will dramatically change OTU relative 
abundances. Finally, Illumina MiSeq sequencing is another error-prone process not only at 
the level of base-calling, but at the level of bridge amplification which like PCR could 
introduce errors that propagate exponentially. Refer to Figure 18 for a summary of processes 
that could result in irreproducible OTUs or variation in OTU relative abundances.  
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Figure 18. Sources of error and variation in experimental processes used in 
this study. A) Sampling of the same oral site in the same individual could 
result in collection of different microbial communities, which could 
introduce new OTUs or change relative abundance of existing OTUs. B) 
DNA extraction is not 100% efficient and the fraction of DNA extracted 
from an environment could serve as a source of variation across different 
samples.  C) PCR introduces errors that could present themselves as novel 
OTUs or cause variation in abundance of genuine OTUs. D) Sequencing also 
introduces errors both at the level of base-calling and bridge amplification. 
 
To quantify how reproducible a given phage community composition is, we obtained 
3 different samples from subject 37 tongue dorsum. We then performed DNA extraction 
and PCR separately on each sample and sent samples for sequencing (sequencing run #2). 
The logic behind this experiment was to capture a lumped measure of noise arising from 
various processes depicted in Figure 18. After performing quality control steps 1-4, 
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demultiplexing reads based on their barcode sequences, clustering reads based on 98% 
sequence similarity threshold for OTU formation, rarefying the OTU table to 4000 reads per 
sample, and calculating the relative abundances of OTUs, we measured the standard 
deviation in the relative abundance of each OTU across these three samples (Figure 19). 
Remarkably, relative abundance values across these three samples were highly consistent, 
with the majority of OTUs having standard deviations below 0.2% and the maximum 
standard deviation observed was less than 0.7% relative abundance. 
 
Figure 19. Standard deviations of OTU relative abundances calculated for all 
experimental processes. Three data points per OTU are used for standard 
deviation calculations. These three data points correspond to measurements 
of OTU relative abundances obtained for three different samples obtained 
from subject 37 tongue dorsum (HB1 marker) which underwent separate 
sampling, DNA extraction, PCR and PCR cleanup procedures. The 
maximum standard deviation observed is less than 0.007 relative abundance, 
and majority are close to 0. 
 
  Identifying non-reproducible OTUs. To identify OTUs that were non-
reproducible across the three samples from subject 37’s tongue dorsum (HB1 marker), we 
flagged OTUs that had appeared in only one or two samples out of three. We then plotted 
the histogram of non-reproducible OTUs as a function of their relative abundance (for those 
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OTUs appearing in 2 out 3 samples, the higher relative abundance value was used). The 
thresholds defining each bin, b, were selected to be the following: 0>b1≥0.00025 (OTU of 
size 1 sequence since the total number of sequences per sample is 4000), 0.00025>b2≥0.0005 
(2 sequences), 0.0005>b3≥0.00075 (3 sequences), 0.00075>b4≥0.001 (4 sequences), and 
0.001<b5 (5 or more sequences).  
Figure 20 demonstrates the number of non-reproducible OTUs drops as a function 
of OTU relative abundance, and all OTUs with more than 4 sequences (0.001 relative 
abundance) are reproducible. This result is consistent with previously established OTU noise 
threshold of 0.001 relative abundance, obtained during the rarefaction study (see 
Rarefaction). To conclude, using two different approaches and across two different 
sequencing runs, we arrived at 0.001 relative abundance as the detection threshold for 
OTUs.   
 
Figure 20. Number of non-reproducible OTUs across three samples 
obtained from subject 37 tongue dorsum (HB1 marker), presented as a 
function of OTU relative abundance. A total of 30 OTUs appear in one or 
two samples out of three, and therefore are considered non-reproducible. 21 
out of 30 OTUs are defined by a single sequence which translates into 
0.00025 relative abundance since samples are rarefied to 4000 sequences. The 
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number of non-reproducible OTUs drops as a function of OTU relative 
abundance, and all OTUs with more than 4 sequences (0.001 relative 
abundance) are reproducible across three samples. This relative abundance 
threshold for noise-induced OTUs was previously obtained using a different 
approach, different set of samples, and a different sequencing run (Figure 
17). 
 
In addition to capturing a lumped sum of noise across all experimental processes for 
subject 37 tongue dorsum sample (Figure 19,Figure 20), for samples from subjects 3, 6, 10, 
16, and 17, we performed a second set of PCR on previously extracted DNA samples, and 
submitted those samples for sequencing (Figure 21). In addition to these replicates, we 
acquired new samples from the tongue dorsum for subjects 31, 35, 37, and 38, and 
submitted these samples for the second sequencing run. In obtaining replicate phageprints, 
we were able to demonstrate that with proper quality filtration steps phageprints are highly 
reproducible even when they are generated from two separate PCR and sequencing steps 
(Figure 21).  
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Figure 21. Panel A is the Pearson correlation matrix of all HB1 phageprints. 
Each phageprint is derived from the analysis of 4000 sequences associated 
with an individual and a particular oral site. OTUs are defined at 98% 
sequence similarity and OTUs with less than or equal to 0.1% relative 
abundance across all phageprints were filtered out. Phageprints are color-
coded based on the individual they originate from. Oral sites shown to be 
positive for the HB1 marker are the tongue dorsum (TD), buccal mucosa 
(BM), supra-gingiva (SP), and sub-gingiva (SB). Phageprints that were 
acquired from sequencing run #1, are those marked as replicate #1. Panel B 
shows that to confirm reproducibility of phageprints, a second set of PCR 
was performed on previously extracted DNA from all samples included in 
sequencing run #1 and those PCR products were included in sequencing run 
#2. Phageprints derived from the second sequencing run are marked as 
replicate #2. 
 
Identifying phage marker homologs and phylogenetic tree construction. The 
most abundant sequence from each OTU was retrieved using pick_rep_set.py to serve as a 
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representative sequence. BLASTx function was used to detect the closest homolog to each 
OTU’s representative sequence from within the NCBI’s non-redundant protein database. 
The output of BLASTx for each marker is summarized in SI Table 1 and SI Table 3. These 
tables summarize the amino acid percent identity between each OTU representative and its 
closest homolog, as well as the E-value associated with the match.  
HB1 representative sequences were aligned using Geneious (68), using a gap open 
penalty of 30 and gap extension penalty of 15 and a 65% similarity cost matrix. No gaps 
were introduced. The alignment is shown in SI Figure 7. SeaView was used to create a 
PhyML maximum likelihood phylogenetic tree from the alignment. General Time Reversible 
model was used with empirical nucleotide equilibrium frequencies.  
Phage networks. OTU tables were input to createNetwork.py, an in-house script that 
creates node and edge tables. The nodes represent samples and phage OTUs, and a directed 
edge connects samples to the OTUs that they host. The weight of this connection is based 
on the relative abundance of the OTU in that sample. Gephi software (69) was used to 
visualize the resulting networks, and to obtain the degree distribution.  
Averaged phage biogeography patterns. Given 6 oral sites, there are up to 15 
pairwise interactions possible. For each possible interaction, i, the number of subjects 
positive for the interaction was divided by the total number of subjects, while still accounting 
for the missing oral samples. The shorthand for this fraction is Ei.  Moreover, the Pearson 
correlation coefficients  associated with each interaction were averaged across the subjects 
positive for the interaction (ri). The edges in SI Figure 2.B are weighted based on the product 
of Ei and ri.; however, edges with low ri (<0.35) are not shown. 
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5.5 SI 
 
SI Figure 1. Pearson correlation matrix of PCA2 phage family. Samples that 
have an asterisk are those that are used in error analysis (see Methods) and 
have been replicated experimentally at least twice.  
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SI Figure 2. Phage biogeography patterns in the human mouth. Six different 
oral sites were tested for presence of phage families HA, HB1, and PCA2. A) 
Each hexagon summarizes the community composition of a particular phage 
family across different oral sites within a given individual. Each vertex of a 
hexagon symbolizes an oral site, and the presence of a marker is signified by 
a filled-in vertex. The marker is considered present at an oral site if at least 
4000 high-quality sequences (see Methods) belonging to a terminase family 
are found at that oral site. The unfilled vertices are those samples that did not 
harbor phage markers. The missing vertices, correspond to samples that were 
unavailable and consequently were not tested for presence/absence of phage 
makers. The edges connecting different vertices represent the similarity of 
the phage community at one oral site to another. The thicker the edge, the 
more similar are the phageprints of the two connected oral sites. Here, the 
measure of similarity is the Pearson correlation value obtained by the pair-
wise comparison of phageprints from different oral sites. B) The average 
biogeography patter for each phage family is denoted. The edge weight is a 
product of f and ravg, where f represents the fraction of individuals that 
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harbor the connection and ravg is the average of Pearson correlation value for 
that connection across all individuals who harbor the connection.  
 
 
SI Figure 3. HA phage family network. Two types of nodes exist: OTU 
nodes (purple), and subject nodes. Subject nodes and edges are color-coded 
based on the individual they represent. Each directed edge connects an 
individual to a phage OTU that he/she harbors, and the edge weight is 
proportional to the relative abundance of the OTU in that individual’s oral 
community. OTU node sizes and labels are proportional to the number of 
individuals the OTU is present in. For OTU nodes, the node ID is the OTU 
Subject(nodes(
Subject(node(ID(and(color1code(
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ID, which can be matched to IDs in SI Table 3 for obtaining taxonomic 
information regarding each OTU’s representative sequence. See SI Figure 4 
to see a similar network that shows OTUs present at different oral sites.  
 
 
SI Figure 4. HA phage-host network (expanded version of SI Figure 3, 
showing each oral site). Purple nodes are the OTU nodes and all other nodes 
represent samples. Sample nodes and edges are color-coded based on the 
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individual they originate from. Subject node color code, ID, and the oral sites 
are displayed above sample nodes. Each edge connects an OTU a sample it 
exists in, and the edge weight is proportional to the relative abundance of the 
OTU in that sample. Node IDs are displayed. For OTU nodes, the node ID 
is the OTU ID which can be matched to IDs in SI Table 3 for identifying 
taxonomic information regarding each OTU. For sample nodes, the nodes 
IDs are simply the subjects’ IDs.  
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SI Figure 5. HB1 phage family network (expanded version of Figure 7). 
Purple nodes are the OTU nodes and all other nodes represent samples. 
Sample nodes and edges are color-coded based on the individual they 
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originate from. The oral site associated with each sample is abbreviated next 
to the sample’s node. Each edge connects an OTU a sample it exists in, and 
the edge weight is proportional to the relative abundance of the OTU in that 
sample. Node IDs are displayed. For OTU nodes, the node ID is the OTU 
ID which can be matched to IDs in SI Table 2 for identifying taxonomic 
information regarding each OTU. For sample nodes, the nodes IDs are 
simply the subjects’ IDs.  
 
 
SI Table 1. Closest homolog to each OTU’s representative sequence (HB1 
phage family). Each OTU’s representative sequence was used as a query for 
NCBI’s BLASTx homology search against the non-redundant protein 
database. The table summarizes the E-value and the percent amino acid 
identity across the query sequence and the closest homolog, as well as the 
closest homolog’s name, sequence ID, and taxon ID.  The taxon ID is color 
coded, and the taxonomic classification corresponding to each taxon ID can 
be retrieved from the following table. Note with the exception of a few 
“putative uncharacterized” homolog names that most are identified as 
terminases or TerLs (terminase large subunits). 
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Query&
Sequence&
ID&(OTU&
ID)
Percent&
Identity
E&
value Closest&Homolog
Closest&Homolog&
Sequence&ID
Closest&
Homolog&
Taxon&ID
0 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
1 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
10 67.9 3.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
103 69.14 5.00E(30 terminase.[[Clostridium].scindens] gi|639772655|ref|WP_024738760.1| 29347
104 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
106 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
109 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
11 72.84 1.00E(34 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
112 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
117 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
118 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
12 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
122 70.37 2.00E(19 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
123 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
128 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
13 70.37 6.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
132 70.37 4.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
134 67.9 3.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
14 67.9 3.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
140 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
142 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
149 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
15 71.6 5.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
161 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
162 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
164 72.84 2.00E(32 TerL.[Rhodococcus.phage.ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
165 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
166 71.6 5.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
17 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
170 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
176 71.6 3.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
178 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
18 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
183 66.67 7.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
184 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
189 71.6 4.00E(33 TerL.[Rhodococcus.phage.ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
19 72.84 1.00E(34 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
195 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
196 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
197 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
2 66.67 7.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
202 67.9 3.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
203 65.43 2.00E(28 TerL.[Rhodococcus.phage.ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
206 70.37 2.00E(32 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
207 71.6 5.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
208 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
21 67.9 3.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
210 71.6 2.00E(31 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
213 69.14 2.00E(29 TerL.[Rhodococcus.phage.ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
216 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
218 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
22 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
220 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
221 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
222 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
225 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
227 66.67 7.00E(30 terminase.[[Clostridium].symbiosum] gi|489596073|ref|WP_003500516.1| 1512
229 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
231 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
233 71.6 2.00E(33 TerL.[Rhodococcus.phage.ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
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236 70.37 2.00E(32 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
237 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
238 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
24 71.6 5.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
241 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
242 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
245 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
249 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
25 71.6 3.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
250 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
255 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
256 72.84 4.00E(34 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
257 66.67 7.00E(30 terminase-[[Clostridium]-symbiosum] gi|489596073|ref|WP_003500516.1| 1512
259 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
26 71.6 5.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
260 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
261 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
262 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
264 71.6 3.00E(32 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
265 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
27 62.96 2.00E(26 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
272 70.37 3.00E(32 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
273 67.9 2.00E(30 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
274 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
29 74.07 2.00E(35 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
3 67.9 3.00E(29
terminase-[Clostridiales-bacterium-VE202(
03] gi|639707411|ref|WP_024723669.1| 1232439
30 64.2 2.00E(28
putative-uncharacterized-protein-
[Ruminococcus-sp.-CAG:17] gi|547240587|ref|WP_021976510.1| 1262951
32 67.9 3.00E(30 terminase-[[Clostridium]-symbiosum] gi|489596073|ref|WP_003500516.1| 1512
33 67.9 3.00E(31 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
34 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
36 76.54 2.00E(35 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
37 67.9 3.00E(30 terminase-[[Clostridium]-symbiosum] gi|489596073|ref|WP_003500516.1| 1512
38 66.67 2.00E(29 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
4 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
40 66.67 3.00E(32
putative-uncharacterized-protein-
[Ruminococcus-sp.-CAG:17] gi|547240587|ref|WP_021976510.1| 1262951
42 64.2 3.00E(26 terminase-[[Clostridium]-symbiosum] gi|489596073|ref|WP_003500516.1| 1512
44 66.67 5.00E(19 terminase-[[Ruminococcus]-torques] gi|490985259|ref|WP_004846995.1| 33039
46 67.9 3.00E(30 terminase-[[Clostridium]-symbiosum] gi|489596073|ref|WP_003500516.1| 1512
48 71.6 9.00E(34 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
5 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
50 86.42 3.00E(44 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
51 67.9 3.00E(30 terminase-[[Clostridium]-symbiosum] gi|489596073|ref|WP_003500516.1| 1512
54 65.43 6.00E(31 terminase-[[Clostridium]-symbiosum] gi|489596073|ref|WP_003500516.1| 1512
59 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
6 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
60 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
62 69.14 2.00E(30 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
67 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
68 74.07 1.00E(34 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
7 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
71 70.37 2.00E(31 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
72 62.96 4.00E(27 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
75 70.37 8.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
77 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
8 56.79 9.00E(26 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
80 69.14 3.00E(31 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
81 74.07 7.00E(33
putative-uncharacterized-protein-
[Ruminococcus-sp.-CAG:17] gi|547240587|ref|WP_021976510.1| 1262951
82 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
86 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
87 67.9 1.00E(27 terminase-[[Clostridium]-hathewayi] gi|493833739|ref|WP_006781000.1| 154046
89 74.07 1.00E(34 TerL-[Rhodococcus-phage-ReqiPoco6] gi|593774729|ref|YP_009012597.1| 691964
9 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
90 71.6 2.00E(33 TerL-[Rhodococcus-phage-ReqiPepy6] gi|593779801|ref|YP_009017628.1| 691965
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SI Table 2. Taxonomic classification of closest homologs (HB1 phage 
family). Majority of OTUs (86 out of 123) have the closest match to 
ReqiPoco6 terminase large subunit, whereas 15 OTUs have closest homologs 
belonging to ReqiPepy6.  
 
 
SI Table 3. Closest homolog to each OTU’s representative sequence (HA 
phage family). Each OTU’s representative sequence was used as a query for 
NCBI’s BLASTx homology search against the non-redundant protein 
database. The table summarizes the E-value and the percent amino acid 
identity across the query sequence and the closest homolog, as well as the 
closest homolog’s name, sequence ID, and taxon ID.  The taxon ID is color 
coded, and the taxonomic classification corresponding to each taxon ID can 
be retrieved from the following table. Note with the exception of a few 
“putative uncharacterized” homolog names that most are identified as 
terminases or TerLs (terminase large subunits). 
Closest'
Homolog'
Taxon'ID
Kingdom Phylum Class Order Family Genus Species
1262951 Bacteria Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus
Ruminococcus7
sp.7CAG:17
691964 Viruses
dsDNA7viruses,7
no7RNA7stage Caudovirales Siphoviridae
unclassified7
Siphoviridae
Rhodococcus7
phage7 ReqiPoco6
691965 Viruses
dsDNA7viruses,7
no7RNA7stage Caudovirales Siphoviridae
unclassified7
Siphoviridae
Rhodococcus7
phage7 ReqiPepy6
1512 Bacteria Firmicutes Clostridia Clostridiales Lachnospiraceae Lachnoclostridium
Clostridium7
symbiosum7
29347 Bacteria Firmicutes Clostridia Clostridiales Lachnospiraceae Lachnoclostridium
Clostridium7
scindens7
33039 Bacteria Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia
Ruminococcus7
torques7
1232439 Bacteria Firmicutes Clostridia Clostridiales
unclassified7
Clostridiales
unclassified7
Clostridiales
Clostridiales7
bacterium7VE202P
03
154046 Bacteria Firmicutes Clostridia Clostridiales Lachnospiraceae Lachnoclostridium
Clostridium7
hathewayi
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Query&
Sequence&ID&
(OTU&ID)
Percent&
Identity E&value Closest&Homolog
Closest&Homolog&
Sequence&ID
Closest&
Homolog&
Taxon&ID
0 97.56 4.00E)49 hypothetical4protein4[Streptococcus4sp.4F0442] gi|497418421|ref|WP_009732619.1| 999425
1 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
10 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
100 98.78 4.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
101 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
102 100 2.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
103 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
104 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
106 100 2.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
107 100 2.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
108 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
109 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
11 98.78 1.00E)48 terminase4[Streptococcus4oralis] gi|446545997|ref|WP_000623343.1| 1303
110 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
111 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
112 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
113 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
114 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
117 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
118 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
119 98.78 3.00E)49 terminase4[Streptococcus4oralis] gi|446545997|ref|WP_000623343.1| 1303
12 100 2.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
120 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
121 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
122 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
123 98.78 3.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
125 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
126 98.78 3.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
127 98.78 3.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
128 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
129 98.78 1.00E)48 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
13 98.78 1.00E)49 hypothetical4protein4[Streptococcus4sp.4F0442] gi|497418421|ref|WP_009732619.1| 999425
130 98.78 2.00E)49 terminase4[Streptococcus4oralis] gi|446545997|ref|WP_000623343.1| 1303
131 98.78 6.00E)48 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
132 98.78 1.00E)48 terminase4[Streptococcus4oralis] gi|446545997|ref|WP_000623343.1| 1303
133 98.78 7.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
134 98.78 6.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
135 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
136 98.78 5.00E)49 terminase4[Streptococcus4oralis] gi|446545997|ref|WP_000623343.1| 1303
137 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
138 98.78 3.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
139 98.78 1.00E)48 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
140 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
141 98.78 1.00E)48 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
142 97.56 4.00E)48 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
143 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
145 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
146 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
147 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
148 98.78 2.00E)48 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
15 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
150 98.78 9.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
151 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
152 98.78 3.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
153 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
154 97.56 1.00E)48 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
155 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
156 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
157 98.78 3.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
158 97.56 1.00E)48 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
159 98.78 9.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
16 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
160 98.78 4.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
161 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
162 98.78 3.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
164 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
165 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
166 97.56 1.00E)48 terminase4[Streptococcus4oralis] gi|446545997|ref|WP_000623343.1| 1303
167 100 2.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
168 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
169 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
17 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
170 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
171 98.78 3.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
172 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
173 100 2.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
174 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
175 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
176 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
177 97.56 1.00E)48 terminase4[Streptococcus4oralis] gi|446545997|ref|WP_000623343.1| 1303
178 98.78 4.00E)49 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
179 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
18 100 2.00E)49 terminase4[Streptococcus4infantis] gi|493136448|ref|WP_006154887.1| 68892
180 100 1.00E)49 terminase4[Streptococcus4pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
181 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
182 100 9.00E)50 terminase4[Streptococcus4sp.4SR1] gi|726981126|ref|WP_033585808.1| 1161416
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183 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
184 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
185 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
186 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
19 98.78 3.00E'49 terminase2[Streptococcus2parasanguinis] gi|671602035|ref|WP_031575397.1| 1318
2 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
20 96.34 2.00E'48 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
21 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
22 91.46 8.00E'46 hypothetical2protein2[Streptococcus2sp.2F0442] gi|497418421|ref|WP_009732619.1| 999425
23 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
24 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
25 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
26 98.78 3.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
27 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
28 98.78 7.00E'50 terminase2[Streptococcus2parasanguinis] gi|671602035|ref|WP_031575397.1| 1318
29 98.78 7.00E'49 terminase2[Streptococcus2infantis] gi|493136448|ref|WP_006154887.1| 68892
3 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
30 100 2.00E'49 terminase2[Streptococcus2infantis] gi|493136448|ref|WP_006154887.1| 68892
31 98.78 6.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
32 98.78 4.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
33 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
34 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
35 98.78 1.00E'49 hypothetical2protein2[Streptococcus2sp.2F0442] gi|497418421|ref|WP_009732619.1| 999425
36 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|565851306|ref|WP_023933954.1| 257758
37 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
38 98.78 7.00E'50 terminase2[Streptococcus2parasanguinis] gi|671602035|ref|WP_031575397.1| 1318
39 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
4 98.78 4.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
40 98.78 2.00E'49 hypothetical2protein2[Streptococcus2sp.2F0442] gi|497418421|ref|WP_009732619.1| 999425
42 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
43 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
44 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
45 98.78 9.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
47 98.78 7.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
48 98.78 3.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
49 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
5 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
50 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
51 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
52 98.78 3.00E'49 terminase2[Streptococcus2oralis] gi|446545997|ref|WP_000623343.1| 1303
53 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
54 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
56 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
57 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
59 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
6 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
60 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
61 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
62 98.78 4.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
63 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
64 98.78 3.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
65 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
66 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
68 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
69 98.78 4.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
7 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
71 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
72 100 1.00E'49 putative2phage2terminase,2large2subunit2[Streptococcus2tigurinus] gi|494783687|ref|WP_007519095.1| 1077464
73 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
74 98.78 3.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
76 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
77 98.78 3.00E'49 terminase2[Streptococcus2oralis] gi|446545997|ref|WP_000623343.1| 1303
78 98.78 3.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
79 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
8 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
80 98.78 3.00E'49 terminase2[Streptococcus2oralis] gi|446545997|ref|WP_000623343.1| 1303
82 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
83 97.56 1.00E'48 terminase2[Streptococcus2oralis] gi|446545997|ref|WP_000623343.1| 1303
84 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
85 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
86 95.12 3.00E'48 terminase2[Streptococcus2oralis] gi|446545997|ref|WP_000623343.1| 1303
87 98.78 3.00E'49 terminase2[Streptococcus2oralis] gi|446545997|ref|WP_000623343.1| 1303
88 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
89 98.78 2.00E'48 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
9 98.78 3.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
90 98.78 4.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
93 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
95 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
96 98.78 4.00E'49 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
97 100 1.00E'49 terminase2[Streptococcus2pseudopneumoniae] gi|446545996|ref|WP_000623342.1| 257758
98 100 9.00E'50 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
99 97.56 1.00E'48 terminase2[Streptococcus2sp.2SR1] gi|726981126|ref|WP_033585808.1| 1161416
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SI Table 4. Taxonomic classification of closest homologs to each OTU’s 
representative sequence (HA phage family).   
 
 
SI Table 5. Closest homolog to each OTU’s representative sequence (PCA2 
phage family). Each OTU’s representative sequence was used as a query for 
NCBI’s BLASTx homology search against the non-redundant protein 
database. The table summarizes the E-value and the percent amino acid 
identity across the query sequence and the closest homolog, as well as the 
closest homolog’s name, sequence ID, and taxon ID.  The taxon ID is color 
coded, and the taxonomic classification corresponding to each taxon ID can 
be retrieved from the following table. Note with the exception of a few 
“putative uncharacterized” homolog names, most are identified as terminases 
or TerLs (terminase large subunits). 
Closest'
Homolog'
Taxon'ID
Kingdom Phylum Class Order Family Genus Species
1318 Bacteria +Firmicutes +Bacilli +Lactobacillales +Streptococcaceae +Streptococcus+ +Streptococcus+parasanguinis
1077464 Bacteria +Firmicutes +Bacilli +Lactobacillales +Streptococcaceae +Streptococcus+ +Streptococcus+tigurinus
257758 Bacteria +Firmicutes +Bacilli +Lactobacillales +Streptococcaceae +Streptococcus+ +Streptococcus+pseudopneumoniae
999425 Bacteria +Firmicutes +Bacilli +Lactobacillales +Streptococcaceae +Streptococcus+ +Streptococcus+sp.+F0442
1161416 Bacteria +Firmicutes +Bacilli +Lactobacillales +Streptococcaceae +Streptococcus+ +Streptococcus+sp.+SR1
1303 Bacteria +Firmicutes +Bacilli +Lactobacillales +Streptococcaceae +Streptococcus+ +Streptococcus+oralis
68892 Bacteria +Firmicutes +Bacilli +Lactobacillales +Streptococcaceae +Streptococcus +Streptococcus+infantis
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Query&
Sequence&
ID&(OTU&
ID)
Percent&
Identity
E&
value Closest&Homolog
Closest&Homolog&
Sequence&ID
Closest&
Homolog&
Taxon&ID
0 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
10 90 2.00E&28 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
100 76.27 4.00E&21 terminase0[Peptostreptococcaceae0bacterium0CM2] gi|497213446|ref|WP_009527708.1| 796939
101 98.33 1.00E&30 terminase0[Fusobacterium0nucleatum] gi|495968206|ref|WP_008692785.1| 851
103 98.33 2.00E&30 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
104 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
107 98.33 1.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
108 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
109 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
11 93.33 3.00E&30 terminase0[Fusobacterium0periodonticum] gi|496096975|ref|WP_008821482.1| 860
110 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
111 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
112 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
113 98.33 6.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
115 73.33 4.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
116 73.33 5.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
117 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
12 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
120 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
123 83.33 6.00E&25 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
124 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
126 98.33 1.00E&30 terminase0[Fusobacterium0nucleatum] gi|495968206|ref|WP_008692785.1| 851
127 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
128 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
129 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
13 35.59 4.00E&04 terminase0[Bacillus0bogoriensis] gi|651939129|ref|WP_026673624.1| 246272
132 98.33 1.00E&30 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
135 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
136 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
137 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
138 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
139 96.67 4.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
14 96.67 5.00E&30 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
140 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
141 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
142 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
143 91.67 1.00E&29 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
144 98.33 4.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
146 98.33 2.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
147 98.33 6.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
149 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
15 73.33 2.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
150 98.33 2.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
151 98.33 3.00E&31 terminase0[Fusobacterium0periodonticum] gi|496096975|ref|WP_008821482.1| 860
152 98.33 1.00E&30 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
153 98.33 2.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
154 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
155 98.33 6.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
156 98.33 5.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
16 98.33 1.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
2 91.67 1.00E&29 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
21 73.33 7.00E&21 terminase0[Fusobacterium0nucleatum] gi|495968206|ref|WP_008692785.1| 851
22 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
23 73.33 5.00E&21 terminase0[Fusobacterium0nucleatum] gi|495968206|ref|WP_008692785.1| 851
24 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
25 98.33 4.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
26 98.33 1.00E&30 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
27 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
29 98.33 2.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
3 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
32 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
33 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
34 98.33 4.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
36 96.67 1.00E&29 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
4 96.67 1.00E&30 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
40 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
41 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
45 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
47 73.33 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
5 75 1.00E&21 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
50 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
51 98.33 2.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
54 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
56 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
60 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
62 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
63 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
64 93.33 3.00E&29 terminase0[Fusobacterium0periodonticum] gi|496096975|ref|WP_008821482.1| 860
65 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
66 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
67 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
  
V-71 
 
 
 
SI Table 6. Taxonomic classification of closest homologs to each OTU’s 
representative sequence (PCA2 phage family).   
 
 
 
70 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
72 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
73 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
75 96.67 2.00E&30 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
77 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
78 90 5.00E&29 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
79 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
8 95 5.00E&30 terminase0[Fusobacterium0periodonticum] gi|496096975|ref|WP_008821482.1| 860
80 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
81 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
82 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
83 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
84 98.33 1.00E&30 terminase0[Fusobacterium0nucleatum] gi|495968206|ref|WP_008692785.1| 851
86 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
89 90 5.00E&29 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
90 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
91 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
92 98.33 8.00E&31 terminase0[Fusobacterium0nucleatum] gi|495968206|ref|WP_008692785.1| 851
93 96.67 9.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
94 96.67 4.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
95 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
96 100 7.00E&32 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
97 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
99 98.33 3.00E&31 putative0phage0terminase0large0subunit0[Fusobacterium0sp.0CAG:649] gi|547450305|ref|WP_022069933.1| 1262900
Closest'
Homolog'
Taxon'ID
Kingdom Phylum Class Order Family Genus Species
860 Bacteria Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium gonidiaformans
851 Bacteria Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium Fusobacterium8nucleatum
796939 Bacteria Firmicutes Clostridia Clostridiales Peptostreptococcaceae
unclassified8
Peptostreptococcaceae
unclassified8
Peptostreptococcaceae8
(CM2)
246272 Bacteria Firmicutes Bacilli Bacillales Bacillaceae Bacillus
Bacillus8bogoriensis8(ATCC8
BAAF922)
1262900 Bacteria Fusobacteria Fusobacteriia Fusobacteriales Fusobacteriaceae Fusobacterium Fusobacterium8sp.8CAG:649
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SI Figure 6. Percentage of HB1, PCA2 and HA phage family OTUs 
belonging to each taxonomic group identified in SI Figure 4, SI Figure 5, and 
SI Table 3.  
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SI Figure 7. The nucleotide alignment of HB1 phage family OTU 
representative sequences. Sequences were aligned using Geneious (68). No 
gaps were introduced. Each base is color-coded according to its relative 
abundance within a column in the alignment. Conserved bases are black and 
highly variable sites are denoted in white.
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